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Abstract
PSD-95 is a synaptic adaptor molecule that binds a wide range of proteins, including
transmembrane receptors and channels, signalling molecules and adhesion proteins to form
a large multiprotein complex. PSD-95 has been implicated in a number of NMDA receptor
dependent processes including excitotoxicity, spinal hyperalgesia and learning and memory,
and our understanding of these processes has been advanced by the generation of a PSD-95
mutant mouse. However, this conventional knockout mutation did not allow spatial or
temporal control over gene inactivation, properties that would enable better dissection of
PSD-95's role in behavioural responses such as learning and anaesthesia. The aim of this
thesis was therefore to characterise the PSD-95 locus and generate a conditional allele of
PSD-95 such that the gene could be deleted in specific brain regions, ideally with temporal
control.
Murine PSD-95 consists of 23 exons spanning 27kb of genomic sequence, with similar
organisation and identical intron-exon boundaries to the human homologue, DLG4.
Additionally, a novel mouse splice variant and an alternative transcriptional start site were
identified, indicating a greater potential variety in PSD-95 protein structure. The generation
of a conditional allele, using Cre-loxP technology is also described, including generation of
the targeting construct and embryonic stem cell targeting.
The volatile anaesthetic halothane has been reported to bind PSD-95. To explore the role of
PSD-95 in anaesthesia, the halothane sensitivity of PSD-95 mutant mice was tested using a
behavioural test. Halothane dose response curves generated for PSD-95 mutants and wild
type littermates demonstrated a reproducible increase in sensitivity to halothane in PSD-95
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The functioning of the brain requires the electrical activity of neurons and the chemical
transmission (called neurotransmission) of information between neurons. Neurons are
bipolar in structure, forming dendritic and axonal processes that receive and transmit
information respectively. The branched structure of dendrites and axons enables
neurons to form numerous connections such that a single neuron can receive
information from many thousands of others. Neurons are able to integrate and modulate
this large input of information, and the connections between neurons may be important
sites for such modulation.
The connections between neurons are called synapses and the structure of a synapse is
shown in the electron micrograph and simple schematic in figure 1.1. Vesicles
containing neurotransmitters are clustered at the presynaptic active site and electrical
activity in the presynaptic neuron stimulates the release of neurotransmitter from these
vesicles. In close apposition to the presynaptic active site is the postsynaptic
membrane, where neurotransmitter receptors are clustered. Release of neurotransmitter
into the synapse will activate the postsynaptic receptors, transmitting information to the
postsynaptic cell. The short distance between neurons at synapses and the juxtaposition
of release and receptive sites allows the very rapid transmission of information between
neurons that is essential for brain function.
In addition to the clustering of neurotransmitter receptors at synapses, many
cytoplasmic proteins are also enriched at these sites and some, such as postsynaptic
density protein 95 (PSD-95), are directly associated with neurotransmitter receptors
(Kornau et al. 1995). PSD-95 is important in modulating the strength of signal
transmitted to the postsynaptic cell and in learning and memory (Migaud et al. 1998).












Figure 1.1 Structure of excitatory synapses. Electron micrograph of an
excitatory synapse showing synaptic vesicles (SV) clustered at the presynaptic
terminal and the postsynaptic density (PSD) just below the postsynaptic membrane.
Picture adapted from Cowan et al.,2001Schematic representation of an
excitatory synapse showing postsynaptic NMDA and AMPA receptors associated
with some of their known binding partners: CaMKIl, PSD-95 or SAP102 can bind
NMDA receptors. GRIP and stargazin interact with AMPA receptors, stargazin also
being capable of binding SAP102 or PSD-95. Adaptor proteins such as GRIP,
SAP102 and PSD-95 are capable of multiple interactions, as shown by PSD-95
binding nNOS, guanylyl cyclase (GC) and AKAP. AKAP in turn can interact with
PKA. It should be noted that this depiction of interactions is far from exhaustive.
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While it is clear that neurotransmitters activate postsynaptic receptors, the complex
molecular events triggered by receptor activation are less well understood. The
cytoplasmic proteins associated with synapses are therefore of great interest. The
synapse-associated cytoplasmic proteins form an organised network beneath the
postsynaptic membrane, interacting with surface receptors, ion channels and adhesion
molecules as well as cytoplasmic adaptor proteins, signalling molecules and cytoskeletal
components (Kennedy 1997; Garner et al. 2000). The density of the clustered
postsynaptic proteins is such that it appears as a dark strip along the postsynaptic
membrane in the electron micrograph and is termed the postsynaptic density (PSD; Fig.
1.1). The PSD was first observed at excitatory synapses by Palay and Gray (Palay 1958;
Gray 1959), however the constituents of the PSD were to remain a matter of conjecture
until a method for its purification by subcellular fractionation was developed (Cotman et
al. 1974; Cohen et al. 1977).
To better understand the molecular composition and function of the PSD, Cotman and
colleagues identified a 95 KDa antigen in the PSD, termed PSD-95 (Nieto Sampedro et
al. 1981). The PSD-95 antibodies also recognised a 95 KDa antigen in synaptic junction
preparations from numerous other species from sharks to mammals (Nieto Sampedro et
al. 1982), suggesting an important, conserved role for PSD-95 at the synapse. This was
further supported by evidence that PSD-95, in addition to the PSD, was lost from
deafferented synapses (Nieto Sampedro et al. 1982).
In 1992, rat cDNA encoding a protein with the same electrophoretic mobility as PSD-95
was independently cloned by two groups and referred to as PSD-95 and SAP90
respectively (Cho et al. 1992; Kistner et al. 1993). PSD-95/SAP90 was found to be
homologous to the product of a Drosophila tumour suppressor gene, dig (Woods and
Bryant 1991), a protein present at epithelial septate junctions and neuromuscular
synaptic junctions (NMJ) (Woods and Bryant 1991; Lahey et al. 1994). The
conservation of this gene between fly and rat allowed some functions for PSD-
95/SAP90 to be inferred from studies of the neuronal phenotype of dig mutant flies.
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1.1 Drosophila Discs large (DLG)
The Drosophila dig locus was first identified in 1972 as lethal(l)discs large-1, a
recessive oncogenic mutation (Stewart et al. 1972) and subsequently cloned in 1989
(Woods and Bryant 1989). Mutation of dig produced neoplastic growth of the imaginal
discs and abnormal development of septate and synaptic junctions (Woods and Bryant
1991; Lahey et al. 1994; Budnik et al. 1996; Woods et al. 1996). Comparisons between
Drosophila DLG (Woods and Bryant 1991) and the mammalian proteins PSD-95 and
zona occludens-1 (ZO 1), associated with neuronal synaptic junctions and tight
junctions respectively (Cho et al. 1992; Kistner et al. 1993; Willott et al. 1993),
identified three repeated domains in their N-terminal sequence, termed PDZ (PSD-95,
DLG, ZO-1) domains. DLG, ZO-1 and PSD-95 also all contained an SH3 domain and
an enzymatically inactive guanylate kinase (GK) homology domain (Kistner et al. 1995;
Kuhlendahl et al. 1998), and were categorised as a new protein family: the membrane
associated guanylate kinases (MAGUKs).
Compared to other MAGUKs, DLG contains an extended linker sequence between the
SH3 and GK domains, termed the HOOK domain. Expression of deletion constructs in
Drosophila indicated that correct localisation of DLG requires the presence of the
HOOK and GK domains in addition to either PDZ 1 or 2 (Hough et al. 1997; Thomas et
al. 2000). However, DLG localisation only required the GK domain in the absence of
endogenous DLG (Thomas et al. 2000), suggesting wild type DLG can traffic GK-
deleted DLG to the NMJ through direct or indirect association. Due to the known role
of calcium-calmodulin dependent kinase II (CaMKH) in the regulation of Drosophila
synaptic development (Wang et al. 1994) and behavioural plasticity (Griffith et al.
1993), studies were performed to determine the effect of CaMKII on DLG localisation.
Expression of a constitutively active CaMKII mutant (T287D) reduced DLG staining at
NMJ synapses while expression of a CaMKII inhibitory peptide enhanced DLG
localisation to synaptic boutons (Koh et al. 1999).
DLG is required for correct localisation of the Shaker potassium channel and the cell
adhesion molecule FASH to the NMJ synapse (Thomas et al. 1997), both of which DLG
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binds (Tejedor et al. 1997; Thomas et al. 1997; Zito et al. 1997). NMJ synaptic
development is regulated by the amount of FASH at the synapse. In th&fase86 and fase76
hypomorphs, synaptic FASH is respectively -50% and -10% that of wild type animals
yet the number of synaptic boutons are increased and decreased respectively (Schuster et
al. 1996). In CaMKH T287D mutant flies, the induced DLG relocation also results in
dispersion of FASH from the synapse (Koh et al. 1999). Combined these data suggest
that regulation of FASH levels at synaptic boutons via CaMKH mediated DLG dispersal
may be one mechanism for the action of CaMKII in Drosophila synaptic plasticity.
1.2 Mammalian Neuronal MAGUKs
In mammals, gene duplication has distributed the roles of DLG across a large number of
MAGUKs. Located at tight junctions, thought to be the mammalian equivalent of the
Drosophila septate junction, are zona occludens-1, -2 and -3 (Stevenson et al. 1986;
Jesaitis and Goodenough 1994; Haskins et al. 1998), while in the central nervous system
(CNS) four related MAGUKs were identified: synapse associated protein 97 KDa
(SAP97; Muller et al. 1995)/ human discs large (hDLG; Lue et al. 1994); synapse
associated protein 102 KDa (SAP102; Muller et al. 1996)/neuronal and endocrine dig
(NE-dlg; Makino et al. 1997); channel-associated protein of synapses-110 KDa
(chapsyn-110; Kim et al. 1996)/postsynaptic density protein 93 KDa (PSD-93; Brenman
et al. 1996a) and postsynaptic density protein 95 KDa (PSD-95; Cho et al.
1992)/synapse associated protein 90KDa (SAP90; Kistner et al. 1993). For simplicity,
these proteins will be referred to as SAP97, SAP102, chapsyn-110 and PSD-95
respectively.
The PSD-95, SAP102, chapsyn-110 and SAP97 have been shown to bind a wide range
of important synaptic proteins including the NR2 subunits of the N-methyl-D-aspartate
(NMDA) receptor (Komau et al. 1995; Muller et al. 1996; Niethammer et al. 1996),
neuronal nitric oxide synthase (nNOS; Brenman et al. 1996a; Brenman et al. 1996b) and
cytoskeletal proteins such as protein 4.1 (Lue et al. 1994) and MAPIA (Brenman et al.
1998). They form multifunctional complexes that can influence processes as diverse as
synaptic plasticity (Migaud et al. 1998) and cell cycle progression (Ishidate et al. 2000).
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Analyses of the tissue distribution pattern of the CNS MAGUKs identified PSD-95 as
nervous system specific in the adult (Cho et al. 1992; Kistner et al. 1993; Muller et al.
1996), while chapsyn-110 message was identified in the embryonic thymus and
submandibular gland in addition to the nervous system (Brenman et al. 1996a).
SAP102 message was observed in brain, spinal cord, pancreas, thyroid, trachea and
prostate (Makino et al. 1997) while SAP97 message had the widest distribution, being
found in adult brain, heart, spleen, lung, liver, muscle, kidney, placenta, pancreas and
testes (Lue et al. 1994; Muller et al. 1995; McLaughlin et al. 2002). Western blotting
confirmed the presence of SAP97 in brain, muscle, liver and heart (Muller et al. 1995),
and SAP97 was shown to co-immunoprecipitate with the inward rectifier potassium
channel Kir2.2 in the heart (Leonoudakis et al. 2001).
Further interest in SAP97 was generated when its interaction with the tumour suppressor
adenomatosis polyposis coli (APC) protein was discovered (Matsumine et al. 1996).
Overexpression of SAP97 or APC in NIH3T3 cells blocked cell cycle progression,
while mutation of any one domain in SAP97 or deletion of the C-terminal PDZ binding
motif of APC blocked their activity (Ishidate et al. 2000). SAP97 was further
implicated in tumour suppression when two groups showed human adenovirus and
human papillomavirus (HPV) oncoproteins to bind the PDZ domains of SAP97 (Kiyono
et al. 1997; Lee et al. 1997), and that the C-terminal PDZ recognition motif of HPV
16E6 protein was required for morphological and tumourigenic transformation of
transfected cell lines (Kiyono et al. 1997).
The mouse SAP97 gene was mutated by the insertion of a gene trap vector (Caruana and
Bernstein 2001). Gene trap vectors are promotorless, so selected clones result from the
gene trap vector inserting into an endogenous gene that drives expression of the
selection cassette. This event necessarily interrupts the endogenous gene, resulting in a
truncation of the endogenous transcript. The SAP97 gene trap mutant produces a fusion
protein of SAP97 PDZ domain 1, 2 and 3 and (3-geo, therefore lacking the SH3 and GK
domains (Caruana and Bernstein 2001). Although truncation of the GK domain in
6
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Drosophila dig mutants results in neoplasia (Woods et al. 1996), SAP97 gene trap
mutants displayed a mildly retarded growth in utero instead of an overgrowth phenotype
(Caruana and Bernstein 2001). The perinatal lethality of the SAP97 gene trap mutant
(Caruana and Bernstein 2001) precluded further analyses of the tumour suppressor
activity of SAP97 in these animals, though it should be noted that SAP97 and SAP 102
could rescue both the neoplasia and NMJ abnormalities in dig Drosophila mutants when
overexpressed at sufficiently high levels (Thomas et al. 1997).
These studies demonstrate some similarity in function between Drosophila and
mammalian MAGUKs, however, MAGUKs also display specificity for certain ligands,
for example, specific PDZ-mediated interactions have been observed between the
AMPA GluRl subunit and SAP97, but not SAP102 or PSD-95 (Leonard et al. 1998).
Further specificity is likely achieved by differential distribution of the MAGUKs and
functional variety engendered by splice variants.
I.2.1 Splice Variants
PSD-95, SAP97, SAP102 and chapsyn-110 all generate alternative isoforms, as
indicated in figure 1.2. SAP102 transcripts have been reported to include 2 insertions:
II, an 18aa insertion prior to PDZ1, and 12, a 14aa insertion between the SH3 and GK
domains (Muller et al. 1996). Chapsyn-110 can contain three alternate splice insertions
at 2 sites, a 52aa insertion between PDZ2 and 3 and a 34aa or 15aa insertion between
the SH3 and GK domians. Additionally, four chapsyn-110 cDNA clones were identified
with distinct 5' sequences leading to the utilisation of four different translation initiation
methionines (Brenman et al. 1996a). Utilisation of alternative transcriptional start sites
by PSD-95 produces distinct N-termini (PSD-95a and PSD-95J3) (Chetkovich et al.
2002). Finally, SAP97 can contain five different insertions at three sites: I1A (33aa)
and/or I1B (18aa) insert before PDZ1; 12 (12aa) and/or 13 (34aa) insert at one site
between the SH3 and GK domains, 15 (13aa) and 14 (13aa) insert between SH3 and GK
domains at sites progressively more C-terminal from the 12/13 site (Lue et al. 1994;
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Figure 1.2 Organisation ofMAGUK domains and alternate variants.
Proteins are drawn to scale and show PDZ domains (green), SH3 domains
(yellow), GK domains (red) and alternate splice insertions (blue). Also
shown are PSD-95a and (5 variants resulting from alternate transcriptional
start sites. Chapsyn-110 variants resulting from alternate transcriptional
start sites are not shown.
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In some instances these diverse splice isoforms have been show to engender functional
differences. Inclusion of SAP97 13 versus 12 results in differential cellular localisation.
13 promotes localisation to sites of cell-cell contact when expressed as an SH3-I3-GK
fusion protein in epithelial cells or colon carcinoma CX-1 cells (Lue et al. 1996), while
the 12 insertion showed no preferential localisation in these cells (Lue et al. 1996).
However, immunostaining for 12 variants transfected into the human epithelial MCF10F
cell line indicated an enrichment in the nucleus (McLaughlin et al. 2002). Another
MAGUK, CASK, has been shown to bind the transcription factor Tbr-1 and activate
transcription in neurons (Hsueh et al. 2000). Combined, these data suggest that a
subclass of MAGUK proteins may be involved in transcriptional regulatory events, and
that this specificity may be gained via regulated splicing.
Other variants produce differential binding activities. For example, the SAP97 I1A+B
variant conferred SH3 binding activity through insertion of proline-rich sequences
(McLaughlin et al. 2002) while the PSD-95(3 variant, which makes up -10% of
expressed PSD-95 protein, encodes a unique N-terminus containing an L27 motif that
enables PSD-95(3 to bind CASK (Chetkovich et al. 2002).
1.2.2 MAGUK Localisation in the Brain
1.2.2.1 Developmental Distribution of MAGUKmRNAs
In situ analysis of developing mouse brain showed overall similarities in the expression
patterns of MAGUKs (Fukaya et al. 1999). PSD-95 and SAP102 were widely
expressed at the earliest time point analysed, El3. Chapsyn-110 expression was weak at
E15, stronger from E18 and highly restricted to the telecephalon. SAP102 expression
remained relatively uniform through development, however, PSD-95 appeared more
dynamic, with expression levels briefly dipping at P1/P7 followed by a large increase in
expression at P14 (Fukaya et al. 1999). In situ analysis has not been performed for
SAP97 transcripts, however postnatal Northern analysis of SAP97 showed a 4.9kb
transcript present at PI that reached peak levels at P15 and a 4.4kb transcript that
appears abruptly at P15, then declined to P75 (Muller et al. 1995). Utilising the SAP97-
(3Geo fusion protein in SAP97 gene trap mice, a snapshot of embryonic development
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was provided by lacZ staining that detected signal in hippocampus and cerebellum at
E10.5 (Caruana and Bernstein 2001). During postnatal development, SAP102 protein
levels decline while PSD-95 protein levels rise. These changes are associated with
decreased SAP102 synaptic staining with increased PSD-95 staining (Sans et al. 2000).
1.2.2.2 Regional distribution of MAGUK Proteins
Immunohistochemical studies in adult rat and mouse brain have shown PSD-95, SAP97,
SAP102 and chapsyn-110 to have predominantly overlapping distributions, all being
expressed in cortex, hippocampus, olfactory bulb, caudate putamen and cerebellum
(Muller et al. 1995; Fukaya and Watanabe 2000). However, differences were observed
in the thalamic nuclei, where immunohistochemical reactivity was strong for SAP102,
weak for PSD-95 and not detected for chapsyn-110 and SAP97. In addition, PSD-95
immunoreactivity was intense in the pinceau formation around the Purkinje cell axon
hillock in the cerebellum. Only chapsyn-110 stained Purkinje cells (Fukaya and
Watanabe 2000).
1.2.2.3 Subcellular Localisation
Immunofluorescent staining of the MAGUKs occurs as bright puncta, indicative of an
enrichment at synapses. PSD-95 immunofluorescent staining in cultured neurons
(Komau et al. 1995) and brain slices (Cho et al. 1992; Fukaya and Watanabe 2000) was
enriched at dendritic spines and, exhibited co-localisation with NMDA receptors
(Komau et al. 1995; Fukaya and Watanabe 2000) and synaptophysin (Fukaya and
Watanabe 2000), although fainter, diffuse staining was also observed throughout
dendrites consistent with extrasynaptic PSD-95. Despite their synaptic enrichment,
electron microscopy studies of PSD-95, chapsyn-110, SAP97 and SAP102 localisation
indicates their presence at both pre- and postsynaptic sites, and at extrasynaptic
locations, predominantly dendritic shafts (Brenman et al. 1998; El-Husseini et al. 2000;
Aoki et al. 2001; Sans et al. 2001). Earlier reports described a much more restricted
distribution of the MAGUKs (Muller et al. 1995; Brenman et al. 1996a; Kim et al.
1996; Muller et al. 1996), a result likely explained by the lower resolution of the
techniques utilized. The later studies reported cytoplasmic PSD-95, chapsyn-110 and
SAP97 staining associated with the endoplasmic reticulum (El-Husseini et al. 2000;
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Aoki et al. 2001; Sans et al. 2001), raising the possibility that MAGUKs regulate
processing or membrane delivery of associated receptors. Indeed, SAP97 has already
been shown to preferentially associate with immature, endoplasmic reticulum localised
AMPA receptors (Sans et al. 2001).
In summary, PSD-95, SAP97, SAP102 and chapsyn-110 are enriched at synapses where
they cluster synaptic proteins, but their presence in other cellular compartments implies
a more diverse role including processes such as protein trafficking (Sans et al. 2001).
1.3 PSD-95
The abundance of PSD-95 at the PSD suggested that PSD-95 might have a key role in
the organisation and colocalisation of the numerous classes of proteins present at the
synapse.
1.3.1 Structure of Binding Domains
Sequences within the protein domains of MAGUKs are relatively well conserved and
therefore are likely to employ similar binding mechanisms. The 724 amino acids
comprising PSD-95 contain three PDZ domains (amino acids 65-151; 160-246; SIS-
BOS), an SH3 domain (amino acids 428-498) and a GK domain (amino acids 534-724).
The structures of all PSD-95 domains have been determined, the PDZ domains as
individual units while the SH3 and GK domain structure was solved as a single module.
1.3.1.1 PDZ Domains
The structures of the PSD-95 PDZ domains have been resolved in complex with ligands
(Doyle et al. 1996; Tochio et al. 2000; Piserchio et al. 2002). These structures, in
concert with the structures of related PDZ domains (Morais-Cabral et al. 1996; Hillier et
al. 1999), provided an insight into how ligand selectivity between PDZ domains was
achieved. The PDZ domain was found to be globular and compact, made up of two a
helices (aA-B) and a beta sandwich consisting of 5 P sheets (PA-E). Ligands occupied
a groove on the surface of the PDZ domain and a hydrophobic pocket (Fig. 1.3A). The
groove was formed between strand PB and helix aB while the hydrophobic pocket was
11
Figure 1.3 Structure of PSD-95 domains. A. Ribbon diagram of PSD-95 PDZ3
complexed with a peptide ligand (yellow). The peptide ligand occupies a groove
between strand (3B and helix aB and the hydrophobic pocket (or carboxylate binding
loop) formed by the f)A-pB loop. Diagram from Doyle 1996. Ribbon
diagram of the SH3 (green), GK domain (orange) and hinge (or hook) region (grey)
that links the SH3 and GK domains. Diagram from McGee al., 2001.
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formed by the (3A-(3B loop that contains the signature GLGF motif of PDZ domains and
side chains from the (32 strand and oc2 helix.
Two types of ligand have been identified for PDZ domains. By far the most common
ligand type, the C-terminal ligand, interacted via the final residues of the extreme C-
terminus and required the interaction of the terminal carboxylate group with the PDZ
domain. The second ligand type, the internal ligand, involved the binding of an
antiparallel (3 finger to the PDZ domain (Fig. 1.4). This ligand did not involve
interaction of C-terminal sequences.
For C-terminal ligand binding, the terminal hydrophobic side chain (valine/isoleucine)
occupied the hydrophobic pocket with the terminal carboxyl group forming hydrogen
bonds with main chain amides of the GLGF sequence and a water molecule associated
with a conserved arginine, also in the (3A-(3B loop (Doyle et al. 1996; Tochio et al.
2000; Piserchio et al. 2002). The rest of the C-terminal ligand lay in the groove in a
highly ordered state, stabilised by interactions between the ligand main chain and
residues forming the groove (Doyle et al. 1996), although these interactions would not
contribute to specificity.
The last three residues of the ligand appear the most important in binding PDZ domains
and not surprisingly, they form clear interactions with PDZ domains in X-ray and NMR
studies. In PSD-95 PDZ1, a smaller hydrophobic domain was noted (Piserchio et al.
2002), consistent with its preference for a terminal valine instead of larger leucine or
isoleucine side chains. Preferences at the -1 position are determined by the second
residue in (3B. A serine at this position in PDZ1 and PDZ2 (Tochio et al. 2000;
Piserchio et al. 2002) requires negatively charged ligand side chains (aspartate or
glutamate) while an asparagine in PDZ3 prefers serine or threonine side chains at -1
(Doyle et al. 1996). The permitted residues at the -2 position are conserved across PDZ
domains, however different mechanisms for binding the -2 residue appear to be
employed between the three PDZ domains of PSD-95. The threonine side chain at the
-2 position of the peptide used by Doyle and co-workers (Doyle et al. 1996), formed a
13
nNOS PDZ domain
Figure 1.4 Comparison of C-terminal and internal ligand binding to PDZ
domains. A. Space-filling diagram of the al -syntrophin PDZ domain (grey)
showing a complexed C-terminal ligand (red). . The al-syntrophin PDZ
domain complexed with an internal ligand. The )3 finger internal ligand and PDZ
domain of nNOS is shown in red. The catalytic domain of nNOS, C-terminal to
the |3 finger, is omitted. Diagram adapted from Harris and Lim, 2001.
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hydrogen bond with a conserved histidine at the N-terminal end of aB in PDZ3. In
contrast, Piserchio and colleagues (Piserchio et al. 2002) described the -2 serine present
in three C-terminal ligands, derived from Kvl.4, CRfPT and GluR6, to bind an
asparagine in the pB-PC loop of PDZ1, close in space to the conserved histidine.
However, binding of the -2 residue in PDZ2 may involve both asparagine and histidine
residues (Tochio et al. 2000; Piserchio et al. 2002) and interestingly, the asparagine is
contained in a 6aa insertion between (3B and (3C, present in PDZ1/2 but absent from
PDZ3. Differences observed between PDZ1/2 and PDZ3 ligand specificities can
therefore be explained to some extent by the substitutions of specific residues, however
these studies have been unable to address the preferences observed at more N-terminal
residues of the ligand.
In addition to binding C-terminal ligands, the PDZ domains of PSD-95, chapsyn-110,
syntrophin and InaD are capable of binding internal ligands (Brenman et al. 1996a;
Brenman et al. 1996b; van Huizen et al. 1998; Xu et al. 1998), although only the
structure of the nNOS-syntrophin interaction has been studied (Hillier et al. 1999; Fig.
1.4). The key question was how an internal sequence could overcome the requirements
for C-terminal binding. In nNOS, a 30aa sequence just C-terminal to the PDZ domain,
but N-terminal to its catalytic domain, made up the internal PDZ binding motif and
formed a P-hairpin 'finger' (pG-H). The P finger demonstrated remarkable stability,
adopting the same structure in both bound and unbound forms, and crucial to this
stability was the interaction between an arginine in pH of thep finger and an aspartate in
the nNOS PDZ domain that pinned the two P strands into a hairpin (Hillier et al. 1999).
The ...LETTF... sequence within the p finger mimicked the ...S/TXV/I PDZ
recognition motif and on invasion of the binding groove, appropriate interactions were
formed and the phenylalanine side chain occupied the hydrophobic pocket (Hillier et al.
1999).
These structure studies have therefore provided useful information for explaining the
mechanisms of binding and the variable specificity of both ligands and PDZ domains.
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In particular, how an internal motif can utilise a binding domain that appears to
specialise in binding C-termini.
1.3.1.2 SH3-GKModule
Crystal structures of the PSD-95 SH3-GK module (Fig. 1.3B) were published
independently by two groups (McGee et al. 2001; Tavares et al. 2001) and displayed a
surprising topology. Although the SH3 and GK domains showed similar organisation to
their homologues, a number of differences in both domains explained their divergence
in function from canonical SH3 and GK domains.
Conventional SH3 domains are made up of 5 contiguous antiparallel (3 strands
(reviewed by Cohen et al. 1995) whereas the PSD-95 SH3 domain was found to consist
of six non-contiguous (3 strands (PA-F). Strands PA-D were contained in the SH3
homologous sequence, while PE was separated from pA-D by the HOOK domain and
from PF, contained in the C-terminus, by the GK domain. The C-terminal PF thus
emerged from the GK domain to form an anti-parallel P sheet with PE, which, in
concert with PA-D, formed the SH3 hydrophobic core. The PSD-95 SH3 domain
therefore differed from conventional SH3 domains by the use of non-contiguous
sequences, the presence of an extra p strand and the replacement of the crucial
polyproline recognition site, usually between PD and PE, by the HOOK domain (McGee
et al. 2001; Tavares et al. 2001). In addition, certain residues important for polyproline
binding are missing from the PSD-95 SH3 domain, however, polyproline-mediated
binding of KA2 and MLK is still observed (Garcia et al. 1998; Savinainen et al. 2001).
The PSD-95 GK domain, like conventional guanylate kinases, consisted of three
structural components: a CORE made up of five parallel P strands (P6, P7, p 12, P13
and P14) and six a helices (a2, a4, a5, a6, al and a8); a GMP binding domain
composed of P8, P9, a3, P10 and P11; and a LID that was formed by the a6-a7 loop
(Tavares et al. 2001). The lack of kinase activity in PSD-95 can be explained by
sequence analysis that shows the absence of residues critical for ATP binding
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addition, Tavares and co-workers failed to observe a large conformational change upon
binding of GMP to the GK domain (Tavares et al. 2001), which in yeast guanylate
kinase moves the GMP binding site towards the active site of the enzyme and enables
the access of ATP (Blaszczyk et al. 2001).
1.3.2 Binding Partners
Experiments interfering with PSD-95 production have demonstrated its importance in
diverse neuronal processes such as synaptic plasticity, learning and memory (Migaud et
al. 1998), thermal hyperalgesia (Tao et al. 2000; Garry et al. 2001) and excitotoxicity
(Sattler et al. 1999; McCulloch et al. 2001). A central function of this adaptor molecule
is the protein interactions it forms. The five protein-protein interaction domains of
PSD-95 enable it to bind a large variety of molecules, presumably in various




PSD-95 Chapsyn-110 SAP102 SAP97 references
Kir2.3 + + - -
$
Inanobe et al., 2002
Kv1.4 + + - + Inanobe et al., 2002 $
GluR1 - - - + Cai et at, 2002 $
KA2 + n/d + - Garcia et al., 1998 IP
BAI1 + n/d - n/d Lim et al., 2002 IP
Kir5.1 + n/d n/d - Tanemoto et al., 2002 IP
Table 1.2 MAGUK binding preferences for associated proteins. Binding is designated by
+, absence of binding is designated -, and n/d signifies that the interaction was not tested.
Brain-specific angiogenesis inhibitor 1 is abbreviated BAIl. Superscript notes appended to
<T
references document the methods used in determining protein interactions ( = protein from
IP
brain homogenate binding to fusion protein on affinity column, = immunoprecipitation from
brain homogenate).
As all MAGUKs contain these protein binding domains, how specific interactions are
determined is an important question. Differential interactions between ligands and
MAGUKs (Table 1.2) can be determined by binding specificity, but also by differential
distributions of MAGUK and ligand. This is exemplified by the NMDA receptor,
which binds all MAGUKs in vitro (Inanobe et al. 2002), yet SAP97 could not be co-
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immunoprecipitated with NMDA receptor subunits from brain preparations (Wyszynski
et al. 1997), consistent with the preferential intracellular localisation of SAP97 (Sans et
al. 2001). However, binding preferences must certainly influence associations.
1.3.2.1 PDZ Domain Binding Preferences
Although the three PDZ domains share considerable homology, it is clear they differ in
their binding preferences which, to some extent, have been defined. Binding to PDZ
domains is generally mediated by the extreme C-terminus of ligands, nNOS being the
exception, which utilises an internal peptide motif. The basic PDZ binding motif
(...S/TXV/I where X is any amino acid) requires a hydrophobic C-terminal residue
(position 0), such as valine or isoleucine, and either a serine or threonine two positions
N-terminal (position -2) to the hydrophobic residue (Table 1.3). Using the yeast two-
hybrid system, Niethammer and colleagues (1998) investigated how specificity between
PDZ domains within PSD-95 was generated by studying the binding activity of two C-
termini, that of the voltage-gated potassium channel, Kvl.4, which binds PSD-95
PDZ 1/2, and the C-terminus of CRIPT (cysteine-rich interactor of PDZ3), which binds
PSD-95 PDZ3. Systematic mutation of Kvl.4 to CRIPT residues showed that changing
binding activity from PDZ3 to PDZ1/2, required only the mutation of residues at the -1
and -3 positions: CREPT ...QTSV to Kvl.4 ...ETDV. Surprisingly, changing PDZ1/2
to PDZ3 binding required more manipulation, Kvl.4 sequence being exchanged for
CRIPT sequence to position -7: ...SNAKAVETDV to ...SNKNYKQTSV (Niethammer
et al. 1998). Thus, in addition to the basic ...S/TXV/I motif, specificity for distinct
PDZ domains requires the use of residues as N-terminal as -7, although more N-
terminal residues may engender even greater specificity in vivo.
1.3.2.2 SH3 Domain Interactions
Prototypic SH3 domains (reviewed by Mayer 2001) were first identified as small
modules present in divergent signalling molecules that could mediate protein-protein
interactions (Cicchetti et al. 1992). SH3 domains bind proline-rich regions and require
a motif generally described as PXXP, where X is any amino acid (Ren et al. 1993;
reviewed by Kay et al. 2000).
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PSD-95 binding C-terminal sequence PDZ domain
protein -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 preference
GluR6 D R R L P G K E T M A 1
Cypin G K Q V V P F S S S V 1 or 2
ErbB4 P P P Y R H R N T V V 1 or 2
KIFlBa A G R E T T V 1 or 2
Kv1.4 C S N A K A V E T D V 1 or 2
NR2A Y K K M P S I E S D V 2
NR2B Y E K L S S I E S D V 2
NR2D S A H F S S L E s E V 2
Citron Q V N K V W D Q s S V 2 or 3
pi Adrenergic receptor G R Q G F s S E s K V 3
CRIPT L D T K N Y K Q T S V 3
a2 Guanylyl cyclase I G T M F L R E T S L 3
Neuroligin-1 P H P H S H S T T R V 3
Neuroligin-2 T L P H P H S T T R V 3
Neuroligin-3 G L P N S H S T T R V 3
Table 1.3 C-terminal sequences of PSD-95 PDZ interacting proteins. Proteins are grouped
according to their PDZ binding preference. References demonstrating preferences: GluR6
(Garcia 1998); cypin (Firestein 1999); ErbB4 (Huang 2000); KIFlBa (Mok 2002); Kvl.4 (Lim
2002); NR2A, B and D (Kornau 1995); citron (Zhang 1999); pi adrenergic receptor (Hu 2000);
CRIPT (Niethammer 1998); a2 guanylyl cyclase (Russwurm 2001); Neuroligin-1, -2 and -3
(Irie 1997).
The PSD-95 SH3 domain binds proteins that contain proline-rich sequences such as
mixed lineage kinase (MLK; (Savinainen et al. 2001) and the kainate receptor KA2
subunit (Garcia et al. 1998), but in addition, it binds protein kinase A (PKA) anchoring
proteins 79 and 150 (AKAP 79/150; (Colledge et al. 2000), which do not contain the
typical SH3 binding motif (.. .PXXP...). The different binding motifs employed by
KA2 and AKAP79 were further highlighted by mutation studies in which a tryptophan
required for polyproline binding was mutated to alanine (W470A). This mutation
reduced binding of KA2 but had little effect on AKAP79 binding whereas a point
mutation (L460P) analogous to the recessive lethal dig"'30 Drosophila SH3 mutation did
ablate AKAP79 binding. The atypical activity of the PSD-95 SH3 domain was clarified





The MAGUK GK domain is enzymatically inactive (Kistner et al. 1995; Kuhlendahl et
al. 1998) and acts as a protein interaction domain. However, the binding mechanism of
the GK domain remains elusive, even though its crystal structure has also been
determined (McGee et al. 2001; Tavares et al. 2001). The only potential binding
mechanism, described by Kim and co-workers, required cooperative binding of 14aa
repeats in GKAP to the PSD-95 GK domain (Kim et al. 1997). GKAP was found to
contain 5 of these 14aa repeats and although a single repeat could bind PSD-95, two
repeats were required for strong binding activity in a yeast two-hybrid assay.
Unfortunately, these repeats have not been identified in other GK ligands.
1.3.2.4 Regulation of Binding
The association of Kir2.3 with PSD-95 can be regulated by PKA, a kinase that is
recruited to PSD-95 by AKAP79/150 binding (Colledge et al. 2000). PKA
phosphorylates the -2 serine of the Kir2.3 C-terminal PDZ binding motif (...RRESAI)
and in HEK cells, forskolin stimulation of PKA via adenyl cyclase disrupted the
association of co-transfected PSD-95 and a Kir2.3 C-terminal protein (Cohen et al.
1996). Therefore, PSD-95 may colocalise the channel with a kinase that regulates its
interaction with PSD-95. Such regulated binding has also been observed for stargazin,
an AMPA-binding protein that also binds PSD-95 PDZ domains (Chen et al. 2000).
PKA phosphorylated the -2 threonine (T321) in the C-terminal PDZ recognition motif
of stargazin (...RRTTPV) and disrupted its association with PSD-95 (Chetkovich et al.
2002; Choi et al. 2002). Moreover, a GFP-tagged stargazin phosphorylation mimic
(T321E) exhibited a diffuse distribution when transfected into cultured neurons, while a
mutant (R318,319A) that disrupted the PKA consensus sequence for T321, exhibited
normal synaptic clustering and was not dispersed by PKA (Chetkovich et al. 2002).
Significantly, the T321E mutant also had a physiological effect, reducing AMPA
receptor mEPSC amplitude and frequency, while R318, 319A had no effect (Chetkovich
et al. 2002). These results are important because synaptic strength depends on the
number of AMPA receptors at the synapse, so regulating the association of stargazin




A number of MAGUKs, including PSD-95, chapsyn-110, SAP97, SAP102 and CASK
can either hetero- or homodimerise (Kim et al. 1996; Masuko et al. 1999; McGee and
Bredt 1999; Nix et al. 2000). When co-expressed in heterologous cells with other
MAGUKs, or with PSD-95 fusion proteins, PSD-95 was found to bind chapsyn-110,
CASK, and SAP97, as well as forming homodimers (Kim et al. 1996; Chetkovich et al.
2002). To associate with MAGUK proteins, PSD-95 employed three different
mechanisms, two of which required the distinct N-terminal sequences encoded by the
two PSD-95 variants, while the third utilised SH3-GK interactions.
N-terminal-mediated dimer formation in PSD-95a required the two N-terminal
cysteines and these were initially proposed to form intermolecular disulphide bridges
(Hsueh and Sheng 1999). However, palmitoylation of the N-terminal cysteines was
shown to be required for membrane localisation (El-Husseini et al. 2000), hence
dimerisation is presumably mediated by another N-terminal sequence. N-terminal
dimerisation has been demonstrated in SAP97 (Marfatia et al. 2000) and a short region
of homology was observed between the PSD-95a and SAP97 N-termini, although the
involvement of this sequence in mediating dimerisation in either protein has yet to be
determined. However, the distinct N-termini of PSD-95 variants make this form of
dimerisation specific to PSD-95a.
Another mechanism of dimerisation is PSD-95(3 -specific. The PSD-95(3 N-terminus
contains an L27 motif, named after Lin-2 and Lin-7, the two proteins in which this motif
was first demonstrated to mediate heterodimerisation. The L27 motif in PSD-95(3
facilitates heterodimerisation with the mammalian homologue of Lin-2, CASK, and is
absent from the more abundant PSD-95a variant, which is unable to interact with
CASK (Chetkovich et al. 2002). Thus both PSD-95 variants are able to dimerise,




The third mechanism involves interactions between MAGUK SH3 and GK domains,
and is presumably not specific to a particular PSD-95 variant. McGee and Bredt (1999)
showed a preference for intra- over intermolecular interactions in PSD-95 SH3-GK
interactions in vitro, while human CASK and SAP97 could be co-immmunoprecipitated
from a human colon carcinoma-derived cell line (Caco-2 cells), an interaction shown to
require SH3-GK interactions in transfected HEK cells (Nix et al. 2000). Interestingly,
the PSD-95 SH3-GK interaction could be abolished by a L460P point mutation in the
SH3 domain (McGee and Bredt 1999), analogous to the dig'"30 lethal Drosophila
mutation (Woods et al. 1996). The L460P mutation did not involve a residue required
for conventional polyproline binding, consistent with the absence of any such motif in
the GK domain, however, L460 did form extensive hydrophobic interactions within the
core of the (3 sandwich. Mutation of lysine to proline may alter the orientation of
surrounding residues involved in stabilising the structure, particularly V459 in (3C,
which faces W717 in the C-terminal (3 strand. McGee and colleagues (2001) proposed
that intermolecular SH3-GK interactions involved domain complementation, that is, the
C-terminal (3 strand from one molecule contributes to the SH3 domain of the other and
visa versa, so maintaining the ability of SH3 and GK domains to bind ligands while
forming dimers (McGee et al. 2001). The L460P mutation in both SH3 domains would
destabilise interactions with the C-terminal (3 strands and ablate dimerisation, whereas
mutation of only one domain would still allow the C-terminal (3 strand from the mutated
molecule to interact with the SH3 domain of the unmutated molecule. This mechanism
is supported by genetic complementation experiments in which a number of recessive
lethal dig mutations that truncate the GK domain (dlgxl~2, digv59 and dig"'20) are viable
as compound heterozygotes with dig"'30, which contains the SH3 point mutation (Woods
et al. 1996). The GK and C-terminal (3 strand from the dig"'30 allele thus presumably
binds and complements the GK deletion mutants.
If PSD-95 intermolecular binding occurs in vivo, it must be regulated since
intramolecular interactions are clearly preferred in vitro (McGee and Bredt 1999).
Regulation may be imparted by ligands binding the HOOK domain, disturbing intra- in
favour of intermolecular interaction. Ca2+/calmodulin has been shown to bind the
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HOOK region of SAP102, utilising a consensus sequence that is conserved in a number
of MAGUKs, including PSD-95. Moreover, heterodimerisation between PSD-95 and
SAP 102 required the presence of Ca2+/calmodulin in the yeast two-hybrid system
(Masuko et al. 1999). Dimer formation would be advantageous by significantly
increasing the binding sites available for co-localisation, enhancing the formation of
signalling complexes. This is seen in Drosophila, where phototransduction requires the
formation of a signalling complex that is coordinated by the inactivation no after-
potential D (INAD) protein (Montell 1998). INAD contains five PDZ domains, and
dimer formation enables the formation of a functional signalling complex that, with the
known binding preferences of INAD ligands, would be unable to form with monomeric
INAD (Xu etal. 1998).
1.3.4 Synaptic Targeting of PSD-95
To isolate the determinants required for PSD-95 synaptic localisation, an array of GFP-
tagged PSD-95 constructs expressed in neurons have been used by a number of groups.
The N-terminus is critical for PSD-95 synaptic localisation, specifically two cysteines
(C3,5) that are palmitoylated (Topinka and Bredt 1998; Craven et al. 1999; El-Husseini
et al. 2000). Abolition of palmitoylation can both prevent PSD-95 targeting to synapses
and disperse PSD-95 already clustered at synapses (El-Husseini et al. 2002), indicating
that palmitoylation is absolutely required for synaptic localisation, even when PSD-95
has presumably bound synaptic membrane proteins.
Despite the importance of palmitoylation, protein interaction domains are also
necessary. For example, at least one PDZ domain is required, in addition to
palmitoylation, for any synaptic localisation of GFP tagged PSD-95 in cultured
hippocampal neurons or cortical slices (Arnold and Clapham 1999; Craven et al. 1999),
however, differences were observed in the effect of deleting a single PDZ domain.
Arnold and Clapham (1999) saw no effect of deleting a single PDZ domain while
Craven and colleagues (1999) showed deletion of PDZ1 or 2, but not PDZ3, to reduce
synaptic clustering. The only obvious difference that might explain this disparity is the
choice of cultures used by the two groups: Craven and co-workers (1999) used dispersed
hippocampal cultures while Arnold and Clapham (1999) used cultured rat cortical slices.
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A PDZ3 ligand may therefore be absent from dispersed cultures that is able to contribute
to PSD-95 localisation in slice cultures.
Another study using GFP-tagged mutants expressed in primary neurons identified a C-
terminal tyrosine-based motif important for PSD-95 synaptic targeting (Craven and
Bredt 2000). Mutating tyrosine 701 to serine or alanine, or mutating valine 704 to a
charged residue impaired PSD-95 synaptic clustering, whereas mutating valine 704 to
other hydrophobic residues had no effect. In addition, two hydrophobic residues at 707
and 708 were found to influence clustering if mutated to charged residues, thus defining
a YXXOXXOO motif where X is any amino acid and O is a hydrophobic residue
(Craven and Bredt 2000). It is noteworthy that this motif is conserved across
MAGUKs, also being found in chapsyn-110, SAP97, SAP102 and Drosophila DLG.
Localisation of PSD-95 at synapses can also be influenced by cytoplasmic PSD-95
interactor (cypin), which reduced PSD-95 clustering when over expressed in cultured
neurons (Firestein et al. 1999). Cypin binds PSD-95 PDZ1 and 2 and its C-terminal
PDZ interaction motif was required to reduce the number of PSD-95 clusters and
abolish SAP102 clustering in neurons (Firestein et al. 1999). However, competitive
binding to PDZ domains 1 and 2 could not adequately explain the redistribution of
MAGUKs since cyan fluorescent protein fused to another C-terminal PDZ-binding
motif did not affect PSD-95 or SAP 102 clustering (Firestein et al. 1999), thus cypin
may mediate the active redistribution of PSD-95.
1.3.5 Roles for PSD-95
The binding of PSD-95 to its numerous ligands should not be considered a static and
inert association, but one in which binding can be regulated and PSD-95 can influence
the behaviour of bound proteins.
1.3.5.1 Receptor Localisation
One of the more striking properties of PSD-95 is its ability to induce clustering of ion
channels when expressed in heterologous cells, which was first observed when PSD-95
was coexpressed with the Kvl.4 (Kim et al. 1995). In neurons, Kvl.4 preferentially
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localises to axons while PSD-95 is enriched in dendrites and PSD-95 exhibited a similar
distribution when biolystically transfected into neurons (Arnold and Clapham 1999).
Transfected Kvl.4 showed no specific localisation but when PSD-95 and Kvl.4 were
cotransfected, Kvl.4 was localised to axons and PSD-95 localised to both axons and
dendrites (Arnold and Clapham 1999). Kvl.4 and PSD-95 also colocalise in the optic
nerve, however in PSD-95 deletion mutant mice, Kvl.4 localisation in the optic nerve is
unaffected (Rasband et al. 2002). It therefore appears that although PSD-95 may be
involved in localisation of Kvl.4, it is not required, perhaps because other MAGUKs
that bind Kvl.4 can also influence its localisation. The experiments of Arnold and
Clapham (1999) might be explained in terms of Kvl.4 transfection saturating the
available MAGUK binding sites such that it was not localised. Only by cotransfecting
PSD-95 could sufficient binding sites be made available for correct localisation.
PSD-95 is also associated with AMPA receptors, not through direct interaction, but via
the stargazin family (Chen et al. 2000) and this interaction appears to regulate AMPA
receptor synaptic localisation. Palmitoylation, essential for PSD-95 synaptic
localisation, is a transient (d/2 ~2hr) lipid modification, the stability of which can be
modulated by synaptic activity (El-Husseini et al. 2002). Blocking palmitoylation by
application of 2-bromo palmitate caused a reduction in both PSD-95 and AMPA
receptor synaptic localisation, measured by both immunofluorescence and
electrophysiology. Surprisingly, no changes were observed in the synaptic localisation
of NMDA receptors (El-Husseini et al. 2002), an unexpected result since PSD-95 and
NMDA receptors directly interact while AMPA receptors are indirectly associated.
1.3.5.2 Modulation of Channels and Receptors
In vitro, the binding of PSD-95 appears to modulate the behaviour of receptors and
channels. Coexpression of PSD-95 with Kir2.3 in HEK cells halves single unit
conductances (Nehring et al. 2000) while transfection of HEK or COS cells with PSD-
95 and GluR6/KA2 kainate receptors changed the receptor's response to agonist from
rapid desensitisation to incomplete desensitisation, maintaining a steady state current at
approximately a third of peak level current (Garcia et al. 1998). Furthermore, such
incomplete desensitisation of kainate currents has been observed in dispersed
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hippocampal cultures (Wilding and Huettner 1997) and slow inward currents were
found in mossy fibre synapses (Castillo et al. 1997; Vignes and Collingridge 1997).
PSD-95 binding has also been reported to reduce NMDA receptor sensitivity to its
agonist, glutamate (Yamada et al. 1999; Rutter and Stephenson 2000), and inhibit
protein kinase C (PKC)-mediated enhancement of NMDA receptor currents (Yamada et
al. 1999).
PSD-95 can also stabilise cell surface channels and receptors at the cell membrane.
Internalisation rates of Kvl.4, Kir5.1, (31-adrenergic receptor and the NMDA receptor
were reduced by coexpression with PSD-95 in heterologous cells (Hu et al. 2000;
Jugloff et al. 2000; Roche et al. 2001; Tanemoto et al. 2002). It is therefore apparent
that PSD-95 can both positively and negatively regulate channels or receptors by either
directly influencing their behaviour or stabilising them at the plasma membrane,
although there has not yet been a clear demonstration of these effects in vivo.
1.3.5.3 Signal Transduction
The promiscuous binding of PSD-95 brings various proteins into close apposition, so
coupling components of signalling pathways. nNOS, when activated by Ca2+ influx
from the NMDA receptor, generates nitric oxide which can inhibit NMDA currents
(Manzoni et al. 1992), is involved in synaptic plasticity (reviewed by Holscher 1997)
and can mediate neurotoxicity in vitro and in vivo (Huang et al. 1994; Dawson et al.
1996 but see Khaldi et al. 2002). Guanylyl cyclase is stimulated by nitric oxide to
produce cyclic guanosine monophosphate (cGMP), which in turn can activates cGMP-
dependent kinase. PSD-95 PDZ domains bind three components of this pathway,
NMDA receptor NR2 subunits (Kornau et al. 1995), nNOS (Brenman et al. 1996a;
Brenman et al. 1996b) and guanylyl cyclase (Russwurm et al. 2001), with binding
preferences compatible with all three molecules being simultaneously bound by a single
PSD-95 molecule. Physiological studies by Sattler and co-workers showed that PSD-95
was required to couple the NMDA receptor to cGMP production; antisense knockdown
of PSD-95 in cultured cortical neurons attenuated NMDA-mediated cGMP production
by more than 60%. In addition, PSD-95 knockdown attenuated NMDA-mediated
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excitotoxicity, potentially by uncoupling nNOS, a mediator of excitotoxicity, from the
NMDA receptor (Sattler et al. 1999).
PSD-95 therefore displays multiple functions and has been shown to influence cellular
processes such as receptor cycling and intracellular signalling. PSD-95 has also been
implicated in more complex phenomena that influence neuronal networks and
behaviour; synaptic plasticity and memory are two such systems.
1.4 Synaptic Plasticity
Hebb proposed the neural basis of memory formation to require an increase in synaptic
strength that is induced by the coincident activity of both pre- and postsynaptic neurons
(Hebb 1949). Although findings such as the weakening of synaptic strengths have
required this theory to be refined, Hebb's postulate remains the basis for many theories
concerning the underlying processes of learning and memory.
Hebb's predictions proved correct with the discovery that trains of stimuli can induce
increased synaptic strength in hippocampal slices (Bliss and Lomo 1973). Changes in
synaptic strength were termed synaptic plasticity, with persistent increases in synaptic
strength described as long term potentiation (LTP) while persistent decreases in synaptic
strength called long term depression (LTD). Altering synaptic strength required specific
frequencies of stimulation, sufficient to result in coincident pre- and postsynaptic
activation; in the hippocampus, low frequencies (1 Hz) induced LTD (Dudek and Bear
1992; Mulkey and Malenka 1992) while higher frequencies (5-100 Hz) induced LTP
(Bliss and Lomo 1973; Thomas et al. 1998).
The mechanisms by which synaptic plasticity is generated became the focus of extensive
research and it became apparent that the NMDA receptor was required for some forms
of synaptic plasticity. While basic moment-to-moment neurotransmission is mediated
by AMPA receptors that depolarise the postsynaptic cell in response to glutamate,
NMDA receptors require depolarisation of the postsynaptic cell coincident with
presynaptic activation. This property of the NMDA receptor has made it an attractive
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candidate for mediating Hebbian synaptic plasticity. In the hippocampal CA1 region
both pharmacological and genetic inactivation of the NMDA receptor has been shown to
impair synaptic plasticity (Collingridge et al. 1983; Coan et al. 1987; Dudek and Bear
1992; Mulkey and Malenka 1992; Kutsuwada et al. 1996; Tsien et al. 1996). The
NMDA receptor is also required for some forms of learning (see below) and NMDA
receptor-dependent plasticity represents a feasible model for the synaptic changes that
occur during learning
1.4.1 Mechanisms of NMDA Receptor-Dependent Plasticity
NMDA receptors flux Ca2+ ions producing a rise in intracellular Ca2+ concentration that
can activate a number of signalling molecules. Determining the relevant molecules
downstream of the NMDA receptor that are responsible for generating synaptic
plasticity has therefore been a focus for considerable research.
1.4.1.1 Kinases
It was recognised that LTP required transient elevations in the intracellular Ca2+
concentration (Lynch et al. 1983) but a long term alteration in synapse function. Protein
kinase C (PKC) and CaMKH were therefore early candidates in mediating long term
modifications in synapse function and inhibitor studies showed both to be necessary for
the generation of LTP (Lovinger et al. 1987; Malinow et al. 1988; Reymann et al. 1988;
Malenka et al. 1989; Malinow et al. 1989; Ito et al. 1991). Further studies using various
kinase inhibitors identified other kinases required for LTP including src family tyrosine
kinases (ODell et al. 1991; Abe and Saito 1993; Lu et al. 1998), PKA (Frey et al. 1993;
Matthies and Reymann 1993; Weisskopf et al. 1994) and the mitogen-activated protein
kinase (MAPK) pathway (English and Sweatt 1997).
Gene targeting technology was also utilised to determine the signalling pathways
necessary for LTP production. Knocking out the aCaMKH subunit or mutating its
autophosphorylation site in mice resulted in reduced hippocampal LTP (Silva et al.
1992; Giese et al. 1998), as did mutation of the src family tyrosine kinase, jyn, although
this mutant also exhibited aberrant hippocampal morphology (Grant et al. 1992). Other
mutations that impaired synaptic plasticity include PKA R1 (3 and C(3l subunit
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knockouts (Brandon et al. 1995; Huang et al. 1995; Qi et al. 1996) and PKCy isoform
knockouts (Abeliovich et al. 1993).
The importance of the MAPK pathway in synaptic plasticity has not yet been clearly
demonstrated using gene targeting. Mice lacking extracellular signal-regulated kinase
(ERK) 2, the ERK isoform that is preferentially activated by high frequency stimulation
(English and Sweatt 1996), die during embryonic development (Adams and Sweatt
2002), precluding analysis of synaptic plasticity. ERK1 is less strongly activated than
ERK2 by high frequency stimulation and mice lacking ERK1 demonstrated this
isoform, to be required for only theta burst (3 trains of 10 bursts of 4 pulses at 100 Hz, 5
Hz burst frequency) induced hippocampal (Mazzucchelli et al. 2002).
1.4.1.2 NMDA Receptor Signalling Complexes
The various interactions of MAGUK proteins and their association with the NMDA
receptor facilitate the physical organisation of signalling pathways downstream of the
NMDA receptor to form NMDA receptor associated complexes (NRCs). One example
of a signalling pathway organised in such a manner is the colocalisation of nNOS and
guanylyl cyclase with the NMDA receptor via PSD-95, mentioned earlier. Another
example is the MAPK pathway. Multiple members of the MAPK pathway, including
MAPK/extracellular signal-regulated kinase kinase (MEK), ERK and ribosomal protein
S6 kinase (RSK), are found in the PSD (Suzuki et al. 2001) and are associated with the
NMDA receptor (Husi et al. 2000). Additionally, a regulator of Ras, synGAP, directly
binds PSD-95 (Chen et al. 1998).
Further evidence of the association of the MAPK pathway with the NMDA receptor was
generated in an experiment that utilised intracellular EGTA. The relatively slow
binding kinetics of EGTA allow local increases in Ca2+ concentration, for instance at the
pore of an ion channel, while preventing global Ca2+ increases. Under such conditions,
NMDA receptor activation of the MAPK pathway was still observed (Hardingham et al.




Many signalling proteins found in the NRC (Husi et al. 2000) are implicated in synaptic
plasticity, including nNOS (Holscher 1997), the MAPK pathway, CaMKII, PKCy and
PKA, which interacts with PSD-95 via AKAP79/150. However, in addition to the
activity of these signalling molecules, gene transcription and protein synthesis,
upregulating immediate early gene (TEG) expression, are also required for long term
synaptic plasticity (Tischmeyer and Grimm 1999; Platenik et al. 2000; Smith et al.
2001). Activity-regulated gene 3.1 (arg3.1) / activity-regulated cytoskeleton-associated
protein (arc) is an IEG product of particular interest because its expression is induced by
LTP, it is the only IEG whose mRNA is rapidly distributed through dendritic processes
(Link et al. 1995; Lyford et al. 1995) and arg3.1/arc antisense impairs the maintenance
of in vivo LTP and learning in the rat (Guzowski et al. 2000). Furthermore, arg3.1/arc
induction has been shown to require PKA and MEK activity (Waltereit et al. 2001) and
it is found in the NRC (Husi et al. 2000). The NRC may therefore not only have a role
in clustering signalling molecules to facilitate their activation, but may also recruit
proteins such as arg3.1/arc that are involved in later phases of synaptic plasticity.
Disrupting interactions within the NRC may allow its importance in synaptic plasticity
to be assessed. The intracellular C-terminal tail of NR2 NMDA receptor subunits is the
site of interaction of many NMDA receptor associated proteins, including MAGUKs.
NR2A and NR2B are the most abundantly expressed NR2 subunits in the adult
forebrain (Monyer et al. 1994), while NR2B expression dominates the embryonic and
early postnatal forebrain (Monyer et al. 1994; Sans et al. 2000). Mutant mice lacking
the NR2 C-termini demonstrated the importance of this region, and by implication, the
NRC.
Mice lacking the NR2B C-terminus (NR2BAC) died perinatally, however some analyses
were possible. NMDA receptor currents were reduced in NR2BAC mutants,
corresponding to reduced NR2BAC expression, while expression of other NMDA and
AMPA receptor subunits were unaffected (Mori et al. 1998; Sprengel et al. 1998).
Interestingly, the number of NR2B immunofluorescent puncta was reduced and some
clusters did not localised to synapses, determined by colocalisation with synaptophysin
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(Mori et al. 1998). NR2BAC protein and NMDA receptor currents were reduced by
about half, however this may not have caused the lethality since NR2B knockout
heterozygotes have a similar reduction in NR2B expression and are viable (Kutsuwada
et al. 1996), so lethality was proposed to result from a loss of associated proteins and
intracellular signalling (Sprengel et al. 1998).
In contrast to the NR2BAC mutants, NR2AAC mice were viable, although LTP in the
hippocampal CA1 region was abolished (Sprengel et al. 1998). However, interpretation
of these data is complicated due to controversy about NMDA receptor expression levels
in NR2AAC mutants. Sprengle and coworkers (1998) reported normal NR2AAC
expression and NMDA receptor currents while Steigerwald and colleagues observed
reduced synaptic NMDA receptors by both immunofluorescent and electrophysiological
analyses (Steigerwald et al. 2000). Whether abolition of LTP was due to reduced
NMDA receptor activation or impaired signalling downstream of the NMDA receptor
therefore remains to be clarified.
1.5 Learning and Memory
1.5.1 Hippocampal-Dependent Learning
The hippocampus is required for the formation of certain types of memories, for
example, episodic (e.g. knowledge of personal events) memory in humans (Scoville and
Milner 1957; Zola-Morgan et al. 1986) and spatial memory in rodents (Morris et al.
1982; Moser et al. 1993). Bilateral lesions of the hippocampus prevent the formation of
new memories (anterograde anaesthesia) and also result in an often temporally graded
loss of existing memories (retrograde amnesia). These phenomena imply the
involvement of the hippocampus in initially encoding memories, but also in
consolidating those memories to generate a more permanent record. The time-scale
over which the hippocampus is required for the retrieval of memories is still, however,
controversial. Many studies in humans, primates and rodents have shown the
hippocampus to be required for the retrieval of recent memories, and that this
requirement decreased with progressively older memories producing temporally graded
retrograde amnesia (Scoville and Milner 1957; Winocur 1990; Zola-Morgan and Squire
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1990; Kim and Fanselow 1992; Winocur et al. 2001). However, other studies reported
either little retrograde amnesia (Zola-Morgan et al. 1986) or profound retrograde
amnesia with little temporal grading. Cipolotti and colleagues reported an example of
the latter in a detailed study of a patient with restricted bilateral hippocampal
dysfunction and revealed a profound retrograde amnesia that extended over 40 years
(Cipolotti et al. 2001). The question of the extent of involvement of the hippocampus in
recall therefore remains to be resolved (reviewed by Rosenbaum et al. 2001; Spiers et
al. 2001).
1.5.2 NMDA Receptor Dependence of Learning
The pharmacological requirements for hippocampal function have also been studied
using a number of receptor antagonists. Intracerebroventricular injections of NMDA
receptor antagonist inactivate the receptor in various brain regions, generating
sensorimotor deficits that may interfere with learning paradigms, confounding
interpretation. To circumvent these side effects, Morris used intrahippocampal
injections of the NMDA receptor antagonist AP5, which prevented spatial learning in
rodents tested in the Morris water maze (Morris et al. 1986; Morris 1989). The
hippocampus, and specifically AMPA receptor activity, is required for the recall of
spatial information (Morris et al. 1990; Riedel et al. 1999), yet the NMDA receptor is
not required for recall (Morris 1989), despite its requirement at the time of learning.
1.5.3 Kinases and Learning
Many studies utilising knockout mice have investigated the role of signalling cascades
in learning and memory with varying success. Initial studies provided promising
evidence of the utility of this technology with mice lacking Fyn and aCaMKII that
showed profound learning deficits, which correlated with impaired LTP (Grant et al.
1992; Silva et al. 1992; Silva et al. 1992). Interpretations of these phenotypes were,
however, accompanied by caveats: Mice lacking fyn exhibited abnormal hippocampal
morphology that could have influenced learning, although field EPSPs and NMDA
receptor contribution to EPSCs were normal (Grant et al. 1992), while the aCaMKII
knockout mice were reported as epileptic (Butler et al. 1995), which may also affect
learning. However, subsequent mutant and transgenic animals established the role of
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aCaMKII in both synaptic plasticity and learning (Bach et al. 1995; Mayford et al.
1995; Mayford et al. 1996; Giese et al. 1998). The role of PKC in learning appears
more peripheral, perhaps acting in a modulatory role, despite early interest from
inhibitor studies in LTP induction in slices. Mice lacking PKCy exhibited impaired LTP
but only mild learning deficits, (Abeliovich et al. 1993; Abeliovich et al. 1993) perhaps
as a result of compensatory activity by other PKC isoforms.
PKA consists of a tetrameric holoenzyme, made up of 2 regulatory (R) subunits and 2
catalytic (C) subunits. Mutation of PKA subunits also generated initially confusing
results. Mice lacking either Rip or C(3l subunits exhibited impaired LTP but normal
learning (Brandon et al. 1995; Huang et al. 1995; Qi et al. 1996), however, PKA
activity was unaffected in mutants and this may explain the dissociation of LTP from
learning (Brandon et al. 1995; Huang et al. 1995). A transgenic mouse expressing
R(AB), an inhibitory form of the Rla that reduced stimulated PKA activity by 25%,
later demonstrated a role for PKA in both synaptic plasticity and learning (Abel et al.
1997).
The MAPK pathway has been implicated in learning by pharmacological inhibition
rather than the use of knockout mice. Infusion of the MEK inhibitor PD098059 into the
hippocampus of rats during water maze training impaired memory performance but not
acquisition of the task (Blum et al. 1999). Unfortunately, mice lacking ERK2 die during
embryonic development (Adams and Sweatt 2002) and therefore cannot provide any
insight into its importance in learning. ERK1 mice displayed some LTP reduction
following strong theta burst (10 bursts of 4 pulses at 100 Hz, 5 Hz burst frequency)
stimulation but 100 Hz-induced hippocampal LTP was unaffected (Mazzucchelli et al.
2002). Spatial learning was not tested, although the two-way avoidance task revealed
improved memory in mice lacking ERK1, which was explained by enhanced ERK2
signalling in the striatum of knockout animals (Mazzucchelli et al. 2002). ERK2 is the
principle ERK isoform activated following high frequency stimulation and MEK
activity (upstream of ERK) is required for LTP induction (English and Sweatt 1996;
34
Chapter 1: INTRODUCTION
English and Sweatt 1997). It therefore appears likely that ERK2 is predominantly
involved in generating LTP while ERK1 might play a modulatory role.
1.5.4 Limitations of Electrophysiological and Behavioural Paradigms
The use of mutant mice reveal not only associations between LTP and learning, but also
the limitations of this technology and the tests for synaptic plasticity and learning. The
limitations of mutant mice are discussed later, however electrophysiological and
behavioural tests will be briefly discussed here.
A common criticism of LTP induction is the use of unphysiological stimuli such as Is
100 Hz, particularly when this is the only stimulation protocol tested. Lower frequency
stimuli (5-10 Hz) and theta burst stimulation (100 Hz bursts at 5 Hz burst frequency)
can also induce NMDA receptor-dependent LTP (Larson et al. 1986; Thomas et al.
1998) and are similar in frequency to theta rhythms that have been observed in the
hippocampus (Bland 1986). Testing only a single stimulation protocol (Is 100 Hz)
might not reveal subtle phenotypes and may be assessing events that are less related to
the molecular mechanisms of learning than LTP generated by more physiological
stimuli. A more rigorous assessment of LTP in mutant animals might therefore test
hippocampal slices over a range of stimulation frequencies and include theta burst
stimulation.
A number of behavioural tests are used to determine learning and memory deficits, yet
often only a single test is used to analyse a new mutant mouse. Again, the use of more
than one test would potentially increase the chances of identifying a learning deficit and
produce more robust conclusions. One of the more widely used tests of learning ability
is the Morris water maze. The Morris water maze was initially designed for the rat,
obviously larger but also more at home in the water than the mouse. This task is
therefore more physically demanding for the mouse and potentially more stressful,
however, with appropriate controls the Morris water maze can be a useful tool in
assessing mutant mice. Overtraining can blunt the sensitivity of the water maze such
that even NMDA receptor antagonists cannot prevent rats learning the position of a
hidden platform (Bannerman et al. 1995). Overtraining may therefore explain some of
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the mutant phenotypes that dissociate altered LTP from learning deficits such as the
inositol-3-phosphate kinase (A) knockout mouse (Jun et al. 1998). This mutant
exhibited enhanced LTP but learning was normal, however, the animals were trained in
the hidden platform task for 40 trials compared to the more common schedule of 20
trials over 5 days. If this mutant were trained over fewer trials, a learning deficit may
therefore be revealed.
1.6 PSD-95, Plasticity and Memory
The clear importance of the NMDA receptor in synaptic plasticity and learning and
memory generated interest in the role of associated proteins such as PSD-95. Could
PSD-95 modulate NMDA receptor function in vivo and did it influence the downstream
effects of NMDA receptor activation?
1.6.1 PSD-95 Deletion Mutant Mouse
To address the role of PSD-95 in vivo, a mutant mouse was generated using
conventional gene targeting techniques (Migaud et al. 1998). An exon encoding part of
PDZ3 was interrupted by a drug resistance cassette; the 5' end of the drug resistance
cassette contained stop codons in all three reading frames, so truncating PSD-95 at
amino acid 346 in PDZ3. Homozygotes were viable and fertile, however, they were
obtained at less than the Medelian frequency: 32% wild type, 52% heterozygote and
16% homozygote. The mutation resulted in the production of a truncated PSD-95
protein containing PDZ domains 1 and 2, expressed at <20% levels of wild type protein.
However, immunoprecipitation assays did not identify the truncated protein associated
with the NMDA receptor (Migaud et al. 1998), consistent with studies that
demonstrated the SH3 domain and C-terminal sequences were required for correct
localisation of PSD-95 (Arnold and Clapham 1999; Craven et al. 1999).
Synaptic localisation of the NMDA receptor was reduced in mice in which the
intracellular C-termini of NR2A or NR2B had been deleted (Mori et al. 1998;
Steigerwald et al. 2000), implying a role for the NR2A/B C-termini in synaptic targeting
and/or stabilising the receptors at the synapse, presumably via proteins binding these
regions. The effect of the PSD-95 mutation on NMDA receptor localisation was
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therefore investigated. NMDA receptor localisation appeared normal in PSD-95
deletion mutants, perhaps because binding of other MAGUKs compensated for the loss
of PSD-95, although expression of other neuronal MAGUKs (SAP102, SAP97,
chapsyn-110) was unaltered (Migaud et al. 1998). Alternatively, PSD-95 binding may
have no effect on the localisation of NMDA receptors. For example, loss of synaptic
PSD-95 by depalmitoylation did not affect the synaptic localisation of NMDA receptors
(El-Husseini et al. 2002).
In addition to its localisation, NMDA receptor function was unaffected by the PSD-95
mutation (Migaud et al. 1998). It was therefore of great interest that NMDA receptor-
dependent synaptic plasticity was profoundly altered in the PSD-95 deletion mutants.
Enhanced LTP was observed at stimulation frequencies from 1-100 Hz, even though 1
Hz stimulation induced LTD in wild type animals (Migaud et al. 1998). Increased LTP
was not due to impaired inhibition or upregulation of NMDA receptor-independent LTP
in PSD-95 deletion mutants since the GABAa antagonist picrotoxin was able to further
enhance LTP while the NMDA receptor antagonist AP5 completely abolished LTP in
mutant mice (Migaud et al. 1998).
In the water maze, PSD-95 deletion mutant mice were found to be profoundly impaired,
unable to learn the position of the hidden platform, even when extensively trained
(Migaud et al. 1998). PSD-95 therefore has a role in NMDA receptor-dependent
synaptic plasticity and learning and memory but does not alter NMDA receptor channel
properties.
1.6.2 The Role of PSD-95 in LTP: CaMKII Competition
PSD-95 may influence NMDA receptor-dependent processes by modulating
downstream signalling. Such modulation may take the form of altering the localisation
of proteins, particularly those associated with the NMDA receptor.
1.6.2.1 PSD-95 and CaMKII Competitively Bind the NMDA receptor
Multiple proteins bind the NMDA receptor but steric hinderance will limit which
proteins can bind concurrently, and thus define the makeup of any one NMDA receptor
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complex. Regulation of binding may therefore change the properties of an NMDA
receptor complex, influencing the signalling output that results from receptor activation.
CaMKII is a major component of PSDs and is activated by NMDA receptor-mediated
Ca2+ influx, which stimulates autophosphorylation of its autoregulatory domain
(threonine 286 in aCaMKII), conferring Ca2+-independent activity on CaMKH. Ca2+-
independent activity allows CaMKII signalling to continue long after the initial NMDA
receptor-meidated Ca2+ influx, and in addition, autophosphorylation of CaMKII induces
it to translocate to the PSD (Strack et al. 1997) where it binds the NMDA receptor
NR2A or NR2B subunits (Gardoni et al. 1998; Strack and Colbran 1998; Gardoni et al.
1999; Leonard et al. 1999).
CaMKII and MAGUKs bind distinct sites on NR2A/B subunits, MAGUKs binding the
extreme C-termini while CaMKII binds two more N-terminal sites in the intracellular C-
terminal tail (Bayer et al. 2001). The binding of CaMKII and MAGUKs to the NMDA
receptor was predicted to be mutually exclusive due to the considerable steric hindrance
conferred by CaMKII (Kennedy 2000; Fig. 1.5) and competitive binding was
demonstrated in hippocampal slices (Gardoni et al. 2001). It was also shown that
glutamate or high frequency stimulation of hippocampal slices resulted in increased
CaMKII association with immunoprecipitated NMDA receptors, with concomitant
decreases in PSD-95 association and that this activity-stimulated competition could be
blocked by the CaMKII inhibitor KN93 (Gardoni et al. 2001).
1.6.2.2 CaMKII-Stimulated PSD-95 Dissociation
What is the role of CaMKII activity in competitive binding with PSD-95? CaMKII can
associate with NR2A and NR2B subunits without being autophosphorylated, although
autophosphorylation enhances binding (Bayer et al. 2001; Gardoni et al. 2001) which
would presumably shift the binding equilibrium towards CaMKII. However, an
alternative explanation might be that CaMKII activity is required to stimulate the
dissociation of PSD-95 from the NMDA receptor. PSD-95 has been shown to be
phosphorylated by CaMKII in vitro (Yoshimura et al. 2000) and a potential
phosphorylation site exists in the linker region between PDZ2 and PDZ3 that is likely to
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Figure 1.5 Representation of PSD-95 and CaMKII binding to the NMDA receptor.
Binding of a CaMKII dodecamer and PSD-95 to the NMDA receptor is likely to be
mutually exclusive due to steric hindrance. Apart from CaMKII, protein structures have
not been determined in their entirety but are based on the structures of individual
domains or related domains (the AMPA receptor extracellular domain has been used for
the NMDA receptor extracellular domain). No structure information is available for the
NMDA receptor cytoplasmic domain, so it is represented by a form depicting its
approximate size based on molecular weight. Diagram adapted from Kennedy 2000.
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be accessible. The proximity of this phosphorylation site to the PDZ2 domain, which
binds NR2 subunits, raises the possibility that CaMKII phosphorylation regulates PSD-
95 association with the NMDA receptor. In epithelial cells, another tight junction
associated protein, zona ocludens-2 (ZO-2) is a target for PKC. The dispersal of ZO-2
from tight junctions, concomitant with tight junction disassembly, required PKC activity
(Avila-Flores et al. 2001) that potentially regulated its protein interactions. Thus, a
similar mechanism may be present at synaptic junctions, with CaMKII-stimulated
dissociation of PSD-95 from the NMDA receptor facilitating the binding CaMKH.
PSD-95 may therefore act as a brake on LTP by competing with CaMKII for NMDA
receptor binding. Similar to voltage-gated Ca2+ channels (reviewed by Augustine 2001),
activation of the NMDA receptor is likely to produce a calcium microdomain around its
pore such that only Ca2+ -sensitive proteins within the 'activation domain' are activated.
PSD-95 may therefore have 2 roles in binding the NMDA receptor: to locate Ca2+-
sensitive molecules such as nNOS to the NMDA receptor activation domain and to
compete with, and therefore limit activation of CaMKII (Fig 1.6A). In PSD-95 deletion
mutants, CaMKII binding to the NMDA receptor, and so localisation in the activation
domain may be increased, resulting in enhanced CaMKII activation following NMDA
receptor stimulation. Increased CaMKII activation might therefore explain the enhanced
LTP observed in the PSD-95 deletion mutants. However, when Ca2+-independent
CaMKII is expressed in transgenic mice, 5 Hz or 10 Hz-induced LTP was abolished,
although LTP induced by 100 Hz stimulation was unaffected (Mayford et al. 1995;
Mayford et al. 1996).
The level of Ca2+-independent CaMKII activity may act as a record of the stimulation to
which a synapse has been exposed. Such a molecular record might then influence future
outcomes of synaptic activity, for example, previously potentiated synapses can be more
easily depressed, or depotentiated, than naive synapses (Staubli and Lynch 1990). The
level of Ca2+-independent CaMKII activity at the time of stimulation therefore appears
critical in determining whether potentiation or depression results. In PSD-95 deletion
mutant mice the Ca2+-independent CaMKII activity is presumably normal at basal
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Induction of LTP
CaMKII / MAPK phosphorylation of PSD-95
activation
Enhanced LTP generated due to
increased CaMKII signalling
Figure 1.6 PSD-95 gates LTP induction by competing with CaMKII for
NMDA receptor binding. A. NMDA receptor stimulation activates associated
CaMKH (Ca2+ microdomain depicted by yellow circle), producing LTP. LTP
may require an increase in the number ofCaMKII molecules associated with the
NMDA receptor, assisted by CaMKII or MAPK induced dissociation of PSD-95.
Wavy lines attaching PSD-95 to plasma membrane represent palmitoylaion.
In PSD-95 mutants, increased CaMKII association with the NMDA receptor may







activity but more molecules are stimulated following NMDA receptor activation,
resulting in enhanced LTP (Fig 1.6B). Indeed, NMDA stimulation of hippocampal
slices taken from PSD-95 deletion mutants produces an enhanced level of CAMKH
activation (T. O'Dell - personal communication).
It should also be noted that increased CaMKII activity caused the Drosophila PSD-95
homologue, DLG to disperse from the neuromuscular junction (Koh et al. 1999), thus
CaMKII-induced PSD-95 dispersal may represent a conserved mechanism important in
regulating neuronal function.
1.6.2.3 MAPK-Stimulated PSD-95 Dispersal
The MAPK pathway might also stimulate PSD-95 dispersal. The activity of the MAPK
pathway is stimulated by, and required for LTP induction (English and Sweatt 1996;
English and Sweatt 1997). Interestingly, hippocampal slices from PSD-95 deletion
mutants exhibit 5 Hz LTP that is insensitive to MEK inhibitors, yet normal ERK
activation is observed when slices are stimulated with glutamate (T. O'Dell - personal
communication). This implies the PSD-95 mutation has uncoupled MAPK from its
effector. The simplest interpretation of these data is that PSD-95 is a major MAPK
target. A mechanism through which MAPK might influence LTP is by stimulating the
dissociation of PSD-95 from the NMDA receptor, MAPK-induced PSD-95 dispersal
facilitating the association of CaMKII with the NMDA receptor. Such a mechanism
would explain why MEK inhibitors have no effect on the enhanced LTP seen in PSD-95
mice.
1.7 Inducible/Conditional Gene Regulation in Mice
Advances in gene targeting technology have made available various methods to control
gene function or expression in a temporally or spatially restricted manner. Such





Targeting the murine genome and the establishment of mutant mouse lines is now a
widespread technique used to study physiological and behavioural processes in vivo.
Key to the generation of mutant mice is the in vitro manipulation of the endogenous
gene locus by homologous recombination. In vitro targeting is performed on embryonic
stem (ES) cells, which are derived from the inner cell mass of pre-implantation embryos
(Evans and Kaufman 1981; Martin 1981) and can be cultured in vitro without losing
their pluripotency. Indeed, cultured ES cells can be injected into blastocysts, forming
chimeras with exogenous ES cell contribution to all somatic tissues, including the germ
line (Bradley et al. 1984). This feature of ES cells is critical for the generation of
mutant mouse lines, since chimeras containing mutated cells are capable of transmitting
the mutation through the germline to their offspring (Gossler et al. 1986; Robertson et
al. 1986).
The targeting of endogenous loci by homologous recombination is a rare event and
therefore the use of drug resistance cassettes increases efficiency considerably. Insertion
of the cassette into the genome can therefore be selected for by the addition of the
relevant drug to the cell media. However, this method does not distinguish between
random and correct insertion of the targeting vector, the drug-resistant clones must
therefore be screened by either polymerase chain reaction (PCR) or Southern blotting to
identify clones with integration of the targeting vector into the correct locus (Vega
1995).
1.7.2 Conditional Control of Gene Expression
The importance of temporal and spatial control is also evident in the study of brain
function, and particularly memory formation. Learning and memory requires the
involvement and interaction of multiple brain regions, however, conventional gene
targeting is unable to address protein function in distinct brain regions. Conditional
techniques allow elegant studies to be performed that can investigate the function of a
protein not only in specific brain regions, but also in different phases of memory, for
example encoding versus retrieval. A conditional approach is therefore desirable and
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two methods are proven in their usefulness, conditional gene inactivation and inducible
gene expression.
1.7.2.1 Inducible Gene Expression
A major system for controlling gene expression exploits the tetracycline (Tet) resistance
operon (tetO). The tetracycline-controlled transcriptional activator (tTA) drives
expression via tetO, but in the presence of the tetracycline analogue, doxycycline,
transcription is repressed (Gossen and Bujard 1992). However, doxycycline is stored in
muscle and bone and so not rapidly eliminated from the body. tTA was therefore
mutated and a reverse tTA (rtTA) identified in which doxycycline stimulates
transcription instead of repressing it (Gossen et al. 1995). Thus, initiation of
transcription follows doxycycline distribution kinetics as opposed to the slower rate of
elimination.
The Tet system therefore consists of 2 elements: a tTA or rtTA transcriptional activator
and a tetO-driven transgene of interest. Regional expression of the transcriptional
activator transgene can be achieved by the use of an appropriate promotor, for instance,
the aCaMKII promotor can drive expression in the forebrain (Mansuy et al. 1998).
However, randomly inserted transgenes, such as those that constitute the Tet system, can
be influenced by chromosomal position effects and copy-number independence
(reviewed by Bishop 1999). Integration into different chromosomal sites can influence
the expression level of the transgene and can affect the tissue distribution and time of
onset of expression. Copy-number independence is observed when the expression level
of a transgene does not correspond to the number of copies of the transgene integrated;
indeed, a high copy-number can result in silencing of the transgene. Another possible
consequence of random transgene integration is mosaic expression, which is observed as
patchy expression of a transgene through a tissue. Inserting transgenes into the genome
at defined loci by homologous recombination can circumvent the problems associated
with random integration of trangenes. The rosa26 locus is well characterised, drives
ubiquitous expression of transgenes (Zambrowicz et al. 1997) but is apparently
dispensable and therefore represents an excellent target for this kind of approach.
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Despite the problems associated with random integration of trangenes, the utility of the
Tet system for the study of learning and memory has been well demonstrated. A Ca2+-
independent aCaMKII mutant or a calcineurin inhibitor peptide have both been
expression under the control of the tetO promotor and both animals exhibited
phenotypes that were entirely reversible with the addition or removal of doxycyclin
(Mayford et al. 1996; Malleret et al. 2001).
1.7.2.2 Conditional Gene Inactivation
For conditional gene inactivation to be useful, the function of the gene of interest must
remain intact until inactivation is desired and inactivation should be complete.
Conditional gene inactivation utilises the bacteriophage recombinase Cre or the yeast
recombinase Flp, which catalyse recombination between short (34 bp) recognition
sequences, Cre recognising loxP sites and Flp recognising FRT sites respectively.
Recombination of two recognition sites in series excises the intervening DNA,
producing a site-specific deletion.
Homologous recombination can deliver loxP or FRT sites into specific loci, and by
placing the recombination sites in introns, gene function is maintained in the absence of
the relevant recombinase. This method has allowed genes such as the NMDA receptor
NR1 subunit to be targeted (Tsien et al. 1996), mutation of which is lethal if inactivated
by conventional vectors (Forrest et al. 1994). Addition of recombinase results in
excision of the DNA flanked by loxP or FRT sites, and a loss of gene product, assuming
essential exons have been flanked. The Cre-loxP system has been more widely used
than Flp-FRT, so studies using Cre-loxP will be focussed on for discussion.
The key to this type of conditional system is the control of the recombinase. Cre can be
delivered to mice containing genes flanked by loxP sites (or floxed) by either crossing
targeted mice with Cre-expressing mice, or by injecting the mice with Cre-expressing




Cre expression can be limited to specific tissues or regions through the use of tissue-
specific promotors. For example, transgenic mice in which Cre expression was driven
by the CNS-specific Thy-1 promotor exhibited expression in the brain but not liver
(Kellendonk et al. 1999) while aCaMKII promotor-driven Cre was restricted to the
forebrain (Tsien et al. 1996). Different transgenic lines may exhibit a range of
expression patterns, although the same promotor may drive expression of Cre. This was
observed for the aCaMKII-driven Cre lines where Cre expression in the T29-2 line was
broadly distributed, with significant expression across the forebrain, while the T29-1
line exhibited enriched expression in the CA1 region of the hippocampus with little
expression seen outside the hippocampus (Tsien 1996a). The serendipitous expression
pattern of the T29-1 line proved particularly useful for the study of CA1 function in
synaptic plasticity and learning and memory (Tsien et al. 1996). Hippocampal or CA1-
enriched expression of Cre therefore allows the involvement of proteins in discrete brain
regions to be examined.
In addition to limiting Cre expression in a regional manner, it is possible to limit either
its activity or expression in a temporal fashion. The Tet system can be used to regulate
Cre expression (St-Onge et al. 1996), however a Tet-driven Cre transgenic exhibiting
suitably restricted brain expression has not yet been developed. Alternatively, the
activity of Cre can be controlled in a hormone-dependent manner by fusing Cre to a
mutated steroid hormone binding domain. The resulting fusion protein requires the
presence of a synthetic ligand for Cre activity, but is not activated by endogenous
steroids. Hence, Cre fused to a mutant progesterone binding domain (Cre-Pr) is
activated by RU486 but not progesterone while Cre fused to mutant oestrogen binding
domain is activated by 4-hydroxy-tamoxifen but not endogenous estrogens (Kellendonk
et al. 1996; Zhang et al. 1996; Schwenk et al. 1998; Kellendonk et al. 1999). Initially,
control of Cre activity in these systems was poor and Cre activity was observed in the
absence of ligand, although further mutation of the ligand binding domain has
considerably reduced background recombination (Indra et al. 1999; Wunderlich et al.
2001).
1.7.2.2.2 Adenoviral Delivery of Cre
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To maximise the benefits of the Cre-loxP system, both spatial and temporal control are
desirable. The direct injection of Cre-expressing vectors such as the adenoviral system
provides one with reasonable control over when and where Cre is expressed. Systemic
injection of Cre-expressing adenovirus resulted in a wide tissue distribution, although
preferential expression in some organs was observed while expression was absent from
the brain (Akagi et al. 1997). Harding and coworkers demonstrated transfection of
hippocampal neurons in vivo by injection of green fluorescent protein-expressing
adenovirus directly into the brains of rats (Harding et al. 1998). The stereotactic surgery
used in this study allows injections to be accurately directed to specific brain regions,
thus not only the time, but also the location of Cre expression can be dictated. Another
major benefit of this system is that one is not constrained by the availability of Cre
transgenics when choosing to target a specific brain region.
1.8 Aims and Objectives
The PSD-95 deletion mutant mouse has enhanced our understanding of the role of PSD-
95 in synaptic plasticity and learning, however, the utility of this mutant is limited due
to the ubiquitous nature of the mutation and the presence of the truncated protein
containing PDZ domain 1 and 2. While the truncated protein was not found in
synaptosomal fractions and did not associate with the NMDA receptor, it remains
possible that the truncated protein acted in a dominant negative fashion. Binding of the
mislocalised, truncated PSD-95 protein with PDZ1 or PDZ2 ligands may result in the
mislocalisation of the associated proteins, altering neuronal physiology. To counter this
argument, a null allele is clearly necessary.
This thesis will describe the generation of a conditional PSD-95 null allele that will
enable the role of PSD-95 to be explored in greater detail. Such a conditional system
will allow PSD-95 function to be modulated in a spatially and/or temporally restricted
manner in vivo to address questions such as the dependence of hippocampal PSD-95
expression for learning. Another interesting question that could be addressed using this




To target PSD-95 and ensure the production of a null allele, the gene has been fully
characterised, including the identification of intron-exon boundaries and splice variants.
The study of mouse PSD-95 yielded interesting data about the organisation and variation
of the gene and its transcripts in addition to providing information for designing the
targeting strategy.
PSD-95 may also have a role in anaesthesia since antisense knockdown of PSD-95 in
the spinal cord results in an enhanced sensitivity to isoflurane. The mechanism of
action of volatile anaesthetics such as isoflurance is still under debate, however, NMDA
receptors do not appear to be major targets for volatile anaesthetics. To further study the
role of PSD-95 in anaesthesia, the sensitivity of PSD-95 deletion mutants to volatile
anaesthetics has been tested.
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All general reagents were analytical grade or better from BDH, Fischer, Fluka or Sigma.
2.1 General Molecular Biology Methods and Techniques
Basic molecular biology techniques were performed as described in Sambrook and
Russell (2001).
2.1.1 Cloning
2.1.1.1 DNA Cloning from Conventional Plasmids
Following restriction enzyme digest, DNA plasmids and fragments were separated by
gel electrophoresis and the desired DNA fragments purified using the Geneclean Spin
kit (Anachem).
Purified plasmids and inserts were ligated at a ratio of 1:1 overnight at 16°C using 1U
T4 DNA ligase (Roche) and the accompanying ligation buffer in a final volume of
between 10 and 20p,l.
2.1.1.2 DNA Cloning from PAC Plasmids
lpg PAC plasmid DNA was cut with 60U restriction enzyme at 37°C overnight. Cut
PAC plasmid DNA was then purified by phenol/chloroform extraction and ethanol
precipitation. pBluescript KSII (Invitrogen) was prepared by restriction enzyme digest
and Geneclean purification and subsequently phosphatased for 30 min at 37°C using 1U
shrimp alkaline phosphatase (Roche) and the accompanying phosphatase buffer.
lp,g digested PAC plasmid was ligated with 5ng phosphatased pBluescript overnight at
16°C using 1U T4 DNA ligase (Roche) and the accompanying ligation buffer in a final
volume of 10pl.
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2.1.1.3 TA Cloning of PCR Products
PCR products were either purified by gel electrophoresis followed by GeneClean Spin
purification or used directly for subsequent steps. If a proofreading polymerase had
been used for PCR, adenosine overhangs were added by 1 hour incubation at 72°C of
product with 1.5mM MgCE, 0.2mM dATP, 1U Taq polymerase (Promega) and the PCR
reaction buffer (Promega) in a final volume of 10 to 20pl. Products ready for cloning
were TA cloned using either pGEM-T Easy (Promega) or TOPO XL (Invitrogen) kits
using the supplier's instructions.
2.1.1.4 Generation and Transformation of Competent E. Coli
5mls of LB was inoculated with a single colony of bacteria (DH-5a or DH-10B) and
grown overnight in a shaking incubator at 37°C. 250mls of LB was inoculated with
5mls of the stationary overnight culture and grown in a shaking incubator at 37°C until
OD6oo had reached -0.5. The culture was transferred to 50ml falcon tubes, chilled on
ice, spun down at 4°C and the supernatant discarded.
2.1.1.4.1 CaCh-Competent Bacteria
Lollowing centrifugation, the bacteria were resuspended in Vi volume (25ml per tube)
ice-cold 50mM CaCE and left on ice for 15min. They were then centrifuged as before,
the supernatant discarded and bacteria taken up in '/i0 volume (5ml per tube) ice-cold
freezing mix (lOOmM KC1, 50mM CaCE, 10% glycerol, lOmM KAc pH 7.5). The
bacterial suspension was aliquoted into eppendorf tubes on dry ice and the aliquots
stored at -70°C.
To transform, up to 5p,l of ligation was added to 200pl bacteria on ice and the mixture
then transferred to a 15ml snap cap falcon tube on ice. The bacteria were incubated on
ice for 30min and then heat shocked at 42°C for 90seconds after which they were chilled
on ice for a further 2-3min. 800pl of SOC medium was added to the bacteria and the
cultures incubated at 37°C for 30-60min in a shaking incubator (225rpm). The
transformed bacteria were spread onto agar plates containing the appropriate antibiotic
and incubated overnight at 37°C.
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2.1.1.4.2 Electrocompetent bacteria
Following centrifugation, the bacteria were resuspended in the 50ml of ice-cold 10%
glycerol. They were centrifuged at 4°C, the supernatant discarded and the ice-cold 10%
glycerol wash repeated. The bacteria were centrifuged a third time, resuspended in
120pl 10% glycerol per tube and 40pl aliquots made in eppendorf tubes, snap frozen in
liquid N2 and stored at -70°C.
l|Lil of ligation was added to a 40pl aliquot on ice and the mixture transferred to a pre-
chilled 0.2ml electroporation cuvette. The bacteria were electrotransformed in a Gene
Pulser (BioRad) set at 25pF, 200L2, 2.5 kV. 1ml of SOC medium was immediately
added to the cuvette, the bacteria transferred to 15ml snap cap falcon tubes and
incubated at 37°C for 30-60min in a shaking incubator (225rpm). The transformed
bacteria were spread onto agar plates containing the appropriate antibiotic and incubated
overnight at 37°C.
2.1.1.5 Screening Transformants
LB containing the appropriate antibiotic was inoculated with a single colony and
incubated overnight at 37°C in a shaking incubator. Plasmid was purified from the
stationary culture (see Plasmid Preparation below) and analysed by restriction enzyme
digest and/or PCR.
2.1.2 Isolation of Nucleic Acids
2.1.2.1 Plasmid Preparation
Small-scale plasmid purification was performed using QIAprep miniprep spin kits
(Qiagen), Wizard plus miniprep kits (Promega) or the lysozyme miniprep method (see
below). Large-scale plasmid purification was performed using Midi or Maxi kits
(Qiagen).
2.1.2.1.1 Lysozyme Miniprep
1.5ml stationary culture was spun down in a bench top microfuge. All supernatant was
removed and the bacteria resuspended in 120pl STET buffer (8% sucrose, 0.5% Triton
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X-100, 50mM EDTA, lOmM Tris pH 7.4). 20pl lysozyme solution (20mg/ml) was
added and the tube incubated at 100°C for 50 s. The tube was immediately spun in a
microfuge for 10 min at 14000 rpm at room temperature (RT). The glutinous precipitate
was removed and 120jll isopropanol added to the supertnatant. Samples were then
placed at -20°C for 20 min, after which the precipitated DNA was recovered by
centrifugation at 14000 rpm for 10 min at RT. The DNA pellet was washed with 70%
ethanol, air dried and resuspended in 35pl of dH20 containing 34pg/ml RNase A.
2.1.2.2 PAC Plasm id Preparation
PAC clones were delivered as E. coli smeared on agar containing kanamycin selection.
Each clone was restreaked onto fresh kanamycin agar plates before use. High quality
PAC plasmid was purified using Qiagen Large Contruct kits. High yield PAC plasmid
purification was performed using a protocol from the University of Oxford
Bioinformatics wed page:
(www.molbiol.ox.ac.uk/~jmejia/more_protocols.html).
2.1.2.2.1 Large-scale Preparation of PAC or BAC DNA
500ml of 2xTY medium containing 0.2 % glycerol and 25pg kanamycin was inoculated
with 5 ml of an overnight culture and shaken at 37°C for 5-6 hours or overnight. The
culture was transferred into three 250-ml polypropylene centrifuge bottles, spun at 5500
rpm for 7 min, 4°C, in the GSA rotor of a Sorval centrifuge and the supernantant
discarded. Each bacterial pellet was resuspended in 20 ml of buffer (50 mM Tris-HCl,
pH 8.5, 10 mM EDTA). 40 ml of 1 % SDS, 0.2 M NaOH solution was added to each
bottle and gently mixed. 30 ml of 7.5 M ammonium acetate was immediately added, the
bottle capped and inverted. The bottles were chilled on ice for 15 min then centrifuged
at 10 000 rpm for 15 min at 4°C. The supernatants were poured into 2 fresh bottles
through a layer of gauze (each of the new bottles will thus hold the contents of IV2
original bottles) that were then centrifuged at 10 000 rpm for 15min at 4°C. The
supernatants were decanted through gauze, 0.5 vol. of isopropanol added and
centrifuged at 10 000 rpm for 10 min at room temperature. Supernatants were
discarded, each pellet resuspended in 1.5 ml of buffer (50 mM Tris-HCl, pH 8.5, 10 mM
EDTA) containing 50 |U,g/ml RNase A and incubated at 37°C for 1 hour. 0.1 volume of
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10 % SDS was added and mixed. Proteinase K was added (final concentration of 0.2
mg/ml) and incubated at 50-60°C for 3-4 hours. DNA was extracted with buffered
phenol (pH 8), buffered phenol-chloroform (1:1) and chloroform, successively with
centrifugations at 2000 rpm in a swinging bucket rotor for 10 min. 7.5 M ammonium
acetate was added to a final concentration of 2.5 M and the DNA precipitated with 0.5
volume isopropanol at room temperature. DNA was spun down in glass Sorval tubes in
a SS34 rotor at 12000 rpm, 5 min. The DNA pellet was washed with 1 ml 70 % ethanol
and resuspended in 300 /xl of TE buffer.
2.1.2.3 Isolation of Genomic DNA
Cells were incubated at 55°C overnight in Laird buffer (lOOmM Tris.HCI pH8.5,
200mM NaCl, 5mM EDTA, 0.2% SDS) containing 20mg/ml proteinase K. DNA was
extracted with buffered phenol (pH 8) and buffered phenol-chloroform-isoamylalcohol
(25:24:1) then precipitated with 1 volume isopropanol. DNA was washed with 70%
ethanol and resuspended in TE.
2.1.2.4 Isolation of RNA
RNA was prepared from tissues using Trizol reagent (Sigma). Brains were
homogenised using 1 ml Trizol reagent per 50-100mg of tissue. Homogenates were
centrifuged at 12000 x g for 10 min at 4°C to remove insoluble material. The
supernatant was collected, 0.2 ml CHCL3/ml Trizol was added and mixed vigorously
and then centrifuged at 12000 x g for 10 min at 4°C. The supernatant was transferred to
a new tube and 0.5 ml isoproanol/ml Trizol was added and incubated at RT for 10 min
and centrifuge at 12000 x g for 10 min at 4°C. Remove supernatant, wash RNA pellet
with 75% ethanol, briefly air dry and resuspend RNA in DEPC H20.
2.1.3 Nucleic Acid Transfer to Membranes
2.1.3.1 Colony Lifts
Nylon filters were laid onto agar plates containing the relevant antibiotic. Transformed
bacteria were then spread onto the filters and incubated overnight at 37°C; these are the
master filters. Duplicate filters were laid on fresh agar plates to wet. A master filter was
peeled off an agar plate and laid, colony side up, onto Whatman 3M papers. A duplicate
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filter was removed from its agar plate and laid, agar side up, on top of the master filter.
The filters were marked for orientation by puncturing 3 holes around their edges with a
needle. Whatman 3M paper was laid on top of the filters and gentle, even pressure
applied to the stack. The filters were carefully separated and replaced to their respective
agar plates. The duplicate filter was then incubated at 37°C for 3-4 hours until the
duplicate colonies had grown. To lyse the bacteria, the duplicate filter were peeled off
the agar plate and placed onto Whatman 3M paper wetted with a 2xSSC, 5%SDS
solution. To bake the DNA onto the filters, they were microwaved at full power for 30-
90 seconds until the colonies looked glassy.
2.1.3.2 Southern Blotting
2.1.3.2.1 Restriction Enzyme Digest of Genomic DNA
For digests using a single restriction enzyme: To approximately 10p,g of genomic DNA
was added 120U of restriction enzyme and 5pl of lOx digestion buffer, the volume
adjusted to 50pi with sterile H20. For digests using 2 restriction enzymes: To
approximately lOpg of genomic DNA was added 120U of each restriction enzyme and
9p,l of lOx digestion buffer, the volume adjusted to 90|u.l with sterile H20. Reactions
were incubated overnight at 37°C.
2.1.3.2.2 Restriction Enzyme Digest of PAC DNA
To l-2p,g of PAC DNA was added 50-60U of restriction enzyme and 5pl of lOx
digestion buffer, the volume adjusted to 50|ll1 with sterile H20. Reactions were
incubated overnight at 37°C.
2.1.3.2.3 Alkali Blotting
Restriction enzyme-digested genomic DNA was run on a 0.6% agarose gel overnight.
The gel was photographed and treated with depurination solution (0.25M HC1) for 15
min. The gel was then treated with denaturation solution (0.5M NaOH, 1.5M NaCl) for
20 min before being placed onto a Whatman 3M filter wick dipped into the transfer
solution (0.4M NaOH). A Hybond N+ nylon membrane, pre-wetted in transfer solution,
was placed onto the gel followed by 4 pieces of Whatman 3M filter paper. A stack of
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paper towels were paced on top of the Whatman filters and finally a weight was added.
Gels were blotted for at least 12 hours. After blotting, the nylon membrane was washed
in 2x SSC.
2.1.4 Hybridisation of Nucleic Acids Bound to Membrane
2.1.4.1 Probes
2.1.4.1.1 PDZ1+2 Probe (nucleotide 1-983)
A PSD-95 PDZl+2-specific probe was generated by restriction enzyme digest of a rat
PSD-95 cDNA plasmid (gift from M. Sheng). Smal-EcoRI restriction enzyme digest
produced a cDNA fragment encompassed the PSD-95a N-terminal sequence and the
first 2 PDZ domains, terminating with the Smal site at nucleotide 983.
2.1.4.1.2 PDZ1, PDZ3 and Exons 1-4 Probes
All probes were generated by PCR (see PCR section below).
2.1.4.1.3 5' Probe for Screening Targeted Clones
Subclone SacI (LR) was cut with EcoRI restriction enzymes and an ~500bp fragment
was purified and used as the 5' probe. This fragment contained sequence between the 2
EcoRI sites in PSD-95 intron 1, which was external to the targeting vector.
2.1.4.1.4 3' Probe for Screening Targeted Clones
A subclone (subclone D) derived from the mouse genomic lambda clone (Migaud et al.
1998) was cut with BamHI and EcoRI restriction enzymes and an ~1735bp fragment
was purified and used as the 3' probe. This fragment contained genomic sequence from
the BamHI site in PSD-95 intron 16 to the EcoRI site in intron 18, which was external to
the targeting vector.
2.1.4.2 32P Labelled Probes
Probes were 32P labelled using the Megaprime DNA labelling system (Amersham).
25ng of probe and random nonomer primers were denatured in 33pl at 95°C for 5min
and allowed to cool to room temperature. Labelling buffer (dATP, dGTP, dTTP in
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Tris/HCl pH7.5, 2-mercaptoethanol, MgCl2), 2U klenow and 50pCi [32P] dCTP was
added to a final volume of 50[il. This mix was incubated at 37°C for 30-45min. The
labelled probe was separated from unincorporated nucleotide by passing through Micro
Bio-Spin 30 chromatography columns (BioRad) at lOOOxg for 4 min.
2.1.4.3 Hybridisation of Mouse Genomic PAC Library
The PAC library, obtained from the UK HGMP resource centre, was constructed using
female 129/SvEvTACfBr mouse spleen genomic DNA partially digested with Mbol.
PAC clones were gridded onto nylon hybridisation filters such that each filter contained
over 18,000 distinct mouse PAC clones per filter with each clone arrayed in duplicate to
allow correct identification of specific versus non-specific signals. The high density
filters were hybridised as per the manufacturer's instructions. Filters were pre-
hybridised in Church buffer (lOmg/ml BSA, ImM EDTA, 0.5M NaP04 (pH7.2), 7%
SDS) for 1 hour at 65°C. The PDZ1+2 probe was 32P labelled (as above) and incubated
with the filters in Church buffer overnight at 65°C. The filters were washed to moderate
stringency (40mM NaP04 (pH7.2), ImM EDTA, 1% SDS) and exposed to film
overnight.
2.1.4.4 Hybridisation of Southern Blots
Hybridisations were performed in Techne hybridisation bottles rotating in a Techne HB-
1 oven using approximately 25mls of hybridisation buffer (0.5M Na2HP04 (pH7.2), 7%
SDS, O.lmg/ml salmon testes DNA). Prehybirdisation, hybridisation and washes were
carried out at 65°C.
Southern blots were prehybridised for 10 min to 1 hour in hybridisation buffer.
Radiolabelled probe was denatured at 100°C, snap cooled on ice and added to the
hybridisation buffer. Filters were hybridised overnight. Following hybridisation, filters
were washed at least 2x 10 min in wash buffer (2x SSC, 0.5% SDS). If required, higher
stringency washes were performed: 2x 10 min using 0.5x SSC, 0.1% SDS. After
washes, filters were wrapped in Saran wrap and exposed either to autoradiographic film
at -70°C for up to 4 days or to phosphorimaging plates for up to 3 days.
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2.1.4.5 Hybridisation of Colony Lifts
Hybridisations were performed in 15cm petri dishes in an Innova 4000 shaking oven
(New Brunswick Scientific). 25mls of formamide hybridisation solution was used (50%
formamide, 0.025% sodium pyrophosphate, 5x SSC, 5x Denhardts). Filters were wetted
with 2x SSC and placed into hybridisation solution. No prehybridisation was
performed; hybridisation was carried out overnight at 42°C. Washes were performed
using Techne hybridisation bottles in a Techne-HBl oven at 65°C as described above.
2.1.5 PCR
PCR reactions were carried out on Omnigene (Hybaid), MJ Research DNA Engine
Tetrad (GRI), GeneAmp 9700 (Applied Biosystems) or Mastercycler gradient
(Eppendorf) PCR machines. dNTPs were supplied by Roche and the Taq polymerase
used is indicated in each protocol. Primer sequences are listed in appendix 4.
2.1.5.1 PAC Diagnostic PCRs
2.1.5.1.1 Determination of Regions of PSD-95 Contained in PAC
To approximately 500ng of PAC DNA was added 5pl of lOx system 1 PCR buffer
(Roche), 1.75pl lOmM dNTPs and lpl of each 20p,M forward and reverse primer
(M8144 and M8145; A8643 and SH3 Spe Bot; GK For and RPD; GK Spe Top and 3N).
The volume was adjusted to 49.25pl with sterile H20 and the tube heated to 93°C for 2
min. 0.75pl of Expand Long Range PCR enzyme mix (Roche) was added and the PCR
continued as follows: lOx (93°C for 10 sec, 59°C for 30 sec, 68°C for 1 min); 20x
(93°C for 10 sec, 59°C for 30 sec, 68°C for 1 min + 20 sec/cycle) followed by 68°C for
8 min.
2.1.5.1.2 Comparison of PSD-95 Gene Structure in PAC and Genomic DNA
To 250p,g mouse genomic DNA or 80ng of Qiagen-prepared PAC DNA was added 5pl
of lOx system 3 PCR buffer (Roche), 2.5pl dNTPs, ljxl of each 20mM forward and
reverse primer (5' start and PDZ1 Rev; Exon 2 For and PDZ1 Rev; PDZ1 For and
A8646; A8643 and B7524) and the volume made up to 49.25pl with sterile water. The
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reaction mix was heated to 94°C for lOmin after which 0.75|4l of Expand long range
PCR enzyme mix (Roche) was added and the PCR continued as follows:
5' start / PDZ1 Rev
lOx 94°C for 10 sec
60°C for 30 sec
68°C for 15 min
20x 94°C for 10 sec
60°C for 30 sec
68°C for 15 min + 20 sec/cycle
lx 68°C for 7 min
PDZ1 For / A8646
lOx 94°C for 10 sec
60°C for 30 sec
68°C for 8 min
20x 94°C for 10 sec
60°C for 30 sec
68°C for 8 min + 20 sec/cycle
lx 68°C for 7 min
Exon 2 For / PDZ1 Rev
lOx 94°C for 10 sec
66°C for 30 sec
68°C for 3 min
20x 94°C for 10 sec
66°C for 30 sec
68°C for 3 min + 20 sec/cycle
lx 68°C for 7 min
A8643 / B5724
lOx 94°C for 10 sec
58°C for 30 sec
68 °C for 4 min
20x 94°C for 10 sec
58°C for 30 sec
68 °C for 4 min + 20 sec/cycle
lx 68°C for 7 min
2.1.5.1.3 Exon Orientation in Subclones
Hotstar Taq (Qiagen) was used for PCRs involving BamHI (9): To lfil of miniprep
(approximately 250ng) was added 5p,l lOx PCR buffer (Qiagen), 1 p.1 lOmM dNTPs, Ipd
of 20mM reverse primer (PDZ1 Rev; PDZ2 Rev), lp,l 20mM t3 or t7 primer, 0.25p,l
Hotstart Taq polymerase (Qiagen) and the volume adjusted to 50p,l using sterile H20.
The reaction mix was cycled as follows: lx (95°C for 15 min); 30x (94°C for 10 sec,
59°C for 30 sec, 72°C for 3 min).
Expand Long Range PCR system 3 was used for PCRs involving SacI (1), SacI (20) and
Kpnl (4): To lpl of miniprep (approximately 250ng) was added 5p,l lOx PCR buffer
(Roche), 2.5 p.1 lOmM dNTPs, lp.1 of 20mM forward primer (Exon 2 For; PDZ1 For; 5'
start) and l|il 20mM t3 or t7 primer. The volume was adjusted to 49.25p.l, the reaction
mix heated to 94°C for 10 min after which 0.75pil enzyme mix (Roche) was added and
the PCR continued as follows: lOx (94°C for 10 sec, 55°C for 30 sec, 68°C for 3 min);
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20x (94°C for 10 sec, 55°C for 30 sec, 68°C for 3 min + 20 sec/cycle) followed by 68°C
for 7 min.
2.1.5.2 Southern Probe PCRs
PCR protocols to generate probes are listed below. Subsequent to PCR, products were
ran out on an agar gel and purified using either QIAEX II (Qiagen) or Geneclean
(Anachem) gel extraction kits.
2.1.5.2.1 PDZ1 Probe (nucleotides 5-503)
To 200ng PSDS-95 cDNA was added 5pl lOx PCR buffer (Qiagen), lpl lOmM dNTPs,
ljLtl 20mM 5' start, lpl 20mM PDZ1 Rev and 0.25)0,1 Hotastar Taq polymerase (Qiagen).
The volume was adjusted to 50pl with sterile H2O. PCR conditions were as follows: lx
(95°C for 15 min); 30x (94°C for 30 s, 60°C for 1 min, 72 °C for 1 min).
2.1.5.2.2 PDZ3 Probe (nucleotides 986-1572)
To 200ng PSDS-95 cDNA was added 5pi lOx PCR buffer (Qiagen), 1 pi lOmM dNTPs,
lpl 20mM A8643, lpl 20mM GK Spe Bot and 0.25pl Hotastar Taq polymerase
(Qiagen). The volume was adjusted to 50pl with sterile H20. PCR conditions were as
follows: lx (95°C for 15 min); 30x (94°C for 30 s, 63°C for 1 min, 72 °C for 1 min).
2.1.5.2.3 Exon 1-4 Probe (nucleotides 5-280)
To 50ng PSD-95 cDNA was added 5pi lOx PCR buffer (Qiagen), lpl lOmM dNTPs,
lpl 20mM 5' start, lpl 20mM M8145 and 0.25pl Hotastar Taq polymerase (Qiagen).
The volume was adjusted to 50pl with sterile H20. PCR conditions were as follows: lx
(95°C for 15 min); 35x (94°C for 30 s, 60°C for 1 min, 72 °C for 30 s).
2.1.5.3 RT-PCR
2.1.5.3.1 First Strand Synthesis
First strand cDNA was generated from 2 to 5pg mouse brain total RNA using oligo dT
with Superscript II (Invitrogen) as per the suppliers directions. For 5' RACE, the
SMART cDNA kit (Clonetech) was used for first strand synthesis as per the suppliers
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instructions using 0.9pg total RNA, the SMART IV oligo and Exon 2 Rev reverse
primer with Powerscript reverse transcriptase (Clonetech).
2.1.5.3.2 Exon 2 Splice Variant PCR
To 10% of first strand cDNA was added 10pl of PCR buffer (Promega), 6pl of 1.5mM
MgCh, 2pl of lOmM dNTPs, lpl of 5' start and lpl of PDZ1 Rev. The volume was
adjusted to 49pl with sterile H20 and the reaction mix heated to 94°C for 3 min after
which ljxl of Taq polymerase (Promega) was added and the PCR continued as follows:
35x (94°C for 15 s, 59°C for 45 s, 72°C for 45 s).
2.1.5.3.3 5'RACE
To 20% of first strand cDNA was added 5pi of Expand Long Range PCR kit lOx PCR
buffer (Roche), lpl lOmM dNTPs, 2pl lOmM 5' PCR primer (Clonetech) and lpl
20mM 5' Start Rev. The volume was adjusted to 49pl and the reaction mix heated to
94°C for 1 min after which lpl enzyme mix (Roche) was added and the PCR continued
as follows: lOx (94°C for 10 s, 60°C for 30 s, 68°C for 6 min); 20x (94°C for 10 s, 60°C
for 30 s, 68°C for 6 min + 20 s/cycle).
2.1.5.4 Screening Targeted ES Cell Clones
2.1.5.4.1 Screening for Selection Cassette Excision
To lpl of genomic DNA (~500ng) was added 5pl lOx PCR buffer (Qiagen), lpl lOmM
dNTPs, lpl 20mM Sac 1 For 2, lpl 20mM M3 Rev, lpl 20mM LP3 Rev and 0.25pl
Hotastar Taq polymerase (Qiagen). The volume was adjusted to 50pl with sterile H20.
PCR conditions were as follows: lx (95°C for 15 min); 30x (94°C for 10 s, 60°C for 30
s, 72 °C for 1 min 25 s).
2.1.5.4.2 Screening for Presence of loxP Sites
To lpl of genomic DNA (~500ng) was added 5pl lOx PCR buffer (Qiagen), lpl lOmM
dNTPs and 0.25pl Hotastar Taq polymerase (Qiagen). To PCR across the 5' loxP site,
lpl 20mM Sac 1 For 3 and lpl 20mM M4 Rev was added. To PCR across the 3' loxP
site, IjllI 20mM 631-9 For and lpl 20mM LP3 Rev was added. The volume was adjusted
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to 50|il with sterile H20. PCR conditions were as follows: lx (95°C for 15 min); 30x
(94°C for 10 s, 60°C for 30 s, 72 °C for 1 min). Products generated to screen for the 3'
loxP site were digested with the EcoRI restriction enzyme to determine the presence of
the EcoRI site that was included in the loxP site oligo: To 10pl PCR product was added
3(il buffer H (Roche), 1U EcoRI and the volume adjusted to 30pl with sterile H20. The
reaction was incubated at 37°C for 1 hour.
2.1.6 DNA Sequencing
To 500ng of template was added 3.2 pmoles of primer, 4pl Big Dye Terminator reaction
mix (ABI) and the volume adjusted to 10|ol with sterile H20. PCR conditions were as
follows: 25x (96°C for 30 s, 50°C for 15 s, 60°C for 4 min). Following PCR, reaction
products were precipitated and then ran out by the Centre for Genome Research
sequencing service. All sequences were analysed using GeneJockey 2 (Biosoft).
2.1.6.1 Online Sequence Analysis
2.1.6.1.1 NCBI BLAST
The National Centre for Biotechnology Information (NCBI) basic local alignment search
tool (BLAST; http://www.ncbi.nlm.nih.gov/BLAST) was used to identify local regions
of sequence similarity between a candidate sequence and sequences in the GenBank
sequence database.
2.1.6.1.2 Translate
The Translate tool (http://ca.expasy.org/tools/dna.html) was used to translate all 3
cDNA reading frames of cDNA sequence to protein sequence.
2.1.6.1.3 ScanProsite
ScanProsite (http://ca.expasy.org/tools/scanprosite) was used to scan protein sequences
for patterns in the Prosite database.
2.1.6.1.4 Grail 1.3
The gene recognition and assembly internet link (Grail) version 1.3 (http://compbio.ornl.
gov/Grail-1.3) was used to screen genomic sequence for CpG islands.
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2.1.6.1.5 NNPP
Neural network promotor prediction (NNPP; http://www.fruitfly.org/seq_tools/
promoter.html) was used to screen genomic sequences for possible transcription
promoters.
2.1.6.1.6 Proscan 1.7
Proscan 1.7 (http://bimas.dcrt.nih.gov/molbio/proscan) was used to screen genomic
sequences for transcription promoters and to identify transcription factor binding sites.
2.1.6.1.7 UTR Scan
UTR scan (http://bighost.area.ba.cnr.it/BIG/UTRScan) was used screen for untranslated
region (UTR) functional elements defined in UTRsite.
2.1.6.1.8 EMBOSS
EMBOSS (http://www.ebi.ac.uk/emboss/align) was used to perform global pairwise




Mice were killed by cervical dislocation (Schedual 1 procedure in accordance with UK
Home Office regulations), their brains quickly removed and rapidly cooled in ice cold
PBS. All subsequent steps were performed on ice. The brain was hemisected, one
hemisphere being snap frozen in a methanol/dry ice bath while the other hemisphere
was weighed and placed in ice cold deoxycholate (DOC) buffer (1% DOC, 50mM
Tris.Cl pH9, 50mM NaF, 200pM ZnCl2, 0.5mg/ml phenylmethylsulfonyl fluoride
(PMSF), ImM Na vandate, 1.125x Complete protease inhibitors (Roche)) at a ratio of
0.38g wet weight to 7 ml DOC buffer. The hemisphere in DOC buffer was
homogenised with 20 strokes of a loose-fitting type S pestle in a Potter-Elvehjem
homogeniser. The homogenate was cleared by centrifugation at 25000 rpm for 15 min
at 6°C in a MLA-130 rotor using an Optima MAX ultracentrifuge (Beckman Coulter).
Protein concentration was determined using the bicinchoninic acid (BCA) method.
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If a sample was to be used immediately for SDS-PAGE (see below), it was diluted 1:1
in 2x sample buffer (20mM Tris.Cl pH6.8, 4% SDS, 20% glycerol, 200mM
dithiothreitol, lmg bromophenol blue) and denatured at 100°C for 5 min.
2.1.7.2 Immunoprecipitation
All steps were performed on ice or at 4°C. Protein samples were diluted to lmg/ml in
RIPA buffer (1% DOC, lOmM Tris.Cl pH8, 140mM NaCl, 0.025% sodium azide, 1%
Triton X-100, 0.1% sodium dodecylsulphate, 0.5mg/ml PMSF, 1.125x Complete
protease inhibitors (Roche)). To 1ml of protein solution was added lpg anti-NR2B
mouse monoclonal antibody (Transduction Labs), 1.2pg anti-Kvl.4 rabbit polyclonal
antibody (Alomone Labs) or 4pg anti-KA2 rabbit polyclonal antibody (Upstate
Biotechnology). Proteins were incubated with antibody at 4°C overnight on a rotator.
50pl of protein A (for rabbit antibodies) or protein G (for mouse antibodies) sepharose
bead/ phosphate buffered saline (PBS; lOmM phosphate buffered saline, 138mM NaCl,
2.7 mM KC1, pH7.4) slurry was added to the samples and incubated at 4°C for 2 hr on a
rotator. The sepharose beads were collected by a 5 s spin at 10 000 rpm at 4°C, the
supernatant discarded and the beads washed with 1ml RIPA buffer. Washes were
repeated 3 more times. The sepharose beads were resuspended in 25pl of PBS to which
25pi of 2x sample buffer was then added. Samples were then denatured at 100°C for 5
min. Samples were then spun down (5 s spin at 10 000 rpm) and the supernatant loaded
onto 8% polyacrylamide gels.
2.1.7.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Vertical polyacrylamide gels were prepared using BioRad mini gel protein kits. 30%
acrylamide (37.5:1 acrylamide to N,N'-methylene-bis-acrylamide) solution was supplied
by BioRad. An 8% acrylamide resolving gel mix, containing 375mM Tris.Cl pH8.8 and
0.1% SDS was made to which ammonium persulphate and N,N,N',N'-
tetramethylethylenediamine (TEMED) were added to final concentrations of 0.09% and
0.1%, respectively. The resolving gel was then immediately poured and butan-2-ol
layered on top to ensure uniform polymerisation.
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After polymerisation, the butan-2-ol was rinsed off with distilled water. A stacking gel
(4% acrylamide, 125mM Tris.Cl pH6.8, 0.1% SDS, 0.09% ammonium persulphate,
0.2% TEMED) was prepared in a similar manner to the resolving gel. The stacking gel
was poured immediately after ammonium persulphate and TEMED addition and a
Teflon comb inserted into the gel to form wells.
Electrophoresis was performed at RT in electrophoresis tank buffer (125mM Tris,
960mM glycine, 0.5% SDS) at 150V until the dye front reached the bottom of the gel
(approximately 60 min). BenchMark prestained protein ladder (Invitrogen) was
included in all gels.
2.1.7.4 Western Blotting
Following electrophoresis, polyacrylamide gels were washed in Transfer buffer (10%
methanol, 9mM 3-(cyclohexylamino)-l-propanesulphonic acid pHll). Mini trans-blot
cells (BioRad) were then set up as follows: Whatman 3M filter paper was placed onto a
trans-blot fibre pad, both of which were soaked in Transfer buffer. The washed
polyacrylamide gel was placed onto the filter paper and a Hybond-P (Amersham)
membrane was activated in methanol then placed on the gel. Another Whatman 3M
filter paper and trans-blot filter pad (both soaked in Transfer buffer) were placed onto
the membrane. All components were then locked into the cassette which was placed
into the Mini trans-blot cell and covered with Transfer buffer. Electrophoretic transfer
was performed at 100V for 1 hr.
Following electrophoretic transfer, Western blots were transferred to 50ml Falcon tubes
and incubated overnight at 4°C with blocking solution (PBS containing 0.1% TWEEN
and 3% skimmed milk powder). The blocking solution was then discarded and replaced
with fresh block containing anti-PSD-95 mouse monoclonal antibody (Upstate
Biotechnology, clone K28/43) at a dilution of 1:10 000. The anti-PSD-95 antibody was
incubated with the Western blot for 2 hrs at RT and then washed with blocking solution
3 times over 30 min. The Western blot was then incubated with blocking solution
containing anti-mouse Ig sheep antibody conjugated to horseradish peroxidase
(Amersham) at RT for 1 hr. The blot was then washed with PBS containing 0.1%
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TWEEN 3 times over 30 min. Horseradish peroxidase activity was detected using
enhanced chemiluminescence (ECL) Western blotting detection reagents (Amersham)
with Hyperfilm ECL (Amersham). Films were exposed for 5 or 10 s.
2.2 Tissue Culture
2.2.1 ES Cell Culture
General methods for the manipulation of ES cells are based on Hogan et al., 1994. All
ES cell manipulations were performed in laminar flow sterile hoods using a strict sterile
technique that included wiping the hood down and spraying all items entering the hood
with 70% industrial methylated spirits. Cell culture plasticware was supplied by Iwaki.
All cell culture flasks were gelatinised (5 min 0.1% gelatin in PBS) prior to addition of
ES cells. E14TG2a ES cells were used for all experiments. ES cells were incubated in
7.5% CO2 at 37°C in a humidified incubator (Scientific Laboratory Supplies Ltd). All
solutions were tested for sterility and warmed to 37°C prior to use. ES cells were
examined using an inverted microscope (Olympus CK2).
2.2.2 Reagents
ES cells were maintained in lx glasgow minimum essential medium containing: 10%
foetal calf serum; 15% sodium bicarbonate; 0.1% nonessential amino acids; 4mM
glutamine; 2mM sodium pyruvate; O.lmM 2-mercaptoethanol. ES cells were
maintained in an undifferentiated state by addition of differentiation inhibiting
activity/leukaemia inhibitory factor (DIA/LIF). Human DIA/LIF expression plasmids
were used to transiently express DIA/LIF in COS-7 cells (Smith 1991). Serial dilutions
of the supernatant were tested on ES cells for their ability to maintain pluripotency.
Routinely, lOOx the minimum concentration required to keep ES cells undifferentiated
was used as the working concentration. All stock solutions were prepared by Derek
Rout at the Centre for Genome Research. G418 (PAA Laboratories) was at 200pg/ml,
ganncyclovir (Roche) was used at 2.5pM.
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2.2.3 Thawing ES cells
Frozen ES cell vials were taken directly from the liquid nitrogen storage and quickly
thawed in a 37°C water bath. The cell suspension was transferred to a 20ml centrifuge
tube containing 10ml of pre-warned ES cell medium. The cell suspension was then
centrifuged at 1 200 rpm for 4 min (MSE Mistral 2000 benchtop centrifuge). The media
was aspirated and the cell pellet was resuspended in 4 or 10ml ES cell medium and
transferred to a single well of a 6 well plate or a 25cm2 flask, respectively.
24 well plates containing frozen adherent ES cells were removed from the -80°C storage
and thawed by holding between hands. 1ml of pre-warmed ES cell medium was added
to the thawed wells and -80% was then aspirated. Another 1 ml of ES cell medium was
then added to the well and the plate placed in an incubator.
2.2.4 Passage and Expansion of ES Cells
Cultures were monitored every day to ensure that ES cells had not grown past
confluence. Cells were normally passaged every 2 days. Culture medium was aspirated
and cells rinsed twice with PBS. Trypsin solution (0.025% trypsin (Gibco); 0.1%
chicken serum (Flow Labs); 1.3mM EDTA (Sigma) in PBS) was added to the cells and
incubated ay 37°C to -5 min until the cells detached. The trypsin was quenched with at
least 5 ml ES cell medium and the cells dispersed to a single cell suspension with
vigorous pipetting. The cell suspension was centrifuged at 1 200 rpm for 4 min (MSE
Mistral 2000 benchtop centrifuge), the medium aspirated and the cell pellet resuspended
in ES cell medium. Cells were then transferred to fresh well or flasks at dilution ratios
of 1:2 to 1:5, depending on their rate of growth.
2.2.5 Freezing ES Cells
ES cells were frozen at ~5xl06 cells or directly in 24 well plates.
For freezing in vials, cells were trypsinised into a single cell suspension and centrifuged
as above. The cell pellet was resuspended in 0.5ml ice-cold freezing solution (80% ES
cell medium; 10% FCS; 10% dimethylsulphoxide) per vial. The cells were transferred
to Nunc cryotubes and the tubes rapidly transferred to the -80°C freezer. The next day,
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vials were transferred to liquid nitrogen storage. Exposure to dimethylsulphoxide is
kept to a minimum as it is toxic to the cells and is an ES cell differentiation agent.
For freezing 24 well plates, ES cells were grown to -80% confluence. The medium was
aspirated, the cells washed twice in PBS and 0.5ml freezing solution added directly to
the wells. Plates were transferred immediately to the -40°C freezer. Plates were moved
to the -80°C freezer the next day.
2.2.6 ES Cell Electroporation
Exogenous DNA was routinely introduced into ES cells by electroporation. A single
cell suspension was obtained and the cells pelleted as above. Cells were resuspended in
ES cell medium and counted in a haemocytometer. The appropriate volume of cell
suspension was centrifuged again and the cell pellet resuspended in 600pl of PBS. The
cell suspension was then transferred to an electroporation cuvette.
For gene targeting experiments, ~150pg of linearised targeting vector was added to the
cell suspension in lOOpil of PBS. For transient transfection of Cre-expressing plasmid,
60p,g of circular pMC Cre (kind gift from A. J. H. Smith) was added to the cell
suspension in lOOpI of PBS.
Cells were electroporated at 0.8kV, 3pF in a BioRad GenePulser, which would normally
result in a time constant of 0.1. The cells were left for 10 min after eletroporation
before any further manipulations were performed. Cells were then transferred to a fresh
20 ml centrifuge tube containing 9 mis of pre-warmed ES cell medium. Cells were
plated in 10cm tissue culture dishes at densities of 5xl06, 106, 5x10s and 105 cells per
plate. The medium was changed the next day to medium containing G418 selection
(200|ig/ml).
7-9 days after electroporation, drug resistant colonies were isolated and transferred to
individual wells of 24 well plates. Individual colonies were sucked off the culture dish
using a 20jxl pipette with a yellow tip. The yellow tip containing the colony was placed
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into a well of a 96 well plate containing ~100p,l of trypsin solution and incubated at
room temperature for ~5 min. The contents of the well were then transferred to a well
of a 24 well plate containing 2 ml ES cell medium. The medium was changed the next
day. As wells became confluent they were passaged to generate duplicate plates, one
plate to freeze for storage and another plate from which DNA was extracted for analysis
by Southern blotting.
2.3 Animals
All animals were housed and treated in accordance with the animals (scientific
procedures) act 1986. Animals were housed in a 12:12 light dark cycle with food and
water provided ad libitum. Wild type litter mate controls were used with PSD-95
deletion mutants.
2.3.1 Loss of Righting Reflex Test
A diagram of the apparatus used is shown in figure 2.1. Mice (30.5 to 61.5g) were
placed into a Perspex tube (14cm diameter x 80cm) and the ends sealed with Perspex
plates containing a single hole at their centre to allow inflow of gas at one end and
outflow at the other. To prevent the animals huddling together, the tube was separated
into two equal sections by a wire mesh placed across the tube's diameter. 2 strips of
rubber tubing were placed along the internal base of the tube to prevent the mice sliding
during the loss of righting reflex test. To maintain body temperature during the
procedure, the ambient temperature was maintained between 28 and 32°C and the tube
heated from above by two 60W lamps. Insulation (bubblewrap) was placed on external
underside of the tube. Halothane was supplied in 100% 02 and gas concentrations
measured inline at the exhaust with a Datex CapnoMac Ultima (Datex). A rectal
temperature probe was fed into the tube via the gas inflow pipe and used to monitor
either mouse or tube internal temperature. Lamp height was adjusted to maintain tube
internal temperature at 33.5 ±1.0°C.
Usually 4 different halothane concentrations were tested in one experiment. 6 mice of
the same genotype were placed into the tube, 3 in either section. The highest






Figure 2.1 Diagram showing LORR apparatus. A perspex tube was separated
into 2 compartments by wire mesh to prevent mice from huddling together. The tube
was heated from above by lamps and bubblewrap was attached to the underside of
the tube to provide insulation. Ambient or internal temperature was monitored using
a rectal temperature probe fed into the chamber via the gas inlet. The gas outlet was
sampled by a gas analyser.
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the inflow end of the tube was opened after the halothane concentration within the tube
had been stable for at least 7 min. The rectal probe was inserted into one of the mice
and the end of the tube was rapidly replaced and mouse internal temperature monitored
for at least 10 min. To avoid injuring the animal, the probe was removed from the
mouse, but not the tube, prior to performing the loss of righting reflex test. Removing
the probe from the mouse could be performed without opening the tube, thus the
internal halothane concentration was undisturbed by the process. Tube temperature was
monitored for the rest of the experiment.
The loss of righting reflex (or obtunding test) was performed only when the internal
halothane concentration had been stable for at least 10 min. The test consisted of rolling
the tube sufficiently (<120°) to turn the mice onto their backs. Not all mice were
obtunded by a single roll of the tube, so 2-3 rolls were performed to test all mice within
the tube. Loss of righting reflex was scored as being unable to right within 5 s of being
obtunded.
At the end of each experiment, mice were removed from the tube and allowed to recover
under supervision in the warmth of the experiment room. Once recovered, mice were
returned to the mouse house.
2.4 Data Analysis
Data from halothane-induced LORR experiments was fitted to a dose response curve by
nonlinear regression using GraphPad Prism 3.0. Data generated from halothane-induced
LORR experiments measured an all-or-nothing response (righting or not righting) across
a range of halothane concentrations. Because of the difficulty in dictating halothane
concentration delivered to the LORR apparatus, concentrations between genotypes
could not be matched. For these reasons, probit analysis was used to analyse the data.
95% confidence intervals were computed and compared at the EC50 values of wild type
and PSD-95 deletion mutant animals. This allowed the null hypothesis "the halothane
EC50 is unaffected by PSD-95 genotype" to be tested.
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Chapter 3: RESULTS Cloning and Characterisation Of
Mouse PSD-95
3.1 Introduction
At the start of this project, there was no information about the genomic structure of the
human PSD-95 gene and detail about the murine gene was limited to the 3' region
coding from PDZ3 to the GK domain. PSD-95 isoforms were originally considered
species-specific with rodent and human proteins exhibiting distinct N-termini, however,
exons encoding 'human' PSD-95 were identified in mouse genomic sequence (described
below) . Furthermore, the 'human' transcript and protein was recently identified in rat
brain extratcts (Chetkovich et al. 2002). In the interest of clarity, I have adopted the
nomenclature used by Chetkovich and coworkers to describe the PSD-95 variants and
the exons that encode these variants, the rodent variant being designated PSD-95a and
the human variant PSD-95(3.
As mentioned in the introduction, PSD-95a constitutes the major transcript and has two
N-terminal cysteines that, when palmitoylated, mediate synaptic localisation. PSD-95J3,
which makes up approximately 10% of PSD-95 protein, encodes a longer N-terminus
that does not contain cysteines, but does contain an L27 protein interaction domain that
mediates synaptic localisation and enables PSD-95(3 to bind CASK (Chetkovich et al.
2002).
The human PSD-95 gene (DLG4) corresponding to PSD-95(3, was cloned in 1999 and
found to span ~30kb of genomic sequence (Stathakis et al. 1999). In contrast to studies
in rodents, human PSD-95 transcripts were found in a wide range of tissues including
brain, mammary gland, pancreas and testes (Stathakis et al. 1997) and splice variants
distinct from PSD-95a and PSD-95(3 were found to exhibit tissue-specific distributions
(Stathakis et al. 1999).
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Targeting the exon encoding part of PDZ3 had not generated a null allele (Migaud et al.
1998), so to ensure the generation of a conditional null allele, a more 5' region of the
gene needed to be targeted. In generating the original PSD-95 deletion mutant, part of
the murine gene had already been characterised from a lambda library clone, identifying
exons coding from the third PDZ domain to the end of the open reading frame (Migaud
et al. 1998). However, exons encoding PDZ domains 1 and 2 and the alternative
transcriptional start sites were not contained in the lambda clone and therefore were not
characterised (Fig. 3.1). Thus the 5' region of PSD-95 needed to be cloned and
characterised to provide detailed information about the gene structure such as intron-
exon boundaries and any alternative splicing events. These properties of PSD-95 would
influence the targeting strategy design and the cloned sequence could then also be used
for the generation of a targeting vector.
3.2 Identification and Analysis of PAC clones
Since the previously screened lambda library (Migaud et al. 1998) did not yield any
clones containing 5' sequence of PSD-95,1 elected to use a different genomic library, a
PI artificial chromosome (PAC) mouse genomic library. PACs are large capacity (up to
250 kb) vectors that generate good quality genomic libraries used for genome mapping
and sequencing as well as gene cloning. A 129/SvEvTACfBr mouse genomic PAC
library from the human genome mapping project (HGMP) was screened (Osoegawa et
al. 2000). The library segment used had an average insert size of 147 kb and with
128,899 clones, provided 6.3x genomic coverage (Osoegawa et al. 2000), thus the
probability of identifying at least one positive clone was >99%.
3.2.1 Screening of PAC Library
The project was initiated when only rat and mouse PSD-95 cDNA, corresponding to
PSD-95a, had been published, so all PCR primers and cDNA probes were generated
using PSD-95a cDNA as a template. The PAC library was constructed using
129/SvEvTACfBr mouse genomic DNA and PAC clones gridded onto nylon
hybridisation filters such that each filter contained over 18,000 distinct mouse PAC
clones per filter. Each clone was arrayed in duplicate in a pattern that allowed correct
identification of specific versus non-specific signals.
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Figure 3.1 Known PSD-95 structure at start of project. Figure shows 3'
end of gene containing exons that encode PDZ3, SH3 and GK domains of
PSD-95 (Migaud et al. 1998). 5' exons encoding the N-terminal region,
including PDZ domains 1 and 2. Exons are shown as blue boxes and relevant
restriction enzyme sites are labelled.
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To identify PAC clones that contained the outstanding 5' PSD-95 sequence, the PAC
library filters were screened with a rat cDNA probe (nucleotides 1-983; GenBank Acc.
No. M96853) specific to the 5' sequence of PSD-95a and the first two PDZ domains
(PDZ1+2 probe). This probe had previously been demonstrated to hybridise to mouse
genomic DNA on a Southern blot. When the PDZ1+2 probe was used to screen the
PAC library, strong signals were seen for four clones (456, 534, 612 and 631), while
weak signals were observed for another eight clones (377 2C, 377 16E, 390, 431, 460,
484, 500, 507). All twelve clones were ordered from the HGMP resource centre to be
used in a second round of screening.
PAC clones were delivered as E. coli smeared on agar. Clones were restreaked and
grown up as miniprep cultures to provide DNA for secondary screening. A different
probe was used to screen the PAC clones by Southern blot for false positive clones.
Previous blots of genomic DNA had identified an approximately 12 kb BamHI fragment
that positively hybridised to the PDZ1+2 cDNA probe. Following BamHI or EcoRI
digestion, Southern blotting, and probing with a PDZ1 probe (nucleotides 5-503), clones
456, 534, 612 and 631 produced positive signals (Fig. 3.2A), these clones having
generated strong signals in the original PAC library screen (Table 3.1). Clones 456, 612
and 631 showed positively hybridising BamHI bands of -12 kb while 534 had a
positively hybridising band of much greater than 12 kb. Other clones that had
hybridised weakly in the primary screen failed to hybridise when analysed as Southern
blots (see Table 3.1).
Finer analysis of the PAC clones was required to ensure that they overlapped with, and
contained sequence 5' to the genomic sequence derived from the lambda clone
identified by Migaud and coworkers (1998). A PCR strategy was used to assess the
regions of the PSD-95 open reading frame present in clones 456, 534, 612 and 631.
Primer pairs (Fig. 3.3) were used that were specific to PDZ1 (M8144, M8145), PDZ3
(A8643, SH3 Spe bot), SH3 (GK for, RPD) and GK domains (GK Spe top, 3N). The
PDZ1 reaction failed in all clones, however, M8145 was designed from cDNA sequence
and was later found to span an intron-exon boundary and thus was unable to anneal to
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Figure 3.2 Analysis of PAC clones 456, 534, 612 and 631. A. Southern blot of BamHI and
EcoRI digested PAC DNA hybridised with PDZ1 probe. No difference was observed in the size of
positively hybridising bands with EcoRI digested DNA, but clone 534 exhibited an anomalous sized
band (arrowhead) with BamHI digestion. B. Ethidium-stained gel showing PCR products generated
using primer pairs specific to either PDZ1, PDZ3, SH3 or GK coding regions of PSD-95. Lanes
containing size markers are labelled M. PAC clone 456 was shown to contain partial sequence of
PSD-95, the GK-coding region being absent. Clone 534 appeared to not contain PSD-95 sequence
while clones 612 and 631 contained regions of the gene encoding the PDZ3, SH3 and GK domains.
The PDZl-specific reaction was later found have failed because one of the primers was intron
spanning. C. Comparison of the PSD-95 locus in genomic and PAC 631 DNA. Ethidium-stained
gel shows overlapping PCR products that span most of the PSD-95 locus. Genomic and PAC DNA
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the genomic sequence. The other PCR reactions identified clones 612 and 631 as
containing PDZ3, SH3 and GK domains, clone 456 contained PDZ3 and SH3 domains
while 534 did not show any amplification using PSD-95 specific primers (Fig. 3.2B),
consistent with its aberrant BamHI Southern band. PSD-95 therefore appears to be
represented in this PAC library at a frequency of 3/128 899 clones. Analyses of the
PAC clones are summarised in Table 3.1.
PAC Signal strength in Signal in Southern blot screen and comments PSD-95 domains
clone no. library filter screen identified by PCR
analysis
377 2C weak no n/d
377 16E weak no n/d
390 weak no n/d
431 weak no n/d
456 strong yes; hybridising fragments correct sizes PDZ3, SH3
460 weak no n/d i
484 weak no n/d
500 weak no n/d
507 weak no n/d
534 strong yes; hybridising BamHI fragment of incorrect size 0
612 strong yes; hybridising fragments correct sizes PDZ3, SH3, GK
631 strong yes; hybridising fragments correct sizes PDZ3, SH3, GK
Table 3.1 Results of primary and secondary screens for PSD-95. The PACs were screened
using a probe (PDZ1+2 probe) specific to the outstanding 5' coding sequence of PSD-95. The
12 clones identified in the primary screen of the PAC library are shown. 4 clones (456, 534,
612, 631) positively hybridised to the PDZ1+2 probe in the secondary screen of Southern blots,
however clone 534 exhibited an aberrantly sized positively hybridising BamHI fragment. In
further analysis by PCR, no PSD-95 sequence was identified in clone 534. n/d indicates that a
clone was not tested.
As clones 612 and 631 were initially identified using the PDZ1+2 cDNA probe, I was
confidant that, despite the failure of the PDZ1 PCR, these clones contained sufficient 5'
sequence to be useful. Southern blots of PACs 612 and 631 produced identical patterns
of positively hybridising bands and clone 631 was chosen for subsequent analysis and
cloning of PSD-95.
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3.2.2 Comparison of PAC and Genomic PSD-95 Structure
Both DNA rearrangement and chimeric clones have been identified in PAC libraries.
The library used in this study was analysed for chimerism and rearrangement: -1% of
clones were chimeric; no deletions of >10 kb were identified although smaller
rearrangements were identified in <10% of clones (Osoegawa et al. 2000). To
determine whether rearrangement had occurred in the PSD-95 locus of PAC 631,
comparative Southern blots were performed on PAC and mouse genomic DNA
(gDNA). Identical hybridisation fingerprints were observed for both PAC and gDNA,
demonstrating the PAC and genomic loci to be grossly similar. Further analyses were
performed by long range PCR (LR-PCR) using primer pairs (5' start + PDZ1 Rev; Exon
2 For + PDZ1 Rev; PDZ1 For + 3N; A8643 + B7524) that generated overlapping
products spanning from the 5'UTR of PSD-95oc to the GK domain. Again, the PAC and
genomic loci were shown to be identical by the equally sized products (Fig. 3.2C).
In additional PAC Southerns, a provisional restriction enzyme digest map of PSD-95
was generated using a panel of restriction enzymes in conjunction with probes specific
to either PDZ1 (nucleotides 5-503) or PDZ3 (nucleotides 986-1572). The 12 kb BamHI
and larger EcoRI fragment identified in earlier Southern blots (Fig. 3.2A) were found to
hybridise to both PDZ1 and PDZ3 probes, implying that the fragments overlapped with
the PDZ3 containing lambda fragment. This was supported by the presence of BamHI
and EcoRI sites in the lambda clone, 3' to PDZ3 (Fig. 3.1). The 12 kb BamHI fragment
was therefore an obvious starting point in subcloning the PSD-95 gene.
3.3 Subcloning PSD-95 Genomic Fragments
Large scale PAC preparations were required to facilitate subcloning, however the -160
kb PAC proved difficult to grow in Luria Bertani medium and purification using Qiagen
midiprep columns failed to generate good yields due to inefficient elution of the PAC
from the column matrix. A variety of methods were therefore tested until reasonable
yields (500qg DNA from a 500ml culture) were obtained using a protocol obtained from
the Oxford University Bioinformatics Centre (see Methods). This method utilised a rich
medium (2xTY) and alkaline lysis but resin columns were not used to purify the PAC
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DNA. Instead, RNA and protein contaminants were degraded followed by
phenol/chloroform extraction to remove degraded proteins and added enzymes.
The PAC's size also complicated the isolation and subcloning of the 12 kb BamHI
fragment. Following digest, gel separation and purification, the yield of the correct
fragment was low and after extensive optimisation, the fragment could still not be
subcloned using standard methods. I therefore performed shotgun cloning: Digested
PAC was added directly to ligation reactions to generate a library of PAC fragments in
pBluescript KSII that was then transformed into E. coli. The resultant colonies were
screened by colony hybridisation using the PDZ1 probe to identify correct subclones.
This method yielded the correct 12.4 kb BamHI subclone, BamHI (9) and was
subsequently used to isolate other useful subclones: SacI (1), SacI (20) and Kpnl (4).
These subclones are shown in relation to the genomic structure of PSD-95 in figure 3.3.
BamHI (9), SacI (1) and Kpnl (4) were mapped by restriction enzyme digest and
confirmed to overlap with each other, and BamHI with the lambda clone. The positions
of exons were determined by PCR using exon-specific primers while sequencing
identified the intron-exon boundaries.
SacI (20) was also analysed by restriction enzyme digest and PCR but was found not to
overlap with Kpnl (4), the most 5' of the overlapping subclones. To characterise the
intervening region, LR-PCR was performed using a forward primer specific to the PSD-
95a 5' UTR (5' start) and a reverse primer specific to PDZ1 (PDZ1 reverse). The LR-
PCR product was digest mapped and compared to the Southern digest map of PSD-95,
allowing a SacI fragment containing the intervening sequence to be identified.
However, the genomic sequence that separated SacI (20) from Kpnl (4) proved
impossible to subclone from the PAC library using the probes available (e.g. exons 1-4
probe), but was subcloned from the 5' start-PDZl rev LR-PCR product (SacI (LR)),
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3.4 Characterisation of PSD-95 Gene Structure
I focussed on characterising the 5' region of mouse PSD-95 since the 3' region had
already characterised and the 5' region was to be the target of any subsequent mutation.
I therefore wanted to determine not only the intron-exon boundaries, but also identify
alternative splice variants and promotor sequences.
Using the information from the subclones combined with LR-PCR data, the genomic
structure of PSD-95 could be clarified and is shown in Fig. 3.3. All sequences were
cloned and analysed prior to the publication of PSD-95a and PSD-95P (Chetkovich et
al. 2002), however I have adopted the nomenclature used by Chetkovich and coworkers
in the interest of clarity. SacI (20) was completely sequenced, thus sequence alignment
was performed to determine the presence of exons homologous to what was thought at
the time to be the human PSD-95 variant, PSD-95(3. In concordance with Chetkovich
and coworkers (2002), the PSD-95P~specific exons (Pl\ Pi") were found 5' to the
single PSD-95a exon (al; Fig. 3.4A). Homology in the 5'UTR sequence encoded by
exon pi was weak, however sequence surrounding the translation start codon was
reasonably well conserved (Fig. 3.4B). Murine PSD-95 therefore spans over 27kb of
genomic sequence.
Comparing mouse PSD-95 with its human homologue, DLG4 (Stathakis et al. 1999),
revealed identical intron-exon boundaries (Table 3.2). Intron and exon sizes are shown
in table 3.2, as are splice donor and acceptor sequences, which show 53% - 93%
homology to consensus sequences. In addition, the human and mouse genes exhibit a
remarkably similar exon distribution, in particular, exons 3-8 encoding PDZ domains
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Figure 3.4 Alternate transcriptional start sites generate N-terminal variety in
PSD-95. A: Genomic organisation of alternate 5' exons. B: Homology between
mouse and human (31 exons is limited to sequence surrounding the translational start
codon (red). Human PSD-95P cDNA (top; GenBank U83198) aligned against mouse
genomic sequence from subclone SacI (20) (bottom). Vertical line designates intron-
exon boundry C: Diagrams on left show partial open reading frames of PSD-95
isoforms. Diagrams on right show translated protein products. Open reading frames
and protein products of PSD-95a and PSD-95 (3 are known while those of PSD-95y
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Figure 3.5 Relationship of mouse PSD-95 to its human homlogue, mRNA transcript and
protein sequence. The genomic structure of DLG4, the human homologue of PSD-95, is shown top
with the genomic structure of mouse PSD-95 shown beneath it. Loci are shown as solid lines with
exons depicted as grey boxes. Exons encoding the unique PSD-95a or -(5 sequences are labeled.
Below, the gene structures is shown the PSD-95a mRNA; the 5' UTR is indicated by diagonal blue
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3.4.1 PSD-95y
Sequence analysis identified exons (31, (31' and (31" in the cloned murine genomic
sequence. To determine whether the sequence encoded by these exons was expressed, I
screening it against mouse expressed sequence tags (ESTs) using NCBI BLAST. PSD-
95(3 was not identified, which is surprising in light of the findings of Chetkovich and
colleagues (2002), however BLAST analysis did identify a mouse EST (GenBank
accession number: BI731555) that contained sequence homologous to exon (31". EST
BI731555 is the 5' sequence of a partial cDNA clone identified from a mouse retina
cDNA library and contains a unique first exon (yl), a second exon consisting of exon
(31" followed by sequence homologous to PSD-95 exons 2 through 5. The unique yl
exon of BI731555 was identified in SacI (20), between exons (31 and (31' (Fig. 3.4A).
BI731555 is only a partial cDNA sequence and alignment of BI731555 sequence to
PSD-95 cDNA revealed some sequencing errors i.e. insertion of incorrect bases.
Following correction of BI731555 sequence by removal of these spurious bases,
BI731555 cDNA sequence was translated using the Translate programme (see Methods
section). Reading frame 1 generated a protein at least 117 amino acids in length,
however analysis using ScanProsite failed to identify any potential protein domains.
Reading frame 2 produced a 14 amino acid peptide. Reading frame 3, in frame with
PSD-95, generated a protein containing part of the first PDZ domain of PSD-95 by
utilising a start methionine encoded in PSD-95 exon 4. Sequence information is
limited, preventing the establishment of whether the entire PDZ domain is encoded and
thus functional, however, BI731555 could represent another PSD-95 variant, PSD-95y
(Fig. 3.4C), with a novel 5' UTR that is encoded by an alternative start site.
To examine the potential variety of PSD-95 isoforms at the protein level,
immunoprecipitations and Western blots were performed on mouse brain homogenate.
The blots were probed with an anti-PSD-95 antibody that recognised an epitope between
amino acids 77 and 299 (from the middle of PDZ1 to between PDZ2 and PDZ3), a
region that is not alternatively spliced. Immunoprecipitations were performed using an
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anti-NR2B antibody to determine whether any PSD-95 isoforms identified also bound
the NMDA receptor.
The anti-PSD-95 antibody identified 3 immunoreactive bands in mouse brain
homogenate: a major band presumably corresponding to PSD-95a, a minor band (band
1) of slightly higher electophoretic mobility and a much smaller band (band 2) of
approximately 70 KDa (Fig. 3.6). If PSD-95y transcribed exons 2 to 20, a protein would
be expected that lacked the first 60 amino acids of PSD-95cc, with an estimated
molecular weight of ~87KDa. Band 1 may represent such an isoform. It is notable that
the PSD-95a band and band 1 are both observed in the immunoprecipitant (Fig. 3.6),
indicating that the band 1 protein retains the ability to bind the NMDA receptor. No
known PSD-95 isoforms are able to generate a protein the size of band 2, therefore it
might represent a cross-reacting protein, consistent with its absence from the
immunoprecipitant (Fig. 3.6). It therefore appears that at least one smaller PSD-95
isoform is present in the brain that is capable of interacting with the NMDA receptor.
3.4.2 5' RACE
The published PSD-95a mouse cDNA has a very short 5' untranslated region (UTR)
compared to PSD-95(3 (1198 nucleotides). To determine the full length of the PSD-95a
5'UTR and to facilitate promotor analysis, rapid amplification of cDNA 5' ends
(5'RACE) was performed on mouse brain RNA. Sequences corresponding to PSD-95(3
and PSD-95y were not identified by this method, possibly due to their low expression.
A prominent product of approximately 500bp was cloned and sequenced, identifing an
additional 371bp of PSD-95a 5' UTR (Fig. 3.7A). Thus, all PSD-95 variants have long
5'UTRs (428, 1198 and 333 nucleotides for PSD-95a, (3 and y respectively) implying
possible translational control of these transcripts. UTR scan (Pesole et al. 2002) failed
to identify translational control elements in these 5'UTRs, however, upstream open
reading frames (uORFs) were identified in the 5' UTRs of all PSD-95 variants: 1 uORF
in mouse PSD-95a (Fig. 3.7A), 8 in human PSD-95P and 4 in mouse PSD-95y. uORFs
in the 5' UTR are able to exert translational control via a number of mechanisms,



















Figure 3.6 Analysis of PSD-95 isoforms and their ability to interact with
the NMDA receptor. Western blot of mouse brain homogenate and anti-
NR2B immunprecipitation. The PSD-95a band is indicated by black
arrowheads and can be seen following immunoprecipitation, indicating its
interaction with the NMDA receptor. Band 1, possibly corresponding to
PSD-95y, is labelled by grey arrowheads and also associates with the NMDA
receptor. A likely cross reactant is labelled with an open arrowhead.
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Figure 3.7 5' UTR and potential promotor sequence of PSD-95a. A: cDNA sequence of
PSD-95a 5' UTR. Upstream open reading frame is boxed in red. Known PSD-95 cDNA
(D50621) is bold, novel sequence is in italic. The translation start codon is in red. B: Alignment
of mouse (top) and human (bottom) genomic sequences reveal potential PSD-95cx promotor.
Exon al is boxed in dark blue. A region of homology (highlighted in yellow) can be seen in the
~200bp 5' to exon al, potentially revealing the promotor driving the PSD-95a variant.
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-372 GCCATCTCCA ACCCCCCCCA CCCCACTCCC CCGCCACGGC CCCTAGCCCC TGGCCGTTTG
-312 GCAAGACCCC CGCATACCCC GGGGCTTCCC GAAATCCAGT TCCCCTCCCC CATCCCAGCT
-252 C'ATGCCCCAG CCCCAGAACT CCGGGGCTGC CAGCCCCCTG TGCCCCTACC CCTCCTGA&A
-192 ATCGGGGTGT GCTCCTCAAG CCCCCTCCCC TCCACTGGGG AGCCCCTTTT AGGGTCCCCC
-132 CTCCCTTCCA CGCTCCCCTA CCCTTCTCTT CTCCAACCTT CTCCTTCCCC TCTCACCCCT
-72 CCCCCCATCC TGGCCCCCCC TGCAAAAGTG GGGTGCGGAG GGGGGAGGGG TGAGAACCCA
-12 CCGAGGGGAG GAACAAAACT CCAATGAAGT CAGAGCCCCG TACTCGCCGC CGCGGCCAGG
48 CCCCCCAACA TGGACTGTCT CTGTATAGTG ACAACCAAG
B
Mouse PSD-95 sequence top, human DLG4 sequence bottom
3640 3650 3660 3670 3680 3690 3700 3710 3720 3730
ATTTCAAT-ACCAGGAAGTCCAGGTCATACTTAATTACTTTTCAGACTTCTTCCTGTGACTCCTAGGGGAGAACTAGGTCCCCAAG-ATTCTCTACTGCC
GTTTCAGGCACTAAAGAGTCTAGGGCTTA ACTTTTTAGGTTTCCCCCTGAGAAACCTGAGGGAGAACTAGGCCCCCAGGGATTGCCTCCTTC-
3330 3340 3350 3360 3370 3380 3390 3400 3410
3740 3750 3760 3770 3780 3790 3800 3810 3820
AGCCCCTCCCTCA ACCCCTTACCCCACGCTATG—GCCTCCCTCCTGCACTCAACCAAGGAGGGATGCTCCCCTCCCAGCTGTGG—GCTTTTT
AGCTCCTCCCTCACACCCGACCCCCTACCGCCTGCCGAGAGGCCTCCCTCCCGTATTCAAATAACCGTGGGTGCTCCCAGCCCAACTATAGATGCTTCCT
3420 3430 3440 3450 3460 3470 3480 3490 3500 3510
3830 3840 3850 3860 3870 3880 3890 3900 3910
TCCTCTAAGGAG-GAATTCCATCCTCCTCATCTTTGCTGTCATCACCGA-GGTTAGCCAGGTCTCCATGTTTGCCGTAGGG-CCTCTCTGCTTGTGCTTC
^2^G^^T3530TCCA^3^0TCGTC'II^TCTCA^56^T^3™^^,I^80TC,r,I^59^GG<^^0GTGC^6^™
3920 3930 3940 3950 3960 3970 3980 3990 4000 4010
TAGCTCCTTTCCCATTATCCGGGTTCCTGCCAGCAGTGAAGGAGTTAACACTGCCAAGGCACCCCCCCCATTCTGGCTCCTAGCTCCCTCCCTCCCTCCC
TATCTCCTTTCCCATTATCCGGGTTCCTGCCAGCACAGAAGGAGTTAACTCTGCCAAGGCACCCCCCCCATTCTGGCTCCTAGCTCCCTCCCTCCCTCCC
3620 3630 3640 3650 3660 3670 3680 3690 3700 3710
4020 4030 4040 4050 4060 4070 4080 4090 4100 4110
CCTGCTTCCTCTCTCCTCCTCTCTCCCCTTCCCTCCTCGGCTCCGCGGCTAC-ATCGGCCGCTfGCCATCT-CCAACCCCCCCCACCCCACT CCCCCG?
CCTGCTTCCTCTCTCCTCCTCTCTCCC( fCQTTTTCCCATCCCCCCNACCCCACTWCCCCCgi
3720 3730 3740 3750 3760 3770 3780 3790 3800 3810
illQ A1A& U&fl il££ ilZfi JUM &m 42QQ 4210
CCACGGCCCCTAGCCCCTGGCCGTTTGGCAAG-ACCCCCGCATACCCCGGGGCTTCCCGAAATCCAGTTCCCCTCCCCCATCCCAGCTCATGCCCCAGCC
3820 3830 3840 3850 3860 3870 3880 3890 3900 3910
Am im mia im ma ma msL Am
CCAGAAC-TCCGGGGCTGCCAGCCCCCTGTG--CCCCTACCCCTCCTGAGAATCGGGGTGTGCTCCTCAAGCCCCCTCCCCTCCACTGGGGAGCCCCTTT
3920 3930 3940 3950 3960 3970 3980 3990 4000 4010
43ia Am Am Am mm Am Am . mo Am 44oo„
TAGGGTCCCC CCTCCCTTCCACGCTCCCCTACCCTTCTCTTCTCCAACCTTCTCCTTCCCCTCTCACCCCTCCCCCCATCCTGGCCCCCCCTGCAA
4020 4030 4040 4050 4060 4070 4080 4090 4100 4110
Am Am mAm AM ma JA&A AML 4480 ^aaxl
AAGTGGGGTGCGGAGGGGGGAGGGGTGAGAACCCACCGAGGGGAGGAACAAAAC-TCCAATGAAG-TCAGAGCCCCCT-ACTCGCCGCCGCGGCCAGGCC
4120 4130 4140 4150 4160 4170 4180 4190 4200 4210
Am 45?,n —Am— 4ho 4550 4seo 4570 4580
CCCCAACATGGACTGTCTCTGTATAGTGACAACCAAQGTAAGCATGATGGGGAAGCCGTGGGGAGGGGGAGTAGGTAATGAATTTGTGGAGAAGGGTTAG
ccccaacATfytAfTnTPTPTnTAT*AfyrfiAr*AApr1AAHPITAAfyATf?ATfyyyyyy?T'TATAA—ApmtyyyyytAfyyyratgagtttgtggggaggggttAG
4220 4230 4240 4250 4260 4270 4280 4290 4300 4310
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translation (reviewed by Morris and Geballe 2000). Both these methods prevent
ribosomes reaching and translating the downstream open reading frame. Translational
control of PSD-95 can also be inferred from the abundance of PSD-95 transcripts in
embryonic mouse brain as early as 13 days post coitum (Fukaya et al. 1999), while the
earliest detection of protein, at low levels, is at postnatal day 2 (Cho et al. 1992).
3.4.3 Promotor Analysis
The apparent use of alternative transcriptional start sites by PSD-95 prompted me to
analyse the cloned genomic sequence for promotor sequences that might drive the
various transcripts. Mouse genomic sequence encompassing sequence 5' to yl, (31, and
al exons was subjected to a number of analyses including promotor scanning services
(ProScan 1.7 and NNPP) and screening for CpG islands (Grail 1.3), which are associated
with approximately 50% of mammalian transcriptional start sites (Antequera and Bird
1999). Unfortunately, these programs failed to identify a promotor or an associated
CpG island, although it should be noted that DLG4 is driven by a TATA-less promotor
(Stathakis et al. 1999). Despite the failure of these analyses, comparison of mouse and
human sequences revealed a high level of homology (88%) in the ~200bp of genomic
sequence immediately 5' to exon al (Fig. 3.7B), potentially exposing a promotor.
3.4.4 Alternative Splicing
The considerable conservation between mouse and human genes, both in structure and
use of alternate transcriptional start sites, led me to investigate alternate splicing in the
mouse. DLG4 exhibits a number of splice variants: a variant in which exon pi" is
omitted; an exon 18 variant that is not expressed in brain, where PSD-95 is highly
expressed; and a variation at exon 2. Since PSD-95P is the minor variant and the exon
18 variant is not expressed in the brain, I focussed on the potential alternative splicing of
exon 2 in the mouse. Following RT-PCR, two products were observed (Fig. 3.8A), a
major product of the expected size and a less abundant product approximately 100 bp
larger than the expected product. Both products were TA cloned and sequenced.
Sequence analysis identified the smaller fragment as PSD-95 and revealed the larger
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Figure 3.8 Mouse PSD-95 is alternatively spliced at exon 2. A: RT-PCR from
mouse brain mRNA generates 2 products, a major product of 276 bp, and a minor
product of 375 bp. B: Cloning and sequencing of the RT-PCR products revealed
the minor 375 bp product to result from a 99 bp extension of exon 2, designated
exon 2b. On the left, partial open reading frames are shown, indicating the inserted
2b sequence (striped). Positions of primers (arrows) used for RT-PCR are shown
above mRNA. The 99 bp extension of exon 2 results in a 33 amino acid insertion,
shown right (striped section of protein). Mouse PSD-95 (mPSD-95) insertion
is aligned against the protein sequences of the analagous human insertion (hPSD-
95) and sequences found constitutively in SAP97 and chapsyn-110. Human
sequences of these proteins are shown; hSAP97 and hChapsynl 10 respectively.
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analogous to that seen in humans (Stathakis et al. 1999). The alternative splicing event
introduced a 33 amino acid insertion after residue 32 of mouse PSD-95, N-terminal to
the first PDZ domain (Fig. 3.8B). The inserted mouse sequence shares 96% homology
with the human insertion at the nucleotide level, resulting in two amino acid
substitutions between mouse and human (Fig. 3.8C). Sequence homologous to the
alternate transcripts is found constitutively in Chapsyn-110 and SAP97 proteins (Fig.
3.8C), however, when analysed by ScanProsite the PSD-95 inserted sequence contained
only a putative casein kinase II phosphorylation site that has a high probability of
random occurrence. Thus a function for this insertion has yet to be determined.
Western blot analysis should have identified the exon 2b splice variant and PSD-95(3 at
higher molecular weights than PSD-95a, however these were not observed (Fig. 3.6).
The exon 2b splice variant and PSD-95(3 may not have been expressed at levels high
enough to be seen at the exposure shown (Fig. 3.6), and at higher exposures they may
have been masked by the strong PSD-95a signal, which masked weaker nearby signals
such as band 1.
3.5 Discussion
The cloning of murine PSD-95 has revealed considerable similarity between the mouse
and human homologues, both in the organisation of the gene and the intron-exon
boundaries. Further similarity was demonstrated with the identification of the murine
exon 2b splice variant, while a novel putative variant, PSD-95y was found to result from
an alternative transcriptional start site. Murine PSD-95 is a -27 kb locus containing 24
exons, exons 2-20 being included in the PSD-95a and PSD-95(3 isoforms, and possibly
the PSD-95y isoform.
3.5.1 PSD-95 Variants
Exons al, (31 and yl are utilised by alternative transcriptional start sites, generating
protein diversity in the N-terminal region through the use of different translation
initiation methionines. This N-terminal variety results in the inclusion of palmitoylation
sites in PSD-95a and an L27 domain in PSD-95(3, which alter the membrane targeting
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mechanisms used by PSD-95 and its protein interactions. It should be noted that the
putative translated PSD-95y lacks both palmitoylation and L27 sites, so another
membrane targeting mechanism must used if PSD-95y interacts with the NMDA
receptor.
In addition to generating differences in the protein, however, alternative splice sites also
allow greater variety in the control of transcription by the use of different promotors or
translation through the generation of distinct 5'UTRs. This is particularly pertinent in
light of the developmental expression profile of PSD-95, which is observed at the
transcript level in embryonic mouse brains (Fukaya et al. 1999), but protein is not seen
at substantial levels until after birth (Cho et al. 1992; Sans et al. 2000). Transcriptional
and translational control therefore provides considerable potential for variants to be
expressed with distinct developmental and/or regional distributions.
3.5.2 MAGUK Evolution
MAGUKs are found in species as diverse as C. elegans and man. Moreover, a
homologue of ZO-1 has been identified in Hydra (Fei 2000), a member of the second
oldest phylum in the animal kingdom, indicating that MAGUKs arose early in
evolution.
A notable feature of the genomic organisation of PSD-95 is the cluster of exons
encoding PDZ domains 1 and 2. The clustered arrangement of exons encoding PDZ
domains 1 and 2 and their intron-exon boundries are conserved in the genomic
oganisation of another mouse MAGUK, SAP102 (P. Cuthbert - personal
communication). In addition, a similar arrangement of coding sequence is observed in
Drosophila\ sequence encoding PDZ domains 1 and 2 of DLG consists of 2 exons that
are separated by a 61 nucleotide intron (Fig 3.9). Interestingly, the close association of
PDZ 1 and 2 encoding exons is mirrored by a close association between PDZ 1 and 2
protein domains; PDZ domains 1 and 2 form a single, protein module that is resistant to
protease digestion (Marfatia et al. 1996). These observations therefore raise interesting
questions about the development of the MAGUK genes with evolution. Interesting
information about the evolution of the MAGUK genes may be gained from a species
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evolutionarily intermediate between Drosophila and mouse. Although a PSD-95 related
MAGUK has yet to be cloned from zebrafish, this species may yield interesting
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Conditional Allele
4.1 Introduction
The PSD-95 mutant mouse (Migaud et al. 1998) was generated using conventional gene
targeting technology; that is, the gene was interrupted by the insertion of a selectable
cassette. This technique can be relatively rapid and ablates gene function ubiquitously
and constitutively, allowing a first investigation of protein function to be performed. A
disadvantage of this form of gene targeting is that it does not provide any control over
the timing and distribution of gene inactivation. This may limit the usefulness of a
mutation if the mutants are embryonic lethal since limited analyses can be preformed.
Alternatively, there may be difficulty in breeding homozygous animals if less than
Mendelian numbers of homozygotes are obtained, as is the case with the PSD-95
deletion mutant. The spatial and temporal control over gene expression that is possible
with conditional systems can circumvent deleterious phenotypes.
4.2 Assessment of Available Technology
The Tet system is useful for the expression of inhibitor peptides, dominant negative or
constitutively active proteins as well as overexpression of wild type protein. These
strategies, however, are inappropriate for the study of PSD-95 since the multiple binding
activities of PSD-95 cannot be out-competed by a single peptide and dominant negative
forms of the protein have not been identified. The best use of the Tet system would be
to conditionally induce wild type PSD-95 expression in the PSD-95 deletion mutant
background. However, such a system would operate in the presence of the truncated
PSD-95 protein and which would complicate analysis. Furthermore, an extensive
breeding strategy would be required to generate a mouse that was homozygous for the
PSD-95 deletion allele and carried both the Tet transcriptional activator and PSD-95
transgene. Such a breeding strategy is particularly daunting when it is considered that
PSD-95 deletion homozygotes do not breed well. Another system, such as conditional
gene inactivation, would therefore be preferable.
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Compared to conventional gene targeting, conditional gene inactivation using the Cre-
loxP system requires a more complex cloning strategy to insert loxP sites either site of
the target region and also requires more in vitro manipulation of ES cells to excise the
selection cassette prior to their injection into blastocysts. However, the Cre-loxP system
could improve on the existing PSD-95 deletion mutant by generating a null PSD-95
allele with the benefits of conditional inactivation. In addition, Cre-expressing
transgenics were already available to the lab, so I elected to use the Cre-loxP system for
the study of PSD-95 function.
4.3 Vector Design for Cre-loxP Based Mutation
Having decided to use the Cre-loxP system, the design of the targeting vector and
cloning strategy was then considered. In an ideal strategy, the expression of a reporter,
such as green fluorescent protein (GFP), would be activated upon inactivation of the
gene. This might be achieved by flanking critical exons and the polyadenylation signal
with loxP sites (or floxing) and inserting a splice acceptor-GFP cassette with the 3' loxP
site (Fig. 4.1A). Placing such a cassette 3' to the endogenous polyadenylation site
would prevent its transcription in the absence of recombination. However, upon
recombination most of the gene, including the stop codon and polyadenylation signal,
would be removed allowing upstream exons of the endogenous gene to splice to the
reporter cassette, driving transcription of GFP from the endogenous gene's promotor
(Fig. 4.IB). Such a system would allow cells in which recombination had occurred to
be easily identified and scored. Unfortunately, the efficiency of Cre-mediated
recombination declines with increasing distance between loxP sites, thus the size of the
PSD-95 gene precluded the use of such a readout.
Since a truncated protein was generated in the original PSD-95 mutation (Migaud et al.
1998), a null allele would require more 5' sequence to be targeted. The cluster of exons
encoding PDZ domains 1 and 2 (exons 3-8) appeared a good region of the gene to flank
with loxP sites (flox) since there was little coding sequence 5' to these exons, the cluster
was compact enough that the distance between loxP sites would be relatively short and










Figure 4.1 Targeting vector with reporter of recombination. A: The
conditional allele shows loxP sites (red triangles) flanking 3' exons (grey
boxes) of a gene, including the translation stop codon and the
polyadenylation (pA) signal. The translation start codon (ATG) is
indicated on exon 1. A green fluorescent protein (GFP) reporter gene
with a splice acceptor (SA) site is inserted 3' to the endogenous pA
signal. In the absence of Cre recombinase this arrangement allows the
normal production of protein but not GFP. B: Cre-mediated
recombination removes critical exons such that a functional endogenous
gene product is no longer generated. Recombination also removes the
endogenous stop codon and pA signal. The first endogenous exon can
now splice to the GFP gene, resulting in the generation of a GFP fusion
protein that reports recombination.
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mediated deletion of exons 3 to 8 would introduce a stop codon 69 nucleotides into
exon 9, leaving a potential PSD-95a product of 56 amino acids that may be unstable.
Placing loxP sites in introns should not interfere with normal gene function, although
one must ensure that loxP sites do not disrupt splice donor or acceptor sequences. One
must also consider the possibility of interrupting an enhancer element, but unfortunately,
enhancer sequences are not well conserved and are therefore difficult to identify. To
ensure that the loxP sites did not affect splicing sequences, I wanted to place the loxP
sites at least 1 kb from the nearest exon. Restriction enzyme sites were available for
such a strategy, allowing me to insert a floxed thymidine kinase (tk) / neomycin
phosphotransferase (neo) cassette into the Spel site in intron 2 and an isolated loxP site
into an Xbal site in intron 8. Neo would be used during targeting to positively select for
ES cell colonies that had integrated the cassette i.e. they would be resistant to the
antibiotic G418. Tk would be used after transient Cre expression in ES cells in vitro as
negative selection to screen for ES cell colonies from which the cassette had been
deleted, i.e. colonies that were not killed by gancyclovir, which is converted to its toxic
form by tk. Removal of the selection cassette after targeting is required because it can
interfere with gene expression, even if located in an intron. Cryptic splice sites in neo
cause aberrant splicing of the gene product such that neo sequence is spliced into the
endogenous transcript, inserting frameshifts and/or stop codons (Wassarman et al. 1997;
Meyers et al. 1998; Nagy et al. 1998).
The length of homologous DNA flanking the selection cassette or other non¬
homologous sequences critically influences targeting efficiency (Thomas and Capecchi
1987; Hasty et al. 1991). In targeting the PSD-95 locus, experiments performed in our
lab (M. Arbuckle - personal communication) have shown at least 1.5 kb of sequence is
required in a homology arm (Table 4.1).
100
Chapter 4: RESULTS Generation of a PSD-95Conditional Allele
Mutation Homology (kb) Targeting efficiency (%)
5' 3' Total
APDZ3-GK 1.6 4.2 5.8 6.7
SH3* 0.9 4.5 5.4 No targeting
SH3* 3.8 4.5 8.3 2.7
AGK 1.35 4.5 5.85 No targeting
AGK 4.8 4.5 9.3 7.8
Table 4.1 Targeting efficiency is dependent on homology arm length at the PSD-95 locus.
The first PSD-95 mutation (Migaud et cil., 1998) is designated APDZ3-GK. Other mutations
shown are an SH3 domain point mutation (SH3*) and a deletion of the GK domain (AGK).
My final cloning strategy therefore included 3 kb of 5' homology and 10 kb of 3'
homology. A floxed tk/neo (LTNL) cassette was placed in intron 2, which resolved into
a single loxP site following Cre-mediated excision of the cassette in vitro. The 3' loxP
site was introduced as an oligonucleotide containing an EcoRI site, allowing the
presence of the unselectable oligonucleotide to be tracked by restriction enzyme digest.
The construction of the targeting vector to produce this allele is described below and
summarised in figure 4.2.
4.4 Vector Construction
The Xbal site in the pBlueScript KSII multiple cloning site was ablated by a Spel-Xbal
digest followed by religation to form the plasmid pBS KSII (Xbal-). BamHI-EcoRV
digestion of BamHI (9) yields two insert fragments, a 4.8 kb BamHI-EcoRV fragment
and a 7.6 kb EcoRV-BamHI fragment. The 4.8 kb BamHI-EcoRV fragment genomic
fragment containing exons 3 to 8 from BamHI (9) was inserted into pBS KSII (Xbal-) to
produce plasmid B-EV. An EcoRI-loxP oligo with Xbal overhangs was then inserted
into the Xbal site 3' to exon 8 (step 2 in Fig. 4.2), generating plasmid BlpEV.
Meanwhile, the remainder of the BamHI (9) insert, the 7.6 kb EcoRV-BamHI fragment
containing exons 9 to 16, was inserted into a pET29 vector to form plasmid EV-B. To
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Figure 4.2 Construction of floxed PSD-95 targeting vector. Step 1: BamHI-EcoRV
digest ofBamHi (9) (A) to clone 5' fragment into pBS KSII (Xbai-) and 3' fragment into
pET-29a(+). Step 2: Xbai digest ofB-EV (B) to ligate in EcoRI-loxP oligo. LoxP site is
shown as red triangle. Step 3: EcoRV-XhoI digest of both BipEV (D) and EV-B (C) to
clone EcoRV-XhoI fragment from EV-B into BlpEV. Step4: BamHi fragment from
BlpEVB (E) transferred to pBlue (Sall-NotI). (figure continues on next page) Step 5:
BamHi digest of BlpB (F) to insert BamHi fragment from Kpni (4). Step 6: Sall-Spel
digest ofBBlpB (G) to ligate in Sall-Spel fragment from Kpni (4). Step 7: Spel digest of
KBBlpB (H) to insert LTNL cassette as a Xbai fragment. Step8: Sail digest ofKLTNLB
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oligonucleotide, EV-B was cut with EcoRV and Xhol, releasing the 7.6 kb insert and a
portion of the pET-29a(+) multiple cloning site. B-EV was digested with EcoRV and
Xhol to ligate the EcoRV-XhoI fragment into the EcoRV site forming the 3' end of the
B-EV insert and the Xhol site in the multiple cloning site (step 3 in Fig. 4.2), producing
plasmid BlpEVB.
To complete the cloning, a new plasmid (pBlue(Sall-Notl)) was generated by inserting a
new polylinker into pBlueScript KSII as a Sall-NotI fragment. This replaced Clal-
Hindin-EcoRV-EcoRI-Pstl-Smal-BamHI-Spel-Xbal with EcoRI-BamHI-Bglll. The
12.4 Kb BamHI fragment from BlpEVB containing exons 3 to 16 and the inserted
EcoRI-loxP oligo was then inserted into the BamHI-Bgin sites of pBlue(Sall-Notl),
generating plasmid BlpB (step 4 in Fig 4.2). This cloning step ablated the BamHI site at
the 3' end of the BlpB insert, allowing BlpB to be linearised by BamHI. Following
BamHI digestion of BlpB, contiguous 5' sequence was added from Kpnl (4) in the form
of a 1.5 kb BamHI fragment containing a Spel site (step 5 in Fig 4.2), producing
plasmid BBlpB. Sall-Spel digestion of BBlpB excised a fragment from the Sail site in
the BBlpB polylinker to the Spel site in the genomic sequence. Further 5'sequence was
then added by inserting a Sall-Spel fragment from Kpnl (4) into the Sail site in the
BBlpB polylinker and the genomic Spel site (step 6 in Fig 4.2), generating plasmid
KBBlpB. The LTNL cassette was then inserted as an Xbal fragment into the Spel site
of KBBlpB (step 7) forming plasmid KLTNLB. Finally, to select against backbone
insertion, a diphtheria toxin-A (DTA) cassette was inserted as a Sall-Xhol fragment into
the Sail site in the KLTNLB polylinker (step 8). The completed DTA-KLTNLB vector
is shown in figure 4.2.
4.5 ES Cell Targeting
The DTA-KLTNLB vector was electroporated into E14TG2a ES cells. Neomycin-
resistant colonies were picked, expanded and screened by Southern blotting using
probes external to the targeting vector. The LTNL cassette contained two EcoRV sites,
thus wild type gDNA digested with NotI and EcoRV and hybridised with the 5' probe
yielded a 12 kb positively hybridising wild type band while correct insertion of the
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cassette into the PSD-95 locus shortened the positively hybridising band to 5.5 kb (Fig.
4.3).
4 kb separates the LTNL cassette and the isolated loxP site, therefore correct integration
of the cassette did not ensure that the unselected, isolated loxP site was also integrated.
Indeed, integration of a separated loxP site and the selection cassette is inversely
proportional to the distance that separates the two (Torres and Kuhn 1997). Integration
of the isolated loxP site was determined by Southern blotting utilising the EcoRI site
included in the loxP oligo. When EcoRI digested gDNA was probed with the 3' probe a
19.5 kb wild type band was observed, while correct integration of the 3' loxP site
yielded an 11.5 kb band (Fig 4.3). This screening strategy allowed integration of the
floxed cassette and the third isolated loxP site to be independently scored: 63 ES cell
clones were screened with both 5' and 3' probes, 23 (32%) clones were identified that
contained the selection cassette alone while 4 (6%) clones were identified that contained
both the cassette and the 3' loxP site.
Having identified correctly targeted clones, the cells then had to be expanded to perform
a second round of electroporation in order to transiently transfect a Cre-expressing
plasmid to remove the LTNL cassette. Clones 110, 132, 87 and 20 were thawed for
expansion, however only clones 110 and 132 recovered and grew well. Clones 87 and
20 failed to thrive, eventually differentiating and dying.
4.6 Cre-Mediated Excision of Selection Cassette
Transfection of ES cells with a plasmid encoding Cre results in transient expression of
Cre. Cre-mediated recombination of the targeted PSD-95 allele can generate 3 possible
recombined alleles, however, under gancyclovir selection, selecting for LTNL cassette
removal, only two recombination events were viable (Fig. 4.4A). If the two most distal
loxP sites recombined (complete recombination), both the cassette and exons 3 to 8
were excised generating a null allele. If only the LTNL loxP sites recombined (partial
recombination), the cassette was deleted but the flox of exons 3 to 8 was maintained
producing the conditional allele.
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Figure 4.3 Targeting ofPSD-95. A:Wild type PSD-95 allele is shown top, the
targeting vector is shown middle and the targeted allele is shown bottom. LoxP
sites are shown as red triangles. Probes used to screen clones are shown as thick
lines above alleles; red for the 5' probe and blue for the 3' probe. Restriction
enzyme fragments that hybridise to probes are shown as thin lines; red fragments
hybridise to the 5' probe and blue fragments hybridise to the 3' probe. Fragment
sizes are labelled. B: Southern blots using Notl-EcoRV digested DNA with the
5' probe identify integration of the selection cassette into the PSD-95 locus by the
presence of a 5.5 kb band. Southern blots using EcoRI digested DNA with the 3'
probe identify integration of the 3' loxP site into the PSD-95 locus by the
presence of an 11.5 kb band. The Southern blots shown identify clone 132 as
correctly targeted (far left lane) and clones 138 and 162 as integrating only the
selection cassette (middle 2 lanes). Wild type DNA is shown in the far right lane.
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Figure 4.4 PGR screening for selection cassette excision . The targeted
PSD-95 allele is shown (top) with 2 possible recombination events shown:
conditional allele (middle) and knockout allele (bottom). Primers used to screen
clones are shown as arrows above alleles; red for forward primers and blue for
reverse primers. B:Extensiontimes were set such that Sacl For 2 and LP3 were
unable to generate product in the conditional allele. Knockout alleles (clones
110:29 and 110:39) were identified by an ~0.8 kb product. Conditional alleles
(110:94, 110:88, 110:89 and 110:2) were identified by an ~1.4 kb product that did
not resolve from the wild type product.
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The level of Cre expression determines the balance between partial and complete
recombination and in earlier studies this balance was difficult to achieve, such that only
complete recombination was observed (A. J. S. Smith - personal communication). An
appropriate level of Cre expression could, however, be obtained using the weak MCI
promotor. Electroporation of clones 110 and 132 with pMCl-Cre thus yielded clones
with either partial or complete recombination.
PCR and Southern blotting was used to screen clones following transient Cre
transfection. The PCR strategy utilised a common forward primer with a two reverse
primers that generated products specific to either partial or complete recombination
(Fig. 4.4B). Southern hybridisation of the 5' probe with Notl-EcoRV digested gDNA
produced a 12kb band with the cassette excised while total recombination (knockout
allele) produced a positively hybridising band of 8 kb (Fig. 4.5). PCR was used to
confirm the presence of 5' and 3' loxP sites in clones containing the conditional allele
(Fig. 4.6).
From 24 screened clones derived from Cre transfection of clone 110, 15 (63%) had
undergone partial recombination. Clones 110:88 and 110:26, which had undergone
partial recombination (PSD-95+/flox), grew well as ES cells and were therefore used for
the generation of chimeras. From 24 screened clones derived from Cre transfection of
clone 132, 7 (29%) exhibited partial recombination. PSD-95+/flox clone 132:65 thrived
on thawing and was used for blastocyst injection. All clones identified as carrying the
condition allele were confirmed to contain both loxP sites by PCR. The different
percentages of partial recombinants probably represent transfection variation. Fewer
copies of pMCl-Cre transfected into an ES cell would result in a lower expression level,
favouring partial recombination.
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Figure 4.5 Southern blot screening for selection cassette excision. A: The targeted PSD-95
allele is shown (top) with 2 possible recombination events shown: the conditional allele
(middle) containing 2 loxP sites and the knockout allele (bottom) that contains 1 loxP site.
Probes used to screen clones are shown as thick lines above the targeted allele, red for the 5'
probe and blue for the 3' probe. B: Southern blots using Notl-EcoRV digested DNA with the 5'
probe identify excision of the selection cassette from the PSD-95 locus (conditional allele;
clones 110:88, 110:89 and 110:2) by the hybridising fragment reverting back to the wild type
size of 12 kb. Excision of both selection cassette and exons 3 to 8 (knockout allele; 110:4) is
identified by an 8 kb band. A locus that has not undergone recombination is also shown (clone
132). Southern blots using EcoRI digested DNA with the 3' probe cannot differentiate between
conditional (clones 110:88, 110:89 and 110:2) and unrecombined (clone 132) alleles, both
generating 11.5 kb hybridising fragments. Knockout alleles are identified by a 15.5 kb band that
fails to resolve from the wild type 19.5 kb band. Wild type DNA is shown in the far right lane.
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Figure 4.6 PCR screening of 5' and 3' loxP sites. The conditional PSD-95
allele is shown (top) with primers used to screen clones shown as arrows above
the allele; red for forward primers and blue for reverse primers. The small size
of the PCR products allowed the size difference resulting from the presence of
the 32 bp loxP site to be resolved. Sacl For 3 and M4 Rev primers were used to
screen for the 55 loxP site and generated a wild type product of -350 bp and a
product of -390bp when the loxP site was present (middle panel). 631-9 For
and LP3 Rev primers were used to screen for the 3' loxP site. These PCR
products were digested with the restriction enzyme EcoRI to determine the
presence of the 3' loxP site oligo that included an EcoRI site. The wild type
product could not be digested by EcoRI and was seen as a single band. Products
containing the loxP site and the EcoRI site generated 2 bands (bottom panel).
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4.7 Generation of Chimeras
Clones 110:88 and 110:26 were injected into blastocysts to generate chimeras. 110:88
produced one female and four male chimeras, 110:26 produced one male and two
female chimeras. At six weeks of age test crosses were set up using the male chimeras
and monitored for at least eight months. Each male was caged with two MF1 females,
however three chimeras proved sterile while the two fertile chimeras did not transmit
the mutation down the germline (see table 4.2 below).
Litter DOB Number of pups Coat colour
110:88 chimera 1 20/08/01 11 All black
(set up 17/07/01) 01/09/01 2 All black
06/11/01 2 Found dead at birth
Breeding terminated 04/04/02
110:88 chimera 2 07/08/01 12 All black
(set up 17/07/01) 15/09/01 17 All black
25/09/01 2 All black
26/10/01 5 All black
28/10/01 5 All black
05/11/01 14 All black
04/12/01 10 All black
06/02/02 6 All black
03/03/02 4 All black
Breeding terminated 04/04/02
110:88 chimera 3 No litters
(set up 17/07/01) Breeding terminated 04/04/02
110:88 chimera 4 No litters
(set up 17/07/01) Breeding terminated 04/04/02
110:26 chimera No litters
(set up 31/07/01) Breeding terminated 04/04/02
Table 4.2 Results of test crosses set up using male chimeras.
With the failure of the male chimeras to either breed or transmit the mutation down the
germline, each female chimera was subsequently set up with a single male MF1 mouse.
Unfortunately, the females were over 6 months old when they were set up for test
crosses and died before any litters were produced.
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Since chimeras generated in the first round of blastocyst injection did not produce
germline transmission, further blastocyst injections were performed using a different
clone, 132:65. While the earlier injections were performed in a well established facility
at the Centre for Genome Research, the second round of injections were carried out in
new, unproven facilities at the Department of Neuroscience. Unfortunately, the second
round of injections failed to generate any chimeras and further injections were prevented
by the closure of the Centre for Genome Research animal facility to new mutant lines,
the availability of staff trained to perform blastocyst injection and the deadline for the
completion of this project.
4.8 Discussion
A conditional allele of PSD-95 has been generated using Cre-loxP technology. This
allows PSD-95 to be deleted in a temporally and spatially defined manner such that its
function in specific brain regions can be studied. This may prove particularly useful in
addressing the role of PSD-95 in learning and memory, specifically its role in the
hippocampus.
To generate the conditional allele, the targeting vector was designed, constructed and
electroporated into ES cells. Transient Cre transfection of correctly targeted clones
removed the selection cassette, producing a conditional allele in which the endogenous
locus was disrupted to the absolute minimum. Partial recombinants were selected,
expanded and injected into blastocysts. Clone 132:65 failed to produce chimeras and
chimeras generated from clones 110:88 and 110:26 did not transmit the mutation down
the germline. Potential reasons for the failure of germline transmission are numerous,
however the ES cells were not obviously unhealthy and their chromosome number was
normal (D. Rout - personal communication). Further blastocyst injections, particularly
of clone 132:65, are therefore required.
113
Chapter 5: RESULTS PSD-95 and Halothane Anaesthesia
Chapter 5: RESULTS PSD-95 and Halothane
Anaesthesia
5.1 Introduction
Anaesthesia is defined as unconsciousness, amnesia and immobility in response to
noxious stimuli. Volatile anaesthetics are an important and widely used class of general
anaesthetic, however, their mechanism of action is still not fully understood.
5.1.1 Volatile Anaesthetic Mode of Action
There are two main theories for the action of volatile anaesthetics, both related to their
hydrophobicity. Meyer and Overton observed that the potency of a volatile anaesthetic
correlated with its lipid solubility (Meyer 1899; Overton 1901), solubility and potency
increasing with increasing hydrocarbon length. Anaesthesia has therefore been
proposed to result from changes in membrane function precipitated by anaesthetics
dissolving in the cell membrane. This change in membrane function may take the form
of membrane expansion (increasing in volume) or loss of membrane organisation.
However, the changes in membrane properties induced by physiologically relevant
anaesthetic concentrations are of a magnitude that could also be produced by
temperature changes of <1°C, which do not induce anaesthesia (reviewed by Wann and
MacDonald 1988; Franks and Lieb 1994). Furthermore, the Meyer-Overton correlation
is limited by a cut-off in the size of the anaesthetic, beyond which increasing
hydrocarbon length does not increase potency, despite an increase in lipid solubility.
The lipid theory has therefore fallen from favour and considerable research has been
focused on determining the protein targets of volatile anaesthetics.
5.1.1.1 Effects on Receptors and Ion Channels
The binding of volatile anaesthetics to a protein hydrophobic pocket is now a more
commonly favoured theory. Ligand and voltage gated ion channels have been the focus
of many studies into the action of anaesthetics and GABAa receptors, glycine receptors
and two-pore K+ channels appear to be major targets for volatile anaesthetics
(Wakamori et al. 1991; Harrison et al. 1993; Lin et al. 1993; Patel et al. 1999). The
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existence of anaesthetic binding sites can be inferred from the size cut-off seen with the
Meyer-Overton correlation while further studies provide more convincing evidence: The
action of isoflurane, both in vitro and in vivo, was found to be stereoselective (Franks
and Lieb 1991; Moody et al. 1993; Lysko et al. 1994); halothane and enflurane
preferentially enhanced GABA and glycine receptor currents in primary neurons, with
little effect on glutamate receptor currents (Wakamori et al. 1991) while pi homomeric
GABA receptors expressed in F1EK293 cells were insensitive to isoflurane (Harrison et
al. 1993).
Studies in mutant mice suggest that different volatile anaesthetic targets are important
for distinct anaesthetic end points. The loss of righting reflex (LORR) test is used as a
measure of hypnosis and assesses the ability of the animal to right itself after being
turned on its back during exposure to an anaesthetic agent. The minimum alveolar
concentration (MAC) determines the immobilising effect of an anaesthetic by measuring
the concentration of anaesthetic required to prevent movement in 50% of subjects in
response to a noxious stimulus, such as application of a clamp. Mice deficient in the
AMPA receptor subunit, GluR2, were more sensitive to halothane, isoflurane- and
sevoflurane-induced LORR but were no different from wild type animals when MAC
was tested by tail clamp (Joo et al. 2001). The AMPA receptor is not, however, a major
site of action for volatile anaesthetics. Mice lacking GluR2 exhibited reduced AMPA
receptor-mediated excitatory transmission (Joo et al. 2001), potentially making the
mutants more susceptible to enhanced inhibitory transmission induced by volatile
anaesthetics. The lack of difference in MAC between mutants and wild type animals
was therefore explained by absence of GluR2 subunits from spinal motor neurons (Joo
et al. 2001), mutants maintaining the normal balance of excitatory and inhibitory
influence on these neurons.
Mice lacking the (33 GABAa subunit exhibited reduced sensitivity to enflurane when
tested using tail clamp yet were indistinguishable from wild type animals in the LORR
test (Quinlan et al. 1998). The (33 subunit is widely expressed through the CNS and
knockout animals exhibit a severe phenotype including hyperactivity, incoordination
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and epilepsy (Homanics et al. 1997). In the light of such obvious and widespread
impairment in inhibitory neurotransmission, the lack of LORR phenotype is unlikely to
represent a regional difference in the balance in excitatory and inhibitory influences. It
more likely reflects an important role for (33-containing GABAa receptors in mediating
enflurane effects in the spinal cord, while other mechanisms contribute to its LORR
effect. Thus volatile anaesthetics appear to have multiple, though specific targets
through which they produce multiple anaesthetic end points.
5.1.2 Volatile Anaesthetic Site of Action in the CNS
The multiple effects of anaesthetics (unconsciousness, amnesia and immobility in
response to a noxious stimulus) require them to act in both brain and spinal cord and the
interaction between the two appears to be important.
5.1.2.1 Spinal Cord
The role of different regions of the CNS in anaesthesia is dependent on the anaesthetic
end point being determined. MAC appears to measure primarily spinal reflexes, since
cerebral lesions and hypothermic isolation of spinal cord from the brain does not alter
MAC (Rampil et al. 1993; Todd et al. 1993; Rampil 1994). Additional support for the
importance of the spinal cord over the brain in determining MAC was generated by
elegant experiments exploiting the unique goat cerebral circulation, which utilises only
the external carotid artereies to perfuse brain regions higher than the medulla, venous
blood draining via the external jugular vein. The brain can therefore be isolated and
preferentially perfused by the use of a bypass system such that blood draining from the
external jugular vein is gassed and returned to the carotid artery by means of a peristaltic
pump. In this manner, brain isoflurane concentrations can be altered independent of the
rest of the body. With low torso isoflurane concentrations (0.2-0.3%), the brain
isoflurane concentration required to prevent response was 3%, considerably higher than
the previously observed whole body MAC of 1.3% (Antognini and Schwartz 1993).
Another study in the goat showed low brain isoflurane concentrations to reduce MAC
(Borges and Antognini 1994), suggesting an increase in descending inhibition at low
brain concentrations of isoflurane. However, the brain does not appear to influence
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MAC at higher concentrations of anaesthetic since hypothermic transection of rat spinal
cord had no effect on MAC (Rampil 1994).
5.1.2.2 Brain
The brain is the almost certainly the site of action for anaesthetic-induced amnesia and
unconsciousness, specifically the midbrain reticular formation, thalamus, hippocampus
and cortex. Damage to the reticular formation or thalamus causes unconsciousness
while damage to the cortex produces sensory and motor disturbances, though not loss of
consciousness. As described in the introduction, damage to the hippocampus can cause
antero- and retrograde amnesia, though this brain region is not required for
consciousness, as demonstrated by patients with bilateral hippocampal lesions. There is,
however, evidence that the spinal cord can influence these anaesthesia end-points:
Volatile anaesthetics can decrease spinal cord activity in response to noxious stimuli
(Namiki et al. 1980; Yamauchi et al. 2002) and reduce transmission of noxious
information to the brain (Antognini and Carstens 1999; Antognini et al. 2000), reducing
arousal and thus the level of consciousness. This is supported by decreased hypnotic
requirements observed in patients under epidural anaesthesia (Tverskoy et al. 1996).
5.2 PSD-95 Deletion Mutants Are More Sensitive to
Halothane
PSD-95 is expressed in the spinal cord and is required for NMDA-dependent processes
in the spinal cord, such as generation of NMDA- and peripheral nerve crush-induced
thermal hyperalgesia (Tao et al. 2000; Garry et al. 2001). Halothane has been reported
to bind PSD-95 (R. A. Johns - personal communication) and antisense reduction of
PSD-95 protein levels in the rat spinal cord reduced the MAC of a closely related
volatile anaestheitc, isoflurane (Tao and Johns 2001). PSD-95 therefore appears to be a
target for volatile anaesthetics and is involved in anaesthesia endpoints dependent on
primarily spinal processes. However, the study by Tao and coworkers (2001) could not
address the role of PSD-95 in other anaesthetic processes that require the brain.
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To assess the anaesthesia phenotype of PSD-95 deletion mutant mice and to determine
the involvement of PSD-95 in anaesthetic endpoints other than MAC, the animals were
tested for LORR in response to halothane. Since the LORR test requires motor
coordination, it should be noted that PSD-95 deletion mutant mice do not exhibit overt
motor dysfunction and their righting reflex is indistinguishable from littermate controls
in the absence of anaesthesia.
Temperature and CO2 concentration can affect anaesthetic requirements, thus both were
carefully monitored and maintained within narrow ranges: 33.5±1.0°C, maximum C02
0.3kPa. In four experiments rectal temperature was monitored. Mouse rectal
temperature was stable at 36.9±0.3°C for at least 10 min, the internal temperature of any
one mouse not varying by more than 0.3°C over that time.
LORR was tested at a range of concentrations and the dose-response curve plotted (Fig.
5.1). The PSD-95 deletion mutants were significantly (P<0.05) more sensitive to
halothane, exhibiting a 23% reduction in EC50 (wild type EC50 1.23%, PSD-957" EC50
0.95%). Thus PSD-95 appears to affect anaesthetic requirements for both MAC (Tao
2001) and LORR, in contrast to other studies of knockout mice, which have showed
altered sensitivity either MAC or LORR tests, but not both.
5.3 Halothane Does Not Alter PSD-95 binding to Receptors
and Ion Channels
Studies of anaesthetics usually focus on their action on voltage or ligand gated ion
channels. Since PSD-95 associates with a number of receptors and ion channels, it
seemed pertinent to address whether halothane might alter these interactions. Therefore,
the effect of halothane on PSD-95 associations was assessed, focusing on 3 well-
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The effect of halothane on PSD-95 interactions was determined by immunoprecipitation
of brain homogenate from anaesthetised and non-anaesthetised wild type mice.
Anaesthetised mice were maintained in approximately 2.2% halothane for 10 min after
they had stopped moving. Both anaesthetised and non-anaesthetised mice were killed,
their brains rapidly removed and homogenised on ice. Immunoprecipitation was
performed using antibodies to the channel or receptor of interest and the resulting
Western blot probed with an anti-PSD-95 antibody.
In some blots loading was not uniform, but using the IgG band to gauge loading
differences, it was clear that there was no difference in the association of PSD-95 with
NR2B-containing NMDA receptors, KA2-containing kainite receptors or Kvl.4
channels (Fig. 5.2). Halothane therefore does not alter these interactions, although this
does not rule out the disruption of other PSD-95 binding activities.
5.4 Discussion
The increased sensitivity observed in PSD-95 deletion mutants may reflect a
phenomenon specific to halothane and related volatile anaesthetics, consistent with a
specific binding site being influenced in the PSD-95 deletion mutant. PSD-95 itself
may be acting as a halothane binding site, or PSD-95 may mask a halothane binding site
on an ion channel, such that halothane and PSD-95 binding to a specific target is
mutually exclusive. Another possibility is that loss of PSD-95 may produce a general
alteration in neuronal physiology that increases sensitivity to all anaesthetics. To
address these possibilities, PSD-95 deletion mutants should be tested with different
classes of anaesthetics, for example barbiturates and ketamine. A general physiological
alteration would be supported if PSD-95 deletion mutants are more sensitive to all
classes of anaesthetic, however, PSD-95 may be implicated as a specific site of action
for halothane if PSD-95 deletion mutants are more sensitive to only halothane, but not
other classes of anaesthetic.
It should be noted that there is a clearly demonstrated genetic basis for anaesthetic






























































Figure 5.2 The effect of halothane on PSD-95 binding activity. PSD-95
(marked with arrowhead) immunoprecipitated with the NR2B NMDA receptor
subunit, the KA2 kainate receptor subunit or the Kvl.4 potassium channel is
unaffected by halothane anaesthesia when loading differences are gauged by the
strength of signal from the IgG band (marked with asterisk). Immunoprecipitations
(IP) were performed with NR2B, Kvl.4 or KA2 antibodies and immunoblots (IB)
were performed with a PSD-95 antibody. Protein size markers (KDa) are
displayed at the right of each blot. 4 wild type mice were used, 2 exposed exposed
to halothane (halothane +) and 2 not (halothane -), each lane showing an IP from
an individual mouse brain.
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increased sensitivity of PSD-95 deletion mutants resulted not from the PSD-95
mutation, but from co-segregation of linked genes. However, when sensitive and
resistant lines were intercrossed, the offspring exhibited an intermediate anaesthetic
sensitivity, implying that the phenotype was under the control of more than one gene
(Koblin and Eger 1981) and so unlikely to explain the phenotype of PSD-95 deletion
mutants.
PSD-95 therefore appears to play an important role in determining anaesthetic
sensitivity of different anaesthesia end points. Considering the learning deficits in PSD-
95 deletion mutant mice, it would be interesting to also study the role of PSD-95 in the




The assembly and regulation of NRC components may play an important role in
producing appropriate neuronal adaptations to stimuli such as those that generate
synaptic plasticity. Many mechanisms involved in synaptic plasticity are also important
for behavioural tests of learning, so synaptic plasticity appears to be a reasonable in
vitro model of learning and memory. PSD-95 is an adaptor protein that interacts with a
number of proteins important in synaptic plasticity and learning, including the NMDA
receptor. PSD-95 can physically cluster components of NMDA receptor-stimulated
signal transduction pathways to this receptor. This function of PSD-95 may be
important since in Drosophila another adaptor protein, INAD, is required for
phototranduction in the eye. Mutation of inaD results in profound phototransduction
signalling defects and mislocalisation of complex constituents (Tsunoda et al. 1997).
Mutation of PSD-95 in the mouse results in altered synaptic plasticity and profound
defects in learning and memory. Localisation and channel function of the NMDA
receptor is normal, therefore it is believed the phenotype results from altered signalling
downstream of the NMDA receptor. This is supported by observations in stimulated
hippocampal slices that CaMKH activation is greater in PSD-95 deletion mutants than
slices from wild type animals.
6.1 The PSD-95 Conditional Allele
A conditional PSD-95 targeting vector was designed, constructed and targeted to the
PSD-95 locus in ES cells. ES cell clones were injected into blastocysts to generate
chimeric animals, however, the mutation was not transmitted through the germline.
6.1.1 Possible Reasons Why Germline Transmission of the
Conditional PSD-95 Allele Did Not Occur
The existence of the PSD-95 deletion mutant implies that mutation of PSD-95 does not
prevent the establishment of mutant mouse lines. In addition, the conditional PSD-95
allele was designed such that PSD-95 gene function should not be affected by the
insertion of loxP sites. This may not necessarily be the case though, since some
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functions of PSD-95 may have been maintained in the PSD-95 deletion mutant through
the expression of the truncated protein containing PDZ domains 1 and 2. Furthermore,
the loxP sites that make up the conditional PSD-95 allele may have been inserted into an
enhancer element, interfering with PSD-95 transcription in a manner that produced a
constitutive null allele. Thus, the PSD-95 conditional allele may not have been
transmitted because the gene was inactivated and PSD-95 is required for either
spermatogenesis or embryonic development. However, PSD-95 protein was only
detected at postnatal stages of development (Cho et al. 1992; Sans et al. 2000) arguing
against a role for PSD-95 in embryonic development, while PSD-95 expression was not
detected in the testes (Cho et al. 1992; Kistner et al. 1993) making it unlikely that PSD-
95 was required for spermatogenesis.
Interfering with PSD-95 gene function was therefore unlikely to be the reason for the
PSD-95 conditional allele not being transmitted through the germline, however,
targeting the PSD-95 locus with loxP sites might have interfered with the expression of
a distant gene that was required for embryogenesis or spermatogenesis. Enhancer
elements control gene expression but may be located either 5' or 3' to the gene's
promotor at sites that can be many kb distant (reviewed by Blackwood and Kadonaga
1998). The insertion of loxP sites into the PSD-95 locus may therefore have disrupted
an enhancer element controlling the transcription of another gene necessary for
spermatogenesis or embryogenesis and thereby prevented transmission of the mutation.
It is perhaps more likely that the pluripotency of the ES cells influenced the transmission
of mutations through the germline. ES cells were grown in the cytokine DIA/LIF to
maintain them in an undifferentiated state, sustaining their pluripotency. When injected
into a blastocyst, pluripotent ES cells should have contributed to all tissues, including
the germ cells, however, culturing ES cells in DIA/LIF does not guarantee their
pluripotency. It is therefore possible that the ES cells carrying the conditional PSD-95
allele were unable to contribute to the germ cells of the testes, although little
differentiation was observed in ES cell clones used for blastocyst injection based on
observation of their morphology.
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Only 2 fertile chimeras were generated from ES cells carrying the PSD-95 conditional
allele, both derived from a single ES cell clone, 110:88. It is possible that targeted ES
cells simply did not contribute to the germ cells in these chimeras and that generation of
more chimeras will result ES cell contribution to the germ cells and the establishment of
a conditional PSD-95 mouse line. Generation of chimeras using additional targeted
clones (110:26, 110:2, 132:65, 132:17 and 132:42) is also required to address whether
an intrinsic problem existed with the previously injected clones; this may be due to
either the genetic alteration itself or because the ES cell clones used previously were no
longer pluripotent. Even if clone 110:88 was no longer pluripotent, it is likely that
independently derived clones, such as 132:65, 132:17 or 132:42, maintained their
pluripotency and will therefore be competent to generate conditional PSD-95 mouse
lines.
6.1.2 Analysis of PSD-95 Expression in Conditional and Knockout
Alleles
An initial experiment to perform with psD-95flox/flox mice would be to cross them with
Cre deleter transgenic mice. Cre deleter mice express Cre in all tissues from an early
embryonic age by driving Cre with a constitutive promotor such as the cytomagalovirus
promotor (Schwenk et al. 1995). In the presence of Cre, loxP sites are recombined,
therefore a PSD-95,lox/flox mouse carrying the Cre deleter transgene would represent a
ubiquitous null allele (PSD-95~A). To analyse PSD-95 expression in PSD-951 and PSD-
gcjfiox/fiox mjce^ brajn tissue would be taken from these animals and compared with tissue
from wild type mice by Western blotting, Northern blotting and/or RT-PCR. These
analyses would answer 2 basic questions:
1) Does the conditional allele affect normal PSD-95 expression?
The placement of loxP sites in the PSD-95 targeting vector was carefully
considered to avoid interfering with spice donor or splice acceptor sequences.
Therefore, one would not expect the loxP sites to alter PSD-95 expression in
PSD-9^loxJflox mice; expression levels should be comparable between PSD-
g^iox/flox ancj wj]^ type animals.
2) Is the knockout allele a null allele?
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Following recombination of the loxP sites flanking exons 3-8, a frameshift
would be produced, resulting in a stop codon being encoded by exon 9. The
major transcript (PSD-95a) generated following recombination would be 56
amino acids in length and probably unstable. Although unlikely, it is possible
that the transcriptional machinery could splice to a different exon 3' to the
deleted region (exons 3-8), however, only exons 13 and 17 are in frame with
exon 2. Splicing to exon 13 would produce a protein encoding the N-terminus
and GK domain while splicing to exon 17 would encode the N-terminus and the
C-terminal portion of the GK domain. Northern blotting and RT-PCR would
probably only identify transcripts that spliced to exon 9 and Western blotting
would determine if the potential 56 amino acid protein product was stable.
6.1.3 Studying Synaptic Plasticity and Learning using PSD-95
Conditional Mutants
The main aim of this thesis was the generation of a conditional PSD-95 allele that would
allow the role of PSD-95 to be studied in greater depth, particularly its involvement in
learning and memory. How could conditional PSD-95 (PSD-95flox/-fJ"x) mutants be used?
6.1.3.1 Comparison of Ubiquitous Null Allele Mice with PSD-95 Deletion
Mutants
PSD-95 deletion mice were found to express a truncated form of PSD-95 containing
PDZ domains 1 and 2. The truncated protein was expressed at <20% the level of the
normal protein, was not found in synaptic fractions of brain homogenate preparations
(Migaud et al. 1998) and was therefore thought not to be functional. However, it
remained a formal possibility that the truncated protein acted in a dominant negative
manner. Ubiquitous null allele PSD-95~/~ mice would be able to directly address this
issue.
Comparing the performance of PSD-95 deletion mutants and PSD-95'A mice in the
water maze could determine the contribution of the truncated protein to the phenotype of
the PSD-95 deletion mutants. If the truncated protein were inert, PSD-95 deletion
mutants and PSD-95'A mice would exhibit similar learning deficits in the water maze.
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However, if the truncated PSD-95 protein were acting in a dominant negative manner,
one would expect the PSD-95 deletion mutants to exhibit a more severe learning deficit
than PSD-95'A mice. Hippocampal synaptic plasticity could also be compared in slice
derived from PSD-95 deletion mutants and PSD-95'A mice. Again, similar phenotypes
in PSD-95 deletion mutants and PSD-95~A mice would be expected if the truncated
protein were inert.
In both behavioural and electrophysiological paradigms, control animals should include
wild type animals, PSD-95+/+ mice carrying the Cre transgene and PSD-95th>xJflox mice
that do not carry the Cre transgene. These controls would test whether the Cre
transgene, or the floxed PSD-95 allele affects either learning or synaptic plasticity.
Either PSD-95+/+ mice carrying the Cre transgene or PSD-95llox/J1"x mice would not be
expected to differ from wild type animals, as was seen in CA1-restricted NR1 knockout
mice (Tsien et al. 1996).
6.1.3.2 A Hippocampal-Dependent Role for PSD-95?
The hippocampus has been shown to be required for spatial learning and it would
therefore be interesting to test the importance of PSD-95 in this brain region by
knocking out PSD-95 specifically in the hippocampus (.PSD-95hipp). The phenotype of
such a regional-specific knockout could then be compared with the ubiquitous PSD-95'A
null mutant.
Generating PSD-95lupp mutants would require hippocampal-specific Cre expression.
One way to achieve this would be by crossing psD-95,loxyjlox mice with transgenic mice
that preferentially express Cre in the hippocampus. In house, Cre-Prl mice are
available that exhibit hippocampal-specific Cre expression, using the aCaMKII
promotor to drive Cre expression. Another method that might be used would be to
stereotactically inject Cre-expressing adenovirus into the hippocampus of PSD-95fl"x/flox
mice.




1) PSD-95hipp mutants are indistinguishable from ubiquitous mutants, displaying
profoundly impaired learning, indicating that PSD-95 is required only for
hippocampal-dependent plasticity and learning processes.
2) PSD-95hipp mutants exhibit a similar, but less extreme phenotype than
ubiquitous mutants, indicating that other brain regions are also involved in the
performance of mutants in learning paradigms.
3) PSD-95hipp mutants learn normally indicating that the ubiquitous mutant
phenotype is not due to hippocampal dysfunction but rather some other
behavioural system is affected.
The first 2 possibilities would be the most probable outcomes. Control experiments
performed with PSD-95 deletion mutants in the water maze (visual platform training)
did not identify motor or visual deficits (Migaud et al. 1998), therefore it would be
unlikely that their poor performance was entirely independent of the hippocampus.
However, without a hippocampal-specific knockout of PSD-95, the contribution of other
brain regions to the phenotype cannot be assessed and so outcome 3 remains a formal
possibility.
6.1.3.3 The Role of PSD-95 in Synaptic Plasticity: Pre- or Postsynaptic?
Enhanced LTP was observed in the hippocampi of PSD-95 deletion mutants, however,
these animal could not address whether the role of PSD-95 was more important pre- or
postsynaptically, or if PSD-95 was equally important in both pre- and postsynaptic
neurons. It might be expected that PSD-95 would have a more important role
postsynaptically since it is enriched in the PSD.
Stereotactic injection could deliver Cre-expressing adenovirus specifically to the CA3
or CA1 regions of the hippocampus, knocking out PSD-95 in these regions and
generating PSD-95CA3 or PSD-95CAI mutants respectively. Alternatively, pSD-95^ox/Jlox
mice could be crossed with CA1- and CA3-specific Cre-expressing transgenic mice
such as the T29-1 (Tsien et al. 1996) and G32-4 (Nakazawa et al. 2002) lines
respectively. Hippocampi from subregion-specific knockout animals could then be used
for synaptic plasticity experiments. Synaptic plasticity in the CA1 region would be
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induced by placing stimulation electrodes in the CA3 region (presynaptic) and recording
electrodes placed in the CA1 region (postsynaptic). A comparison of PSD-95CA3 and
PSD-95CA1 synaptic plasticity phenotypes would allow the contribution of pre- and
postsynaptic PSD-95 to be assessed.
6.1.3.4 A Role for PSD-95 in Encoding and Retrieval ofMemories?
There are considered to be 3 phases of learning: encoding, consolidation and retrieval.
Encoding is the initial laying down of a memory, while consolidation is the phase in
which pertinent memories are strengthened. Retrieval is the use of a memory, for
instance, to find a hidden platform.
Encoding of spatial memories has been shown to be NMDA receptor dependent (Morris
et al. 1986; Morris 1989), however, retrieval did not require NMDA receptor activity
(Morris 1989). It is therefore likely that PSD-95 plays an important role in the encoding
phase, however, the binding of PSD-95 to other proteins may also make it important in
retrieval. The temporal control possible with PSD-95fh>x/fh'x mutants can be exploited to
ask whether PSD-95 is required for encoding or retrieval or both.
Temporal control of PSD-95 ablation could be achieved by crossing psD-95ftox/Jlox mice
with Cre transgenics that express a Cre-steroid binding domain fusion protein.
Application of a synthetic ligand would activate Cre, inducing the deletion of PSD-95.
Using the water maze, this system could knockout PSD-95 either prior to spatial training
(encoding) or after training but before the transfer test (retrieval). In this way, the role
of PSD-95 in encoding and retrieval could be investigated. An alternative method to
knockout PSD-95 with reasonable temporal control would be to deliver Cre-expressing
adenovirus to the hippocampus either before encoding or retrieval.
6.2 PSD-95 and Anaesthesia
General anaesthetics must act on both spinal cord and brain to induce anaesthesia, which
is described as loss of consciousness, amnesia and immobility in response to noxious
stimuli. The multiple effects of anaesthetics make it unlikely that a single protein target
mediates their action, although mice carrying mutations in single genes have exhibited
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differing sensitivities to anaesthetic agents. The increased sensitivity of GluR2
knockout mice to volatile anaesthetics in the LORR tests was explained by an imbalance
between excitatory and inhibitory transmission, unmasked by the anaesthetic. In PSD-
95 deletion mice, no obvious imbalances were observed (Migaud et al. 1998), therefore
PSD-95 may have acted as a specific target for halothane-related anaesthetics; halothane
might have stimulated the dissociation of PSD-95 from a receptor or channel, altering
the function of that protein in a manner that contributed to anaesthesia. Alternatively,
PSD-95 may have masked a halothane binding site on an ion channel, such that the
binding site only became available with the dissociation of PSD-95 from the ion
channel. In the absence of PSD-95, this halothane binding site would be constitutively
unmasked, possibly explaining the reduced anaesthetic requirements observed in PSD-
95 mice and following antisense knockdown (Tao and Johns 2001), determined by
LORR and MAC respectively. In light of the profound learning deficit in PSD-95
deletion mutant mice, it is also tempting to speculate that halothane and PSD-95 might
interact to influence the amnesia component of anaesthesia.
The brain regions important in the induction of anaesthesia have not yet been well
defined. PSD-95lh,x/l}ux mice could be used to elucidate the brain regions that mediated
the increased halothane sensitivity in the LORR test observed in PSD-95 deletion
mutants. PSD-95 could be systematically knocked out in candidate brain regions such
as the midbrain reticular formation and the thalamus and the mice then analysed in the
LORR test. To produce such regional-specific knockouts, Cre-expressing adenovirus
would be stereotactically injected into target brain regions of PSD-95flox/flox mice.
In summary, murine PSD-95 was cloned, characterised and novel mouse PSD-95
variants identified. A conditional PSD-95 allele was generated that will allow the role
of PSD-95 to be studied in much greater detail. The capacity for temporal and/or
regional control over PSD-95 ablation engendered by this conditional allele will
facilitate interesting studies of the involvement of PSD-95 in synaptic plasticity,
learning and anaesthesia.
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Appendix 2: Sequence of SacI (20) subclone
Appendix 2: Sequence of SacI (20) subclone
al, (31, (31' and (31" exons are highlighted in dark blue, yl exon is highlighted in light
blue.
1 GCAGCCCGGG GGATCCACTA GTTCTAGAGC GGCCGCCACC GCGGTGGAGC TCTGGTCATC
61 CCTTACCTCA AAGAACCGGG CCACTGGTCC CACCAGCTCT TTGAGAAATT GTGCCTGTTC
121 TTCACTGAGC ACTGTATAAT GGGAGAGAAG AGCAGGCTAG TCAGGCAGAG AGGGCTCCCC
181 TGCCCACACT GTCAGTGACT GACTAAGCCT TTACTTACCA GATGGGTATG GGAACACCTG
241 ATCAATGGTA AGCTGGCCTT TGAACATCCC CACAGCAAAG GACTTCGATT CCTAGGCAAG
301 GAAGGAAAGG ATCTTAGGTG GGTGCCTGGG GTGATTCTAC TCCTGGTTTT TAAGTGTCAG
361 TCCAGTTTCC AGTCACTTAC TGCCCTGGCT GGTTTTTCTC TGGTGGAAGC ATCAGAGGAG
421 AGGGTTTCTG GCTTGTCCAG AACTGCCTGG AGGGAAGGGC AGAGCAGTTA GGCTGGAGAT
481 GGGTCTTAAA AGGTGTGCAG GAAGCGCTAG CTCTAGGAAG TGCGTTTGGT GCATGTTCCA
541 TTACTTTCTC ACTAGGGCAC CCTGGCGTGC CCTTTCCCCT ACTTTCAGTG ACAGAACTGC
601 CACCAGGTGA CTGGGTCGAA GAGAGAGACC CCTGTCGGTC GCAGGCTAGT GGGAACTGGC
661 AACTCGCATT TCTACGTCCG TCTCCCTCAT CCACTGTCAC TTACCTGAGT GGCCTCCCTG
721 GCATAAAGTC GCTGGGCAGA GATAGGCCGG GGTTGTCCCT GAAGCACAGT AGTAGATCGC
781 GAGCTGTAAG GAGTCGGGGT TCAAGTTCTG CCCTGGTTCC CANACCCAGT GTCCCCTTGC
841 TATATACGGA CCTTCGGGCC CCCAGCCGCA GCAGCTGTCG CCCCACACTC GGGGTCATCC
901 GAGCCGACTG CATCTCCAAA GCCGCCGCCG AAGTCTTGAC CACTGACCTC TTCTCTTCGC
961 GTCTCGCCTG CCCAAAGGTT GTGTGTCTGG GCCCTGACTC ATGCTCCACA ATGCACTGCG
1021 TGGTGGGGGC GTGGTCTTGG GCCTCNATGC ATGGTGGGAG CTGAAGTTCC NACGTGTGCC
1081 CGGTCCCTGT ATTCTACCTG ACCTAGGGTG ATCCATCTTC AAACGATCCG TTTTCTTTCC
1141 CAAACTCTAT AGAGCCGCTG GTCTAAACTA AAGTCTGATC CACTAAAAAG GGAAGAGATT
1201 AGATAAGAGA AGGAAGAATT AAATGACTAG AAGGTTGGAG GTAGACTGGA GGGAGGACTT
1261 CCTAGCTAAA GTTAAAAGAG AGAAAGGAAA ATATCAGATG CAGAGACCTG GATTATAAGG
1321 AAAAAAATTC TCCTTCAAAT AAAGAGGGGC CGTGAGGTGG CANACTCAAG CTGGGGTGTN
1381 CTCTAAGCGA ATTCTGAGAT CTAGAAGATT TCACCAACTT AAAACACTTC TNAAAGCGCG
1441 TAGTAGGCAC CTCTAGTCTC TCATGGACTT TGGGAGATAA TAAATCACGA TCACTATGAA
1501 TTTGANGCCA CATATACCCT GCTNGAGTGA NGACTCCAAA TACATAAGTC TTAGGAAATG
1561 AATACTTTTT TTTAAAAAAG AACTTTATGT GTGTCTCTGT GTGTCTGTAT ATTAACCGTG
1621 TGCACATGGG TGCANTGCCT ATTGATACAN NANACCAGAA GCTGTGGAGC TGGAGGGAAG
1681 TTGTGAGTCT CCCGACGTGG TTGCTGAGAA CAGAACTAAG GTCCTCTGGA AGAGCAAAAT
1741 GCATCGTGTG TGTGTNGTAT GGTTTTTGTT GTTGTTGGAG GAGGTTTGTT TTTCTGAGAC
1801 AGGGTTTCTC TGTGTAGCCC TGACTGTCCT GGAACTTACT CTGTAAACAA GACTGGTCTT
1861 GAACTCAGAA ATCTGCCTGC CTCTCCTTCC CAAGTACTGG GATTAAAGGT GTGCGCCACC
1921 ACTGCCAGGC TAGTTTTTTT GTTTGTTTGT TTTTTAATTT ATGTATGTGA GTACACTGTA
1981 GCTGTCCTCA GACACATCAN AAGAGGGCAT CGGATCCCAT TATAGATGGC TGTGAGCCAC
2041 AATGTGGTTG CTGGGTATTG AACTCAGGGC CTCTGGAAGA GCAGTCAGTG CTTTTAACCC
2101 CTGAGACATC TCTCCAGCCC TCCCTTTTTT TTTTTTTTTT TTAGGCTTTA AAGGTTTATT
2161 TTAAAATTTT TATATATATG AGTGTTTTGG GTGTATATAT ATATATATAT ATATATATAT
2221 ATATANCCCA CCAAGGTCAG AAGAAGGCAT TAGATCACCT GCAACTGGAA TTACATACAG
2281 TTAGCTGTAC ACTGCCATGT ATGTGGACAC TGGAGACTGA ACACAAGTCC TCTGCCTAAG
2341 AGCAACGCAT GCTCTGATTG CTGAGCTGTC TTGAACCTCA TCTAAAAGTC TGCTTATGCG
2401 AGTGTGCACT CACATAAGCC CTTATCAGAA GACAACTTCC AATAGTTCTC TCCACATTTA
2461 TGTGGGTCCC TGATGACAGG CTTGGCAGTG AGTTCCTTTA CTCAGTGAGC CATGTCACTG
2521 CCCCCGACCC CTTCTCAGTA TGGTCAGGCC TGGGGAGAAA AAGAGCTTAA CTCTGGGTTG
2581 CTGGGACTGC CTTAAATAAA ATCCTCTTTC CCACTCACAG AAAAGCAGCT AAATTATGCC
2641 TGGCATTTGG GAAGGNNCAC TATGCGGAGC AAAGTGTTAC CTGGNGACCT GGGGAAGAAT
exon j31
2701 GGAATCTAGA CCGATTGTCC ACTTTACTAG CTACAACTGC GTAGGCTGAA
2761 ICTTCAATCTT GGCGGATTAG ggaqattaaa TGGAGAGAAG AGAGATGTCC CAGAGACCAAi
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GCCATCTCCA ACCCCCCCCA CCCCACTCCC CCGCCACGGC CCCTAGCCCC TGGCCGTTTG
GCAAGACCCC CGCATACCCC GGGGCTTCCC GAAATCCAGT TCCCCTCCGC CATCCCAGCT
CATGCCCCAG CCCCAGAACT CCGGGGCTGC CAGGCCCCTG TGCCCCTACC CCTCCTGAGi
ATCGGGGTGT GCTCCTCAAG CCCGCTGCCC TCCACTGGGG AGCCCCTTTT AGGGTCCCCC
CTCCCTTCCA CGCTCCCCTA CCCTTCTCTT CTCCAACCTT CTCCTTCCGC TGTCACCCCTi
CCCCCCATCC TGGCCCCCCC TGCAAAAGTG GGGTGCGGAG GGGGGAGGGG TGAGAACCG
CCGAGGGGAG GAACAAAACT GCAATGAAGT CAGAGCCCCC TACTGGCCGC CGGGGCCAGO





























































































































Appendix 2: Sequence of SacI (20) subclone
5761 cgtgtgagtc acaggctggg gagggggtta tatttagtgg gaactgcagc ttcttatggg
5821 aggaagctga ggacacacat gttccttgcc acaaactcac acatgtgtat acacatgcat
5881 tgtgcacgtg tggacatgat tanagactgg ggactgaaga ctttagttct gtatccctca
5941 ccccatctac agggctgctt gtttttctac tggtctgtgg gttttgggcg ttcttccagg
6001 ttgctggctc tctcatcccc tgtagttttc agtacatttt tgtgcctcag ttcttctggc
6061 cctctttcag tcagtgtctg cctgtgctct ttgtgtctct tgtccttagg cctaatcntt
6121 ggccttggca acntaacttg tcatcacctt tgtgcagata ggaaacccat tggaatatgt
6181 gggttctcct aacgcatgag cacatgaaat ccagtaaggg tgaggggctc cgcagcactg
6241 gttaactatt ctgggtggat gcatttattc atttttctgc cccaaattcc tgtgtgttcg
6301 atggagcaca tgattgagca gccctgaagg taggaggctt gtagagagga tcatatgcat
6361 tcgggtctta ctggtttgga gacccaggtt tgccacattc attggccaga aaacttgtca
6421 gcctcaggat ggagggactc caactcccat aaggccttga ggtactagat ccttcaatgg
6481 tagcgtgtgg ttgtccactg gactgttggg agttgtggtt cctctcnatc caggccagtg
6541 gagggtggcc caggaccaac cagcaggggg cacatggctt ctgccctccg caaatgntgg
6601 ggagtgggat taggagtgnt cagcctttgt agtcaccgag ctccaattcg ccctn
135
Appendix 3: Illustrated PSD-95a cDNA
Appendix 3: Illustrated PSD-95a cDNA
The published PSD-95a cDNA is shown (Genbank Acc. No. D50621) with residue number
labelled on the right. PDZ domains are highlighted in green, the SH3 domain is highlighted in
yellow and the GK domain is highlighted in pink. Start and stop codons are underlined and in
bold. Forward primers are highlighted in blue and labelled in black, reverse primers are boxed
in red and labelled in red. Intron-exon boundaries are marked by a vertical black line.
5' start 5" start rev 2
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Appendix 4: Primer sequences
Appendix 4: Primer sequences
pBluescript KSII Primers
t3 KSII 5' CCAAGCTCGAAATTAACCCTCAC 3'
t7 KSII 5' GCCAGTGAATTGTAATACGACTCAC 3'
PSD-95 Forward Primers
4 For 1 5' GGTGTGGGAGGTTCTTGTTCTGG 3'
5' Kpn For 5' TGCTGTCACCCCCTAAATGCCG 3'
5' Start 5' AACTCCAATGAAGTCAGAGC 3'
20 For 1 5' GTGTCAGTCCAGTTTCCAGTC 3'
20 For 2 5' GTTCAAGTTCTGCCCTGGTTCC 3'
20 For 3 5' AGAAGGTTGGAGGTAGACTGGAGG 3'
20 For 4 5' GCTGGAGGGAAGTTGTGAGTC 3'
20 For 5 5' GACACATCAGAAGAGGGCATCG 3'
20 For 6 5' TAAAAGTCTGCTTATGCGAGTGTG 3'
20 For 7 5' CGAGAGAAGAGAGATGTCCCAGAG 3'
20 For 8 5' TGACACACAGAAGCCAGGGGTAG 3'
20 For 9 5' ATTCTCTACTGCCAGCCCCTCC 3'
20 For 10 5' TTATCCGGGTTCCTGCCAGC 3'
631-9 For 5' GCTAGAGGATGTCATGCATG 3'
A8643 5' AACCAAGGCGGATCGTGATCCA 3'
AGAP For 5' GATTCAGCTAGAGACCATG 3'
Exon 2 For 5' GCTACCAAGATGAAGACACG 3'
GK For 5' AGAGTAATAGCCATTCGACCGGAAGATC 3'
Int 1 For 5' TGGCTTGGTGAGCTTTAGTG 3'
Int 1 For 3 5' AAGGTGTAGGAAGAGGGCAGG 3'
Int 1 For 4 5' GGTCTGTGGGTTTTGGGCG 3'
Int 1 For 5 5' CCAGGTTTGCCACATTCATTG 3'
Int 2 For 1 5' TGGGGGAAAAGATGGGGTG 3'
LP3 Rev 5' GTGTTCTAAACGTAAGCCTGTCTG 3'
LR For 1 5' GAGCAGCTTTCTCCCACTCCGTCC 3'
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Sac 1 For 1
Sac 1 For 2
Sac 1 For 3
Sac 1 For 3a
Sub O For













Hu Exon 2 For











































Sac 1 Rev 1
Sac 1 Rev 2
Sac 20 Rev














Sall-NotI polylinker top 5' TCGACGAATTCGGATCCCGGAAGATCTGC 3'
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